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Abstract 
Heart disease is a serious health problem that affects numerous patients 
worldwide. The reliable methods for the severe cases are mainly limited to the heart 
transplantation which is restricted by very limited number of available donor heart. 
The Ventricular assist device (VAD) have been a promising option to support a 
patient, for its versatility to be used in both short and long term, while also possible 
to be removed if the heart is recovered. However, it still suffer from many device 
complications in both term of mechanical failure and damaging of red blood cell 
especially in long term support. The situation is worse in the patients who developed 
bi-ventricular failure in which normally two VADs are required for supporting each 
ventricle that leads to more difficulty for device managements and more limited 
available device. 
This thesis is aimed to solve both the reliability problem and the lack of the 
device for supporting biventricular failure. This was done by proposing the concept 
design of an innovative BiVAD and the use of the computational fluid dynamics 
(CFD) to the development of this new device. CFD was used as a main development 
tool to analyse the flow and pump performance and predict the risk of hemodynamic 
related issue from the early stage of development. The new VAD is a high efficiency 
pump that offer long term support to both ventricle with a single module.      
In this thesis the new design of BiVAD was split for individual analysis on 
LVAD and RVAD functions and was extensively analysed by CFD for its efficiency 
under different low condition of the CHF patients. The hydraulic performance was 
predicted, and the blood damage was estimated from the shear stress information 
obtained from the simulation results. Flow visualisation was used to identify the area 
that have risk of forming thrombosis and possible design correction. Combining 
these information, the pump design was optimised and a prototype was created for 
the experimental evaluation. 
The human mock circulation loop which capable of simulating the pulse flow 
environment and the heart failure condition was specifically designed for this pump 
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testing. The pump was tested in both steady flow to identify the pump characteristic 
and the pulse flow to observe its performance in its real working condition.  
The successful development of this pump and CFD analysis method will 
provide useful techniques in the heart pump development that improve the pump 
performance and reduce the risk of device complications, while also reduce the lead 
time and cost of development. The newly designed heart pump can be developed 
further through later phase of development on animal and clinical trials. Then it will 
able to use for long term support of bi-ventricular failure patient so they no longer 
rely to the limited donor heart supply. 
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 Introduction 
Heart failure is one of the cardiovascular diseases and is a major global health 
concern because of its fatality and the rapidly growing number of diagnosed patients. 
Although there are many treatments available for different degrees of heart failure, 
the only reliable approach for severe cases is heart transplantation. However, the 
availability of this treatment is restricted mainly by the very limited number of heart 
donors, hence only a handful of patients receive transplantations each year.  
A Ventricular Assist Device (VAD) has been developed to address this heart 
shortage problem by providing support to sustain patients while they are waiting for 
donor hearts to become available, or even to use as a permanent support if 
transplantation is not possible. The results for VADs in clinical studies have 
confirmed the viability of the devices for long term support in improving the quality 
of life and in increasing the survival rate compared with the optimal medical 
treatment (Rose, Gelijns, & Moskowitz, 2001). Despite the better performances of 
VADs over optimal medical therapies in many long terms trials, there are two main 
problems related to the devices’performance and structure that are still a major 
concern and limit the use of these devices.  
The first problem involves biventricular support which is used to provide 
support when both ventricles of a patient have failed. Most pump designs are aimed 
for the left ventricle support function as it is the most common case of heart failure. 
Consequently, there are fewer choices of pumps available for patients with 
biventricular failure as it requires pumps that can function in the left and right flow 
environments. Two pumps need to be implanted, one for each ventricle, and operated 
at the same time. Transplanting two pumps into a patient leads to a complex control 
system and additional drivelines, and more space is needed for the implantation. 
Therefore, the development of a bi-ventricular assist device (BiVAD or BVAD) 
within a single module could be the solution for reducing the complications of an 
additional device being needed for biventricular failure patients.  
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The second problem is related to the durability and hemodynamic performance of the 
pump. There are reports of a significant number of adverse cases arising from device 
complications that cause serious issues such as blood damage, blood clots and 
mechanical failure. These problems are major concerns for pump development and 
need to be addressed during the pump design phase. However, to develop a heart 
pump that could achieve the performance requirements with the minimum 
mechanical and hemodynamics complications, several design selections, 
optimizations and an experimental analysis need to be conducted. These processes 
are generally costly and time consuming, which results in a long development time 
for the pump before it could become available for clinical use and it makes the 
device too expensive to be widely accessible for patients. 
To solve these two problems, an innovative BiVAD was designed with a 
unique structure that incorporates two identical sets of rotors and stators for the left 
and right ventricles in a single pump unit. The rotors were designed to operate 
independently from each other and operate at different speed to deliver flow rates 
and pressures to meet the different required perfusion of systemic and pulmonary 
circulation. Computational Fluid Dynamics (CFD) was used as the main design tool 
in the development of this pump to predict the flow and performance of the design 
and conduct the optimization before making a prototype for experiments. 
This study is based on the preliminary design of a BiVAD with five different 
rotor designs to support the left and right heart. The pump design in this study still 
lacks the driving and suspension mechanism for the whole BiVAD unit, hence, the 
confirmation of BiVAD is separated into LVAD and RVAD for individual analysis. 
CFD was used to identify performance of both the hydrodynamics and 
hemodynamics aspects of the design selection to obtain the best performance. In 
terms of the hydrodynamic properties, the simulation was able to predict the pressure 
raised under the average flow rate of the ventricles, the related pump speed could be 
determined, and the efficiency of the pump at each operating condition was 
calculated. In addition to these hydraulic performance parameters, the hydraulic 
force on the rotor was also calculated and can be later used for the suspension and 
actuator design. The hemodynamic analysis focused on the prediction of blood clots 
or thrombosis that is caused by recirculation flow and hemolysis from the excessive 
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shear stress on the red blood cells. This information was used to select the best 
impeller design that would provide the best performance under the designed 
operational range of the pump. 
The pump prototype designed on the individual pump to work on the 
available driving mechanism. It could operate in both LVAD and RVAD functions. 
The detailed simulation was conducted and additional transient simulations were 
used for further analysis on the unbalanced structure of a rotor. The information 
gathered from the simulations were used as a final confirmation before the creation 
of the pump prototype for the experimental evaluation.  
In order to test the pump’s performance, a mock human circulation loop was 
designed and constructed. The loop was capable of replicating the pulse flow 
environment of the left and right ventricles using a piston pump with adjustable 
speed and stroke volume. The compliance effect from the elastance of the arteries 
was simulated by an air-trapped compliance tank, and the vascular resistance was 
replicated by an adjustable valve. 
The information and prototype from this study can be later used in the 
development of the driving and controlling systems in the final stage of the pump 
mechanism design process. 
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1.1 SIGNIFICANCE AND SCOPE 
The significance of this study is it attempts to solve the problem in the shortage 
of hearts for transplantation to heart failure patients, the lack of an efficient device to 
support bi-ventricular failure cases, and the expense and limited lifetime of current 
heart pumps for long term support.  
This study uses CFD for the development process of a new BiVAD. It provides 
a computational simulation methodology that can be used to significantly shorten the 
development time and reduce the development cost which should result in a lower 
cost BiVADs. This would make BiVADs more accessible for patients and the new 
pump would be available on the market faster. With this approach, it will also allow 
the pump’s hydraulic performance to be investigated before making a prototype, so 
the design selection and optimization can be done more efficiently. The hemolysis 
information gathered from the simulation results will allow the pump to be optimised 
to reduce the occurance of thrombosis and blood damage which is one of the major 
issues of the long term use of VADs reported from clinical trials.  
With the information from the CFD simulation and the structural design of the 
pump, a newly developed BiVAD from this study will be a highly efficient pump 
that is durable enough for long term support. The device’s complications involving 
mechanical failure, blood damage and coagulation, which are the major issues in a 
long term blood pump should be minimised. Therefore, this new heart pump would 
be able to provide support for a heart failure patient waiting for heart transplantation 
until a suitable heart become available or until a patient's physical condition is stable 
enough to receive a heart transplantation. Furthermore, it will also provide an 
alternative treatment for permanent support to ease a requirement arising from an 
increasing number of heart failure cases, as well as improve the quality of life for the 
patients with VAD support. 
The limitation of this thesis is mainly dictated by the lack of driving rotor 
suspension mechanism for the BiVAD which need to be done separately in later 
stage of development. To solve this problem, the LVAD and RVAD were analysed 
separately and the prototype was created as a single sided pump that can operated on 
both left and right functions. 
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1.2 AIMS 
This thesis focuses on two important aspects: (i) the development of an 
innovative BiVAD, and (ii) the implementation of CFD analysis to optimize the 
development of a heart pump. The development of a new BiVAD is to create an 
innovative device that will be able to provide long term support for bi-ventricle heart 
failure patients, and limit device complications from mechanical failure and 
hemolytic issues. The implementation of CFD will provide simulation and analysis 
methods that can be used to reduce the development cost and emphasis the processes 
necessary to achieve the requirements of the newly developed BiVAD. 
The specific aims are described as follows: 
I. Literature Review 
- To conduct an extensive review of the VAD designs and requirements for the 
development of a new BiVAD.  
- To review and research the CFD background and techniques used for 
performance prediction of the VAD in both hydraulic and hemodynamic terms.  
II. VAD design and simulations 
- To review the design and structure of a BiVAD and create a fluid model for 
computational simulation. 
- To conduct the computational simulation for design selection and optimisation 
to achieve the BiVAD requirements.  
- To optimise the design by incorporating the driving mechanism and refine the 
pump structure to be suitable for the manufacturing process to produce a working 
prototype. 
III.  Mock Circulation Loop 
- To design and construct a mock circulation loop that is capable of simulating 
the human circulation system for the experimentations of the VAD prototype under 
different physiological conditions. 
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IV.  Experimental Evaluation 
- To identify the hydraulic performance of the pump and verify the accuracy of 
the simulation. 
- To obtain additional information for further design optimization. 
1.3 THESIS OUTLINE 
This thesis is divided into six chapters that detail the basic knowledge of the 
VAD and CFD, the basic structure and simulation process of the pump, the design 
and construction of the test rig, and the testing procedure with the results summary. 
Figure 1-1 outlined the structure of this thesis. 
 
Figure 1-1: Outline of this thesis 
Chapter 2  
This is a literature review to provide background information about the global 
heart failure situation and the significance of the VAD as an alternative therapy. This 
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chapter allows the reader to understand the current development situation, the design 
requirements, limitations and expectations of the VADs. 
The review of CFD simulation is included in this chapter as an effective tool for fluid 
dynamics analysis that could be implemented for the design of the VAD. The review 
covers the strengths of CFD and the information that it could provide, along with the 
background theories for the simulation configurations and analysis of the results. 
Chapter 3 
This chapter discusses the structural design of the BiVAD and the simulation 
process for performance prediction and design selection, design modification, and 
optimization to create a working prototype for the in-vitro evaluation. 
Chapter 4 
The design and construction of human mock circulation loops are reviewed 
and discussed in this chapter. It includes an analysis of the parameters, structures and 
equipment that are required to establish a test rig that could simulate the human 
circulation system and flow variations to reflect the flow conditions of a heart failure 
patient.  
Chapter 5 
This chapter outlines the experimental evaluation procedure of the pump 
prototype in the mock circulation loop with the results and performance analysis of 
the pump in comparison to the CFD simulation results. 
Chapter 6 
This is the conclusion of the thesis with a summary of the outcomes from this 
study, including a suggestion for further development of this pump. 
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1.4 THESIS OUTCOMES AND CONTRIBUTIONS 
The work presented in this thesis describes the development of the BiVAD 
with an implementation of CFD for the analysis of hydrodynamics and 
hemodynamics. The completion of this study has led to the following outcomes: 
1. The computational analysis method for an analysis of the VADs which includes: 
 a. The procedure for the computational model creation, mesh generation and 
boundary conditions for the simulation of VADs. 
 b. The analysis method and results interpreting the hydraulic performance of 
the pump that allows the prediction of pump efficiency and optimum speed to deliver 
the required pressure, including the hydraulic force exerted on the rotor. 
 c. The prediction and analysis method for hemolysis and thrombosis that are 
generated within the pump. 
2. The verification and analysis of an innovative design concept of BiVAD with the 
following features: 
 a. The pump designed as a centrifugal pump which has high durability and is 
suitable for long term usage. The design of the rotors to support LVAD and RVAD 
was selected based on the CFD analysis to ensure the high pump efficiency with a 
low risk of thrombosis and hemolysis.  
b. The proposed design of BiVAD in this thesis has identical structure 
between the left and right side. This allows two pump module that developed in this 
study to be combined as a single BiVAD after the driving mechanism is completely 
designed. The LVAD and RVAD side can be operate at different rotation speed to 
deliver the required perfusion for systemic and pulmonary circulation. 
3. According to the outcomes from (1) and (2), a working prototype of a VAD was 
produced and tested. The pump has been optimized to be able to operate in both 
LVAD and RVAD functions at high efficiency with a low risk of thrombus 
formation and hemolysis. This new pump can function on its own as an individual 
pump, and the information from evaluation in this thesis will be used to combine two 
pump module to a working BiVAD in future study. 
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 Literature Review of Ventricular 
Assist Devices 
This section critically evaluates the literature according to the current 
situation relating to heart failure, the use of mechanical devices for circulatory 
support on heart failure patients, and their impact on heart failure treatment. The 
review also examines and emphasizes the mechanism development process of the 
Ventricular Assist Devices (VADs) including the design tools and technique that 
could be implemented in the development process of a new heart pump, in order to 
identify a gap in heart pump research and development.  
In the first section, the review focuses on the current status of the incidence 
of heart failure, the application and implementation of VADs, and explains how 
VADs could be used instead of donor hearts to treat heart failure. The limitations 
and expectations of a heart pump are examined based on experiments and clinical 
results in order to understand the current issues of heart pumps and the possibility of 
future developments.  
The second section highlights the evolution of the heart pump mechanism. 
The development process and design concerns are listed and analyzed to ensure that 
the newly developed VAD mentioned in this research could meet the performance 
requirements and achieve the objectives of the heart pump development. 
The last section of this literature review focuses on the main development 
tool, the computational simulation. Computational Fluid Dynamics (CFD) is 
investigated for its strengths and the information that it can provide. The details of 
each simulation stage with configuration options and the background theories are 
also covered. 
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2.1 HEART FAILURE 
Congestive Heart Failure (CHF) or chronic heart failure is when the heart 
muscle is weakened and loses its contraction resulting in inadequate systemic blood 
pressure or venous blood return. This event leads to an inadequate perfusion to meet 
the body’s needs, resulting in fatigue and breathlessness. The lack of pressure of the 
circulation also causes the blood to back up in the veins returning to the heart and 
the blood becomes congested in the tissues. This buildup fluid could cause weight 
gain as well as swelling in the ankles, legs, and feet which is called "edema". In 
addition, the fluid can also build up in the lungs and cause congestion in the 
pulmonary system (Braunwald, 2013).   
The common causes of CHF are coronary artery disease, hypertension, and 
diabetes. Statistically, elderly people are more at risk of having this disease, and it is 
the most common cause of hospitalization for the elderly. More than 70 % of CHF 
patients hospitalized in the United States are 65 years and older (Braunwald, 2013; 
M. J. Hall, Levant, & DeFrances, 2015). 
2.1.1 Heart failure incidence 
CHF has become a worldwide health concern, as it has been one of the 
leading causes of death in the past decade with an estimated 38 million patients 
worldwide (Braunwald, 2015), and the number is still rising.  According to the 
World Health Organization, the total number of deaths from all the cardiovascular 
diseases could rise to 23.3 million by 2030. In the past, CHF was more of a problem 
to those in the high income levels due to the lifestyle that risked causing CHF-
related health problems such as obesity, hypertension, and diabetes. However, the 
change in the lifestyles of medium and low income countries leads to an increase in 
CHF becoming a global problem in the near future (Braunwald, 2015; Mendis, 
Puska, & Norrving, 2011). 
In the US alone it was reported that there were almost 300,000 deaths each 
year while there are new cases being diagnosed bringing the total to approximately 
870,000 cases annually (Mozaffarian et al., 2015). The long-term survival rate from 
CHF is relatively low. An estimated 50% of the patients die in the first year of the 
disease and about 70% of patients die by the fifth year (Michael E DeBakey, 2000).  
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2.1.2 Treatment options 
There are several treatment options available for patients with different 
degrees of CHF, from lifestyle adjustments, taking optimum medication, and 
transcatheter interventions to transplantation in the severest cases (Katharine H. 
Fraser, Taskin, Griffith, & Wu, 2011; Harris & Thompson, 2012). Heart 
transplantation is the most reliable way of treating CHF; however, the major 
problem is the limited number of donor hearts as there are only around 2,100 to 
2,500 hearts available annually in the US (Mozaffarian et al., 2015) compared to the 
estimated 35,000 US patients who would benefit from heart transplantation 
(Katharine H. Fraser et al., 2011).  The number of patients is growing each year 
while the number of available hearts tends to be steady. Therefore, there have been 
attempts to develop mechanical circulatory support devices to relieve the need for 
short and long-term circulatory support for patients (Kirklin & Naftel, 2008). The 
devices that have mainly been developed to improve the pumping function of the 
failing heart are the Total Artificial Heart (TAH) and the Ventricular Assist Device 
(VAD). The TAH function is like its name implies, as it completely replaces the 
function of the native heart and requires removal of the ventricles in order to effect 
the transplant, while the VAD operates in parallel with the weakened heart by 
pumping blood from the ventricle to the aorta (Gregory, Timms, Gaddum, Mason, 
& Fraser, 2011) (Figure 2-2). Currently, both devices appear to be a promising 
alternative to heart transplantation, but the use of the VAD has some advantages 
over the TAH because of its flexibility in use as it could be used for both short and 
long-term support, while leaving the native heart in place. This provides some 
chance for the ventricles to recuperate to the stage where the device could be 
removed. 
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Figure 2-1: A transplantation with the CardioWest TAH that requires removal of the 
ventricles (NIH, 2012). 
2.1.3 Applications and implantation of VAD 
Heart failure can occur on both the left and right side of the ventricles but 
failure on the left side is much more common, so the majority of VAD 
developments aim to primarily function as a left ventricular assist device (LVAD). 
However, there have been reports of the development of right heart failure 
following the long-term support from the LVAD at a significant rate from 10 to 
50% (Gregory et al., 2011). This development of the failure of both ventricles is 
called "bi-ventricular failure" and is considered to be serious as it is associated with 
more than 90% of deaths if not treated (Daniel Timms et al., 2008). Patients with bi-
ventricular failure will require an additional VAD to function as the right ventricular 
assist device (RVAD) to support the failing right ventricle, or the alternative 
approach is to totally replace the native heart with a TAH (S. R. Wilson, Givertz, 
Stewart, & Mudge Jr, 2009).    
Currently, an implantation of the VAD can be done either externally for 
short-term support after a cardiac operation, or implanted internally for patients who 
require long-term support (Nishimura, 2014; Teuteberg & Chou, 2014). If the 
device is to be implanted internally, it can be placed sub-diaphragmatically in pre-
peritoneal or intra-abdominal positions and connected to the control unit and 
batteries outside the body with the driveline tunneled through the skin of the 
abdominal wall as shown in Figure 2-2 (S. R. Wilson et al., 2009).  
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Figure 2-2: Ventricular Assist System (VAS) of the HeartMate XVE surgically 
implanted to the abdomen for left ventricle support (S. R. Wilson et al., 2009). 
The pump is typically connected to the circulatory system by the inflow and 
outflow cannula. In the LVAD support, this inflow cannula or inlet of the device is 
normally attached to an apex of the left ventricle and the outflow cannula is 
connected to the aorta for additional blood pumping in parallel with the native flow 
from the heart. For the RVAD, the device works in a similar manner to the LVAD 
by  pumping blood from the right ventricle to the pulmonary artery (Stone, 2007), 
but under a lower flow rate and pressure than the left ventricle support function. 
With the differences in the flow conditions, many of the pumps that are specifically 
designed as an LVAD cannot be operated for the RVAD function. However, some 
of the VADs could be used for either the LVAD or RVAD support; or two 
independent modules can be used to support both ventricles at the same time, which 
is called a bi-ventricular assist device (BiVAD or BVAD). Some examples are the 
Abiomed AB5000, Thoratec IVAD, Berlin heart EXCOR, Levitronix Centrimag, 
Jarvik 2000 and HeartWare HVAD (Gregory et al., 2011).  
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Figure 2-3: Implantation of a VAD for a left ventricle support (left) and both sides 
support at the same time (middle and right) (Stone, 2007). 
 
Figure 2-4: (A) The Centrimag pump and the pump as it is installed on a motor. (B) 
The Centrimag as a BiVAD application with the extracorporeal device placement 
(Teuteberg & Chou, 2014). 
 
Figure 2-5: The combination of HeartMate II for LV support and Centrimag for RV 
support in a bi-ventricular failure patient (Eric A Rose et al., 2001).  
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The current pumps available that could be used for the BiVAD function 
have separate modules for each ventricle, as shown in Figure 2-3 and Figure 2-4 . 
Having two separate pumps makes a transplantation more complicated because it 
would require a more complex control system, additional drive lines and, if the 
devices are to be implanted, more space would be required in the patient's body. 
Currently, the only pump that aims to perform a BiVAD support with a single unit 
is the BiVACOR BV Assist which contains two stator sets on a shared rotating hub 
for the left and right ventricles. This pump was designed to be able to serve as both 
a BiVAD and TAH, however it is still being developed (M. Ferrari, Kruzliak, & 
Spiliopoulos, 2015; Daniel Timms et al., 2008; D Timms, Fraser, Thompson, 
McNeil, & Steinseifer, 2009) and there is still no report of the long-term clinical 
trial results.  
 
Figure 2-6: BiVACOR BiVAD/TAH (Teh, 2015). 
2.2 CLINICAL IMPACT OF VADS 
2.2.1 VAD support indication 
As discussed in the above section, a heart transplant is currently the most 
preferable destination therapy for severe heart disease patients. However, in order 
for the patients to receive the transplantation, they have to pass diagnostic tests in 
the screening process to ensure that they would be able to undertake the operation 
and recovery from the transplantation before they can be placed on the transplant 
list to wait for a suitable donated heart to be available. These processes usually take 
up to several months due to the limited number of heart donations.  
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The uncertainty during these long screening and waiting periods has always 
been a very difficult and stressful period for both the patients and their families. 
Therefore the VAD can be used as a Bridge to Transplantation (BTT) to support 
patients as they wait for the available heart. At present, the advancement in VAD 
technology allows the new generation of devices to generate low hemolysis and 
requires low maintenance. Consequently, the use of a VAD is no longer limited to 
temporary support but it can also be used for long-term support until the patient's 
heart recovers its function which is known as the Bridge to Recovery (BTR), or 
even permanent support, known as a Destination Therapy (DT), in some cases 
(Capdeville & Smedira, 2013; Tang, Oyer, & Mallidi, 2009; Yamane et al., 2010).  
2.2.1.1 ) Bridge to transplantation (BTT)   
The BTT is currently the majority application in the usage of VADs being 
involved in up to 54.1% of cases, according to the report from the Interagency 
Registry for Mechanically Assisted Circulatory Support (INTERMACS) in 2012 
(Kirklin et al.). There are 2 main scenarios for patients to receive this method of 
treatment; the first is as an emergency measure in the event of acute carcinogenic 
shock, for which it has been reported to have a better outcome than emergency 
transplantation. For the second case, VADs are used on patients to stabilize their 
condition while they are waiting for heart transplantations or other proper treatment. 
Additionally, the implementation of a VAD to a CHF patient can also sometimes 
help to improve the organ’s functions and make it possible for a patient who is 
critically ill and ineligible for a heart transplantation to become listable. This is 
referred as a Bridge to Candidacy (BTC) (Attisani et al., 2012; Gaudino et al., 2014; 
Miller et al., 2007). 
With regard to the design and evaluation of heart pumps for the BTT 
application, the devices are generally expected to be able to support patients for at 
least 180 days (Jorde et al., 2014). 
2.2.1.2 ) Bridge to recovery (BTR) 
 There are a small number of cases where the prolonged support of VADs combined 
with drugs for severe heart failure patients has led to myocardial recovery over a 
varying time period from 320±186 days (Birks et al., 2006). Some patients could 
recover to the stage where they no longer require a mechanical support device and 
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thus could have a normal quality of life. Therefore, the use of VADs is usually the 
preferable option over the TAH which requires removal of the native heart.  
Currently there are an estimated 1% of patients who receive this means of therapy 
each year (Kirklin et al., 2013; Nosé, Yoshikawa, Murabayashi, & Takano, 2000).  
2.2.1.3 ) Destination therapy (DT)  
It is estimated that 44% of the total VAD implantations are used as a means 
of DT for CHF patients and the number is continuing to grow (Porepa & Starling, 
2014). The patients who require this means of therapy are those who are ineligible 
for heart transplantation due to the limitations of their physical condition, mainly as 
a result of advanced age. The average age of patients for DT is 61.7 years, which is 
considerably higher than that for other applications of VAD usage which is 
estimated at 52.7 years (Flint, Matlock, Lindenfeld, & Allen, 2012).   
The VAD is one of the most suitable support options for a patient as it could 
suit every role from the BTT, BTR, to DT, as stated above, while still giving a 
chance for the native heart of the patient to recover and become device independent 
again. In addition, the heart itself may also serve as a safety measure for the patient 
to survive in the case of a device malfunction (Gregory et al., 2011). 
2.2.2  Clinical Trials of VADs 
Many clinical trials have been conducted in the past decade to collect and 
assess the data of patients using VADs for long-term support. This data is used for 
several researches and developments and also for the approval of the pump for 
clinical usage. The trial programs that have had a notable clinical impact are the 
REMATCH and INTERMACS programs:  
2.2.2.1 ) REMATCH  
The Randomized Evaluation of Mechanical Assistance for the Treatment of 
Congestive Heart Failure (REMATCH) was a long-term clinical trial program of 
LVADs in collaboration with Columbia University, the National Institute of Health 
(NIH) and Thoratec Corporation. The main objective of the program was to evaluate 
the reliability and effectiveness of the devices in chronic end-stage heart failure 
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patients. This program was run for three years from May 1998 to July 2001. The 
criterion for the patients who participated in the program was that they were 
required to have had New York Heart Association (NYHA) class IV heart failure 
which is the highest severity in the classification. In addition to this requirement, the 
participants must not have had one of the following conditions: aged more than 65 
years old, insulin-dependent diabetes, chronic renal failure, or other clinically 
significant conditions. A total of 129 patients enrolled during the course of the 
program, and were then divided into 2 groups. The first group consisted of 68 
patients who were assigned to receive the Thoratec HeartMate VE LVAD implant, 
while the second group which had 61 patients was a control group and was assigned 
for optimal medical therapy (Eric A. Rose et al., 2001). 
The study outcomes showed a significant reduction in death from heart 
failure for the patients with LVAD support, with 52% of the patients in the device 
group and 25% of the medical therapy group having survived after one year of the 
program.  After 2 years of the treatment, the survival rate for the device group 
declined to 23 % and only 8 % for the optimal medical group. This result indicated 
that a VAD is a promising alternative long-term treatment for the CHF patients. 
However, there was a high number of device failures; up to 35% of all the devices 
had failure problems during the second year of the program, which caused up to 
17% of all the deaths in the device group (Oz et al., 2003; Eric A. Rose et al., 2001; 
Rose et al., 1999; Smart & Palanichamy, 2005) that is still considered to be a 
relatively high risk in terms of pump reliability for the DT. Some discussions also 
suggested that the cost and morbidity associated with the device when compared to 
the  survival rate after 2 years may not provide the benefits that are favourable 
enough for most of the patients who required DT (J. Timothy Baldwin, Robbins, & 
National Heart, 2005; Dembitsky, 2006). 
The results from the REMATCH program were widely accepted in the VAD 
development field by both the device companies and government agencies and so 
then influenced the development direction of the later generation devices. The 
outcome of this study also provided crucial information for the US Food and Drug 
Administration (FDA) to grant premarket approval for the Tharatec HeartMate XVE 
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to be used in DT which made it the first VAD approved for this indication (Raman 
& Jeevanadam, 2004). 
2.2.2.2 ) INTERMACS 
The Interagency Registry for Mechanically Assisted Circulatory Support 
(INTERMACS) is an ongoing program started in June 2006 under the collaboration 
of the National Heart, Lung, and Blood Institute (NHLBI), FDA, Centre of Medical 
and Medicare Services (CMS), 15 device manufacturers and the professional 
community. This program began with the decision by the NHLBI, after the 
completion of the REMATCH program, to create a long-term follow up program  
on the patients who received VADs (Kirklin et al., 2008). Unlike the REMATCH 
program, this program is not limited to LVADs but included the whole range of 
VAD support, including the TAH, in the program; thus, the database contains a 
large variety of devices in real clinical practices. Currently, this program has 
collected the largest database on the clinical outcomes of the mechanical circulatory 
system (MCS) from more than 12,000 patients (Kirklin et al., 2014).  
All the long-term heart pumps implanted in the patients as long-term support 
in the US are mandated to participate in the INTERMACS program, and hospitals 
are required to submit reports directly to the FDA for any serious events relating to 
the devices. Therefore, the clinical results of all the FDA approved devices are 
recorded regardless of type and structure. The major limitation of this program is 
that information on investigative devices under evaluation could not be included in 
the registry, so the results of new pump technologies may not be recorded (Holman, 
2012; Mann, Zipes, Libby, & Bonow, 2014). 
The INTERMACS program has published a series of annual reports that 
accumulates and summarizes the information about the devices and patients in the 
program since 2008 (Kirklin et al., 2008). This series of reports has been used as a 
reference for the many device improvements and publications and also addresses 
several MCS questions such as the influence of the sex of the patient on the 
transplantation outcome, the causes of device malfunctions, and other crucial 
information to increase the effectiveness and safe use and development of the MCS. 
 
 
38 Mechanism Design of Ventricular Assist Device 
 
This information benefits the device companies and researchers, as well as the 
government agencies, by providing a standard guideline for future device approvals.  
The information from 2 different time periods 2006 - 2007 and 2011 - 2013 
in the latest annual report shows a major increase in the number of patients 
receiving devices as DT from 14.7 % to 41.6 %, which indicates a growing trend of 
long-term permanent support, while currently 8.5% of patients have received pump 
replacements during the first three years of the program (Kirklin et al., 2014).  
2.3 MECHANISM AND STRUCTURE OF VENTRICULAR ASSIST 
DEVICE  
A mechanical device to support blood circulation was first used in cardiac 
surgery in 1952 by Dr. Dodrill to perform a left heart bypass operation; the machine 
used in that operation was named the Dodrill–GMR machine and it was a large 
machine with estimated dimensions of 10 x 12 x 17 inches for the external and 
temporary support and used a vacuum pump to circulate the blood through the 
patient's body. That operation was regarded as the beginning of the open heart 
surgery advancement with the help of a mechanical circulatory device (Stephenson, 
Arbulu, Bassett, Silbergleit, & Hughes, 2002; Stoney, 2009).  
With the establishment of the NHLBI artificial heart program in 1964, a 
large amount of funds was invested in the development of short and long-term 
circulatory devices as well as in the total heart replacement pump. Many smaller 
versions of mechanical heart supports were then developed for uses outside 
circulation support during an operation. The DeBakey VAD was developed in this 
period and became the first VAD successfully implanted for post cardiac surgery in 
1966, where it was used to support a 37-year-old woman for a total of 10 days 
(Kirklin & Naftel, 2008; Naughton & Bashour, 2002; Olsen, 2000; Tang et al., 
2009). 
The direction of mechanical circulatory support development became more 
focussed on VADs in the 1970s due to the unsuccessful results of the first TAHs 
and the increasing need for long-term support devices for patients waiting for donor 
hearts (Kirklin & Naftel, 2008; Mancini & Colombo, 2015). The direction of this 
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development became clearer when the NIH invited proposals for the development of 
a more mobile heart assist system. With the support of this NIH program, several 
clinical trials were conducted and large amounts of data were collected, which later 
led to the approval by the FDA of many long-term support VADs. In turn, this led 
to many developments to improve the pumps’ reliability and durability so as to 
increase their lifetimes in the expectation of providing permanent support for 
patients. 
2.3.1 VAD structure 
The improvements in the VAD design over the course of time have resulted 
in several changes to its mechanism. With these changes, the VAD can be generally 
categorized into 3 generations based on the output characteristics and the 
mechanism that generates the output flow. 
2.3.1.1 ) 1st Generation 
 
Figure 2-7: Cross-sectional view of the HeartMate XVE (Thoratec Corp., 2009) 
(ThoratecCorporation, 2006). 
At the dawn of the VAD’s development, the pump designers attempted to 
replicate the pulse flow characteristic of the native heart resulting in positive 
displacement pump designs which usually had a moving diaphragm that could be 
moved to increase the internal pump volume during the filling or diastolic phase and 
which compressed to eject blood during the systolic phase. This type of VAD has a 
major drawback in its reliability and life span as a result of a complicated drive 
mechanism and wear on repeatedly moving parts like the valve, membrane and 
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bearings; moreover, it also had a high risk of causing thrombosis, hemolysis and 
post-operative bleeding while the non-return valves, which are an important 
component that are used to regulate the flow direction, also had a risk of causing 
blood cell trauma (Frazier et al., 1992; Stone, 2007). With the risks of these device 
complications, this pulsatile pump required changing frequently and was not a 
preferable option for long-term support (Greenwood & Herr, 2014).  Examples of 
the first generation pumps are  the HeartMate XVE, Abiomed AB5000, Medos 
HIA-VAD, Berlin Heart EXCOR and Thoratec PVAD. 
2.3.1.2 ) 2nd Generation 
  The development of the second generation VADs was in response to a 
request issued by the NHLBI in 1994 for an implantable VAD that has better 
durability and wider applicability (Tang et al., 2009).  The continuous flow pump 
then became an interesting option for many developers and researchers with its 
advantage of a smaller design, better reliability and lower power consumption, 
despite the remaining concern over the long-term effect of the lack of pulsatility 
(Sciolino, 2012; Zareba, 2002). Therefore, rotary devices such as centrifugal and 
axial flow pumps which provide a continuous flow were evaluated to replace the 
displacement type of VADs. These rotary pumps operate using an impeller rotating 
at high speed to build up the pressure within the pump’s volute and push the blood 
through the outlet port. With this new structure, the components that are exposed to 
repeating forces, like the diaphragm and pump valve, were no longer needed, so that 
the lifetime of the pumps was greatly improved (Kirklin et al., 2013). However, the 
drawback of the pumps in this generation is that the rotating part is operated on a 
shaft which needs to connect to the motor or actuator outside the pump chamber, so 
that it required a bearing to transfer torque and seals to prevent leakage; but these 
components are susceptible to exposure to high shear forces which in long-term use 
could cause problems such as a leaking seal,  gastrointestinal bleeding, or red blood 
cell damage, and thus limit the life span of the pump (Gregory et al., 2011).  
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Figure 2-8: Gyro (a) and DeBakey (b) heart pump (Behbahani et al., 2009).  
The pump from the second generation is still the most common blood pump 
available for clinical usage, and it is generally based on either a centrifugal or axial 
pump structure. Examples of these pumps are the Heartmate II, MicroMed DeBakey 
and Gyro pumps.  
2.3.1.3 ) 3rd Generation  
The target of VAD development was for a device that is able to permanently 
support the heart and, therefore, the heart pump is expected to have a life 
expectancy of at least 2 years (Nosé & Motomura, 2005; Olsen, 1999). To increase 
the durability of the rotary pump, developments were focused on removing the seals 
and bearings which are vulnerable to damage under high shear forces on prolonged 
application. Several designs of both centrifugal and axial flow with a magnetically 
driven pump were proposed on the hydraulic and magnetic bearing concepts with 
the hope that they would provide enough suspension forces to keep the rotor 
levitated within the chamber and eliminate all the mechanical contacts in order to  
reduce the mechanical wear as well as the shear stress exerted on the red blood 
cells, and hence improve the hemolysis performance and increase the lifetime for 
the pump’s long-term support (Olsen, 1999).  
There are many issues that still cause problems for the heart pump in this 
generation. The major problems that related directly to the pump mechanism design 
are blood damage from shear stress and blood clot, which is still a problem in the 
long-term, despite the pump having been greatly improved from the previous 
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generation. More details of these issues will be covered in later sections of this 
literature review.  Others problems are related to the controlling, powering and unit 
cost. All the current VADs require a drive line that connects to the control unit and 
power supply outside the body. This exposed driveline often causes infections that 
became fatal in many cases (Maniar, Kondareddy, & Topkara, 2011; Park et al., 
2012). Another issue is the high power consumption of the VAD which is an issue 
especially when the current aim of the pump is to provide long-term support. 
Currently, each battery can last for only 4-6 hours ("HeartWare Ventricular System: 
Instruction for use," 2012) so it needs to be replaced and recharged frequently which 
is not effective for use in daily life. The high cost of a long-term blood pump is also 
an issue that limits the accessibility of the device to the patient.  
 
Figure 2-9: HeartWare HVAD pump.  
Examples of the third generation pumps that are available are the HeartWare 
HVAD, Thoratec Centrimag, MiTiHeart, BiVACOR, DuraHeart, INCOR and 
HeartMate III. (HeartWare, 2015). 
2.3.1.4 ) Future Direction 
Nosé  (Nosé & Motomura, 2005) suggests that development in myocardial 
treatment using stem cells could later lead to a significant turn in the direction of the 
development of VADs. As one of the major problems currently for the VADs is that 
the unit cost is relatively expensive, so preventing patients from having access to 
these devices, the promise of successful cardiac recovery using stem cell injections 
could be the future of CHF treatment. Studies have reported that it takes only 6-12 
weeks for the heart muscles of heart failure patients to regenerate after injecting 
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bone marrow cells (Perin et al., 2004; Wysoczynski, Hong, & Moore, 2014). If this 
technology becomes available, it would reduce the requirement of long-term support 
such as the BTC and DT while shortening the waiting time for patients on the BTT. 
Therefore, the development of implantable VADs for long-term support that are 
more durable but yet expensive should have less significance, and instead there 
should be more focus on a wearable blood pump which could provide support for up 
to only 6 months. The cost per unit should also be lowered greatly to at least one-
fifth of the cost of a current commercial pump to make it become more widely 
accessible for patients. 
However, with uncertainty about alternative treatments in the future, the 
target for the near future development of heart pumps would still be for the 
permanent support to supplement heart transplantation in order to relieve the limited 
supply of donor hearts by mainly focus on increasing durability, output 
performance, and improving the hemolysis performance (Nishimura, 2014; Olsen, 
1999), while any research should also focus on a miniature pump for better  
implementation on pediatric patients (J Timothy Baldwin et al., 2006; Kido et al., 
2006; Throckmorton & Untaroiu, 2008; J. Wu, Antaki, Verkaik, Snyder, & Ricci, 
2012). 
Other than the pump structure, many authors (Mancini & Colombo, 2015; 
Manolis & Manolis, 2014; Ohuchi & Takatani, 2006; Stone, 2007) have suggested 
that some additional improvements could also be done in the control and power 
systems such as the implementation of remote monitoring , total implantability, and 
the re-introduction of pulsatility to continuous flow (CF) VADs to reduce the risk of 
adverse effects from the long-term lack of pulse pressure such as clot formation 
above the native heart valves and the development of arteriovenous malfunctions. 
2.3.2 Classification of VADs 
At present, the rotary pump has replaced the displacement type of VADs due 
to advantages in almost every aspect. The design of a rotary heart pump can be 
classified into 2 types based on the pump’s structure: the axial flow pump and the 
centrifugal pump. 
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2.3.2.1 ) Axial flow pump 
An axial flow pump is operated by an axial propeller type of impeller 
running in a straight pipe casing which allows the fluid to flow in and to be 
discharged axially. With this design characteristic, the axial flow pump is suitable 
for low head and high capacity pumping applications, while the axial rotor structure 
also makes it possible for this type of pump to achieve a more compact design that 
is suitable for a VAD application in exchange for a higher operating speed. The 
typical operating speed of an axial flow heart pump at the designed flow rate ranges 
around 6,000-12,000 rpm and could exceed 30,000 rpm in the miniature designs 
(Kafagy & Gitano-Briggs, 2013a; Song, Throckmorton, Untaroiu, et al., 2003).  
 
Figure 2-10: Structure of the MicroMed DeBakey axial blood pump (Behbahani et 
al., 2009). 
Advantages:  The compact size of the axial flow pump allows the implantation to be 
less intrusive with a lower trauma of implantation while it is also easy for it to be 
designed and implemented for pediatric use. In addition, the axial pump also has 
less power consumption which means the power supply units could be smaller and 
lighter; thus, it will be more comfortable for patients to wear it on a daily basis (J 
Timothy Baldwin et al., 2006; Kafagy & Gitano-Briggs, 2013a; Song, 
Throckmorton, Untaroiu, et al., 2003). 
Disadvantages: The axial flow pump operates at a very high speed, so that it could 
lead to excessive shear stress and cause hemolysis of the red blood cells. In 
addition, the drive mechanism is also prone to higher stress and heat generation so 
the lifespan could be shorter. The stationary diffuser guide vanes that are usually 
required for controlling the axial position of the impeller create a vulnerable region 
for thrombus formation (Bottrell et al., 2014; Daniel  Timms, 2005).  
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2.3.2.2 ) Centrifugal pump 
The structure of a centrifugal pump is comprised of an impeller and a spiral 
casing. The impeller is a disc with a series of blades attached to it, where the 
number and the design of the blades vary but typically they are designed to curve to 
the opposite side of the rotating direction. During the operation, the inflow fluid 
flows into the suction inlet which is normally located at the eye of the impeller, then 
the inflow fluid will be exposed to the centrifugal force generated by the rotating 
impeller which pushes the fluid circumferentially through the vanes between the 
impeller blades and thus accelerates the fluid to flow along the curved path of the 
volute within the spiral housing and through the discharge outlet (Palgrave, 2005).  
 
Figure 2-11: Basic structure of a centrifugal pump (Wilson et al., 2006) (K. C. 
Wilson, Addie, & Sellgren, 2006). 
Advantages: As a blood pump, the centrifugal pump has good efficiency so that it 
could produce a high head pressure at a low flow rate under a relatively low 
operating speed, typically around 2,000 - 4,000 rpm. This means that a low shear 
stress is exerted on the red blood cells and there is a lower chance of hemolysis 
(Bottrell et al., 2014; Kafagy & Gitano-Briggs, 2013a); in addition, this type of 
pump is also less susceptible to mechanical wear due to its lower operating speed.  
Disadvantages: The spiral housing of the centrifugal pump is inevitably larger than 
the cylindrical casing of the axial pump which makes it harder to implant within the 
patient's abdomen especially in a person who has a small body or in children. In 
addition, the large housing combined with the larger impeller results in more weight 
and it consumes more power to drive the pump.   
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The difference in the properties of the axial and centrifugal types of blood pump are 
summarized by Kafagy et al., (Kafagy & Gitano-Briggs, 2013a), as shown in Figure 
2-12. 
 
Figure 2-12: Comparison of the important parameters of three types of blood pump 
(Kafagy & Gitano-Briggs, 2013a). 
2.3.3 VAD Hydraulic Performance Parameters 
Heart pump designs are generally based on general pump structures that 
have been used for general purpose applications such as with water and other fluids 
pumps. The hydrodynamic performance calculation is based on the same basis and 
the structure has a similar concept with some additional concern for the hemolysis 
performance.  
2.3.3.1 ) Head pressure 
Hydrodynamic performance of the pump is typically identified by the 
difference in pressure across the inlet and outlet designated as "head pressure" 
which represents the work that a pump performs on the liquid and can be calculated 
from the following equation: 
 ܪ ൌ
߂ܲ
ߩ݃ [2-1] 
Where:  H  = Head pressure 
   ΔP = Pressure difference 
   ρ = Fluid density 
The plot between the head pressure and volumetric flow rate known as the 
H-Q plot is one of the pump performance curves that present the performance 
characteristic of each pump.    
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Figure 2-13: H-Q curve (Vogel, 2013). 
2.3.3.2 ) Hydraulic Power 
Hydraulic power is a parameter which indicates the amount of fluid that the 
pump can move in one cycle, as calculated in the following equation:  
  ௛ܲ ൌ ߩ݃ܳܪ [2-2] 
Where:  H  = Head pressure 
   ΔP = Pressure difference 
   ρ = Fluid density 
2.3.3.3 ) Hydraulic efficiency 
The hydraulic efficiency identifies how well the mechanical power of the 
pump is transferred into hydraulic power. For the continuous flow pump, the 
efficiency is the ratio of fluid power (output) to the shaft power (input), as follows: 
 ߟ௛ ൌ ௛ܲ௦ܲ ൌ
ߩ݃ܳܪ
ܶ߱  [2-3] 
Where:  ߟ௛  = Hydraulic efficiency 
   ௛ܲ  = Hydraulic power 
   ௦ܲ  = Shaft power 
   ܶ = Impeller torque  
   ߱ = Impeller angular velocity 
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The hydraulic efficiency can be plotted against the volumetric flow rate, as 
in the example illustrated in Figure 2-7. It can be observed that the pump’s 
efficiency can gradually increase along with the flow rate up to a point where the 
turbulence intensity becomes dominating and the efficiency starts dropping as the 
flow rate continues to increase. The flow rate that allows the pump to operate at the 
highest efficiency is called the "best efficiency point" (BEP), and the pump should 
be designed to operate at this point to obtain the best performance.   
 
Figure 2-14: Efficiency-Q curve (Vogel, 2013). 
Generally, the efficiency of a heart pump is in the range of 20-30% 
(Throckmorton et al., 2004; Untaroiu et al., 2005; Y. Zhang et al., 2008). Since the 
pump needs to be operated under a wide range of conditions, it is preferable that the 
efficiency should have a low variation over the VAD’s operating range (Apel, 
Neudel, & Reul, 2001) and the BEP of a heart pump or the nominal design point is 
typically designed to be at the average flow rate of a normal heart condition 
(Throckmorton et al., 2004; Y. Zhang et al., 2008). 
2.3.4 VAD Design Concerns 
The common targets of the development of most of the current VADs are to 
create a compact implantable pump that has a high hydrodynamics performance and 
causes minimum hemolysis and thrombosis with low maintenance and  at an 
inexpensive price (Capdeville & Smedira, 2013; Michael E. DeBakey, 1997; Frazier 
et al., 1992; Gregory et al., 2011; May-Newman, 2010; Nosé & Motomura, 2005; 
Nosé et al., 2000; Olsen, 1999, 2000; Stone, 2007; Tang et al., 2009; Yamane et al., 
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2010). In order to archive the development objectives, there are several aspects of 
the VADs’ properties that need to be considered.  
2.3.4.1 ) Life Expectancy / Durability of the pump 
In the present development of blood pumps, the developers typically expect 
the device to be durable enough for permanent support (Goldstein, Oz, & Rose, 
1998; Porepa & Starling, 2014; Watanabe et al., 2004). Therefore, the service life of 
this pump type is expected to be at least 5-10 years which is the average survival 
length of heart transplant recipients (Sorensen, 2007). This could be achieved by 
increasing the stability of the mechanical components, and by avoiding the risks of 
thrombosis and hemolysis which are the main factors that limit the blood pump’s 
life span. 
I. Mechanical failure 
The main factor that limits the heart pump’s lifetime is mechanical failure, 
especially on the contact surfaces of parts that are subjected to repetitive stress that 
would make it more vulnerable to failure from wear; thus, the first generation of 
blood pumps that used mechanisms like rollers and a diaphragm, including  the non-
return valves, which are important components to direct the flow in the pulse flow 
pump had a limited lifetime of only 2-3 years (Burke et al., 2001). The REMATCH 
trial also found that there were many problems related to the device’s complication 
that demonstrated a substantial risk of mechanical failure over the course of the 
program, and as many as 65% of those patients who survived up to 2 years in the 
trial had to undergo device replacement relating to these failures (Pagani, 2008).  
There were many attempts to increase the reliable lifetime of the pump 
which led to the development of the 2nd generation of the pump. One of the 
important changes is the removal of a complex pulse generation mechanism that 
should have made it possible for the pump to achieve a 2-year lifetime. The life 
expectation of this 2nd generation blood pump should be sufficient to provide 
enough time for the BTT patients to receive a donor heart for transplantation, and 
long enough to support the recovery of dilating cardio myopathic hearts in the BTR 
application. However the axial pump design is unable to achieve this expected 
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lifetime as the high rotational speed causes high wear of the support bearing systems 
(Sciolino, 2012; Daniel Lee Timms & Queensland University of Technology. 
School of Engineering, 2005). 
The levitating impeller design of the 3rd generation pump could largely 
resolve the mechanical failure problem by removing all the contact surfaces; hence, 
it is expected to greatly improve the durability over the previous design generations. 
However, the long-term evaluation of this type of pump is mostly still ongoing so 
that the actual lifetime cannot be confirmed. The most recent report on the 
durability of the 3rd generation blood pumps is on the data from the clinical trials of 
the INTERMACS program using HeartWare HVAD devices. It has recently been 
reported as achieving 4 years (2009 to 2013) without a report of a mechanical 
breakdown (Özalp et al., 2014).  
II. Thrombosis 
Thrombosis is the formation of a blood clot initiated by the body’s 
hemostatic mechanism to prevent bleeding. This process can be triggered by many 
factors such as blood flow interruption, vascular wall abnormalities and alteration  
of the blood constitution (Behbahani et al., 2009). The formation of thrombosis in 
the VAD may compromise its mechanism causing a drop in flow and pumping 
power leading to failure of the VAD, if left unattended. This blood clot, if it is 
dislodged and circulates in the blood stream, might disturb the flow or occlude the 
blood vessels in vital organs and cause internal damage that could be fatal.  
Currently, thrombosis is a major problem for the long-term VADs on both 
pulse flow and continuous flow designs as it is found to be one of the primary 
causes of death for patients with VAD support (Behbahani et al., 2009), and was 
reported to contribute up to 10% of the total device failure events during the 2 years 
trial of the HeartWare HVAD which is one of the most advanced 3rd generation 
heart pumps for the BTT patients (Najjar et al.). 
The complication of thrombus formation in the VADs makes it difficult to 
prevent as it is involved with many factors from the pump flow rate, pump speed, 
level of anticoagulation and much more (Nakata et al., 2000). However, the risk of 
thrombosis could be reduced by designing a proper washout mechanism to avoid  
 
 
51 
 
stagnation, especially in the low flow region at the gap beneath the impeller in the 
centrifugal pump that has a high risk of stagnation, or by reducing the chance of 
flow recirculation over the whole pump operation flow range, while the foreign 
material surface of the pump that could also cause a blood clot can be overcome by 
the use of an anti-coagulation coating material or medical therapy  (Najjar et al.).  
III. Hemolysis 
Hemolysis is the breakage of the membrane of the Red Blood Cells (RBC), 
causing the release of hemoglobin and other contents into the plasma. The leakage 
of hemoglobin in the blood can deteriorate the patient’s condition or cause kidney 
dysfunction resulting in multiple organ failure (Behbahani et al., 2009). Hemolysis 
could occur as a result of shear stress exerted on the RBC where the degree of 
damage is proportional to the exposure time and the magnitude of the shear force. 
Therefore, it is one of the major concerns in the design of artificial organs especially 
in the rotary blood pump, where the high shear stresses could occur due to high 
rotational speed, and the small clearances between the rotor and housing may lead 
to RBC damage under certain conditions (Katharine H Fraser, Zhang, Taskin, 
Griffith, & Wu, 2012; Paul et al., 2003).  
Paul et al. (Paul et al., 2003) investigated the threshold of blood damage on 
the shear stress and exposure time based on the evaluation on the Couette device in 
the shear stress range of 30-450 Pa and the exposure time from 25-1,250 ms; the 
result indicated the blood damage threshold at the shear stress of 425 Pa and the 
exposure time of 620ms.   
The INTERMACS 2012 third quarter (Cowger et al., 2014) reported the 
hemolytic events in 363 of the 448 patients with the LVAD implanted, out of the 
total of 6,033 patients in the program, and it was found that 8 deaths were directly 
related to hemolysis incidents; the number of events were unclear in the later reports 
but the total of hemolysis-related deaths were stated to have increased to 14 cases 
by the end of 2014 ("INTERMACS Quarterly Statistical Report 2014 Q4," 2015). 
Katz et al. (Katz et al., 2015), suggested that the introduction of CF-VADs does not 
fully resolve the hemolysis problems, which  still affect up to 8% of patients who 
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were under the device support for two years. Hence, it is still necessary for further 
studies to improve the devices and implantation methods.      
Hemolysis index: 
Hemolysis from medical devices such as the VAD with continuous blood flow can 
be evaluated by using either of two indexes outlined in the ASTM F1841-97 
standard: the Normalized Index of Hemolysis (NIH), and the Modified Index of 
Hemolysis (MIH) (ASTM, 1998) (ASTM, 1998).    
These indices are respectively expressed as: 
 ܰܫܪ ሺ݃/100	ܮ	ܾ݈݋݋݀ሻ ൌ ∆݂ܪܾ∆ݐ
ܸ
ܳ ሺ1 െ ܪݐሻ 100 [2-4] 
   
 ܯܫܪ	 ൌ 	 1ܪܾ
∆݂ܪܾ
∆ݐ
ܸ
ܳ ሺ1 െ ܪݐሻ 10
଺ [2-5] 
 
And the relationship between the NIH and MIH is given as the following equation: 
 ܯܫܪ ൌ ܰܫܪ 10
ସ
ܪܾ  [2-6] 
 
Where:  ∆fHb = Increase of plasma free hemoglobin concentration (g/L) 
over the sampling time interval 
V = Circuit volume (L) 
Q = Flow rate (L/min) 
Ht = Hematocrit (%) 
Δt = Sampling time interval (min) 
Hb = Total blood hemoglobin concentration at time zero (mg/L) 
The NIH index is often used to compare the blood damage generation rate across 
the devices.  
2.3.4.2 ) Output Requirements  
The VAD needs be able to provide sufficient head pressure to compensate 
for the pressure loss due to the weakened ventricle in all the degrees of heart failure 
and also must be able to provide sufficient perfusion during the different daily 
activities of the patients such as sleep, rest, exercise etc. Therefore, the pump is 
normally designed to have the head pressure the same as the systemic pressure (for 
 
 
53 
 
the LVAD) plus some additional pressure to compensate for the vascular resistance 
at the BEP point, while the flow rate for the CF-VAD  typically refers to the average 
volumetric flow rate for normal people estimated at 5-6 L/min (Daniel  Timms, 
2005). 
2.3.4.3 ) Size 
The commercial VADs normally have a recommendation value for the 
appropriate patient’s body size depending on the pump size and outflow 
performance. The blood pumps in the first generation are typically large and heavy, 
so that many of them required a minimum body surface area estimated 1.5m2 which 
makes them ineligible for many women and children (Fuhrman & Zimmerman, 
2011; Gagnon, Petty, & Lahpor, 2000; Tang et al., 2009). The rotary VADs’ design 
allows the pump to be much smaller and more suitable for implantation even for the 
very small body size of pediatric patients. 
2.4 COMPUTATIONAL FLUID DYNAMICS (CFD) 
Computational fluid dynamics simulation is the use of finite element 
numerical methods to solve and analyse fluid mechanical problems. While it could 
be considered as a branch of fluid mechanics, it is particularly dedicated to the study 
of fluid dynamics or the fluid flow interaction with restriction surfaces and the 
influence of the fluid behavior such as heat transfer or chemical reactions in 
combustion flows.  
CFD has been established since the 19th century in the form of fundamental 
mathematical equations that can describe the  physical characteristics of fluid in 
motion, known as the "governing equations", but the complexity of geometry and 
boundary conditions require high computational power which limited the usage of 
these calculation techniques until the advancement of digital computers that became 
efficient, affordable and reliable enough for solving such complex flow equations in 
the early 20th century (Bates, Lane, Ferguson, John, & Sons, 2005). The 
advancement of CFD makes the simulation result accurate enough to be accepted as 
one of the three approaches in problem solving in fluid dynamics that traditionally 
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used only experimental and analytical methods and continues to be greatly relied on, 
particularly for complex flow analysis (Tu, 2007).   
In the early era of CFD simulation, study was limited to the engineering area 
of aeronautics and astronautics which had large amounts of funding to acquire the 
powerful equipment to support problem solving; however, now it is widely adopted 
in many engineering fields because of the increase in computer power and 
performance as well as several other advantages compared to the traditional 
methods. These advantages are mainly the ability to provide highly detailed, 
visualized, and other comprehensive information that could substantially reduce 
lead times and the cost of production compared to the experimental based method. 
Meanwhile, it also offers the ability to solve complex flow problems that could not 
be achieved by the analytical approach. CFD also has the capacity for simulating 
flow that is not reproducible in an experimental test such as a dangerous chemical 
flow or a large event like a tsunami (Tu, 2007).  
CFD has been used in VADs’ development since the age of the first 
generation of pulse flow (PF) VADs (König, Clark, & Mokhtarzadeh-Dehghan, 
1999; Medvitz et al., 2007; Moosavi, Fatouraee, & Katoozian, 2009; Okamoto, 
Hashimoto, Inoue, & Mitamura, 2003) and has become widely used in this field 
along with an increase in the popularity of the CF-VADs. In recent studies, CFD has 
been used to calculate hydraulic parameters such as the fluid forces on the rotor, 
torque and efficiency, including hydrodynamic related characteristics such as the 
vortex and stagnation in the flow fields, as well as shear stress for the prediction of 
hemolysis (May-Newman, 2010).  
2.4.1 Geometry modelling of VADs 
The simulation of VADs could be divided into the PF and the CF types of 
VADs that have different basic structures and require different approaches in 
simulating the flow. 
2.4.1.1 ) Pulse flow VAD (PF-VAD) modelling  
The CFD simulation of the PF-VADs is relatively complicated because it 
involves many moving parts and there is a large flow variation during the pump 
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cycle; thus, the pump models are often simplified to reduce the computational cost 
(König et al., 1999; Moosavi et al., 2009). The most difficult part to simulate in this 
type of pump is the flexible diaphragm which moves up and down in simulating the 
systolic and diastolic ventricle phase. Instead of actually moving the wall that 
requires a dynamic grid motion, several authors simulated the effect by directly 
injecting and removing the blood at the diaphragm surface.  The inlet and outlet 
valves are other issues for CFD modelling that are difficult to replicate with the 
actual movement in the CFD model; thus, some authors assume that the valves are 
always in an open position and blood can flow freely in and out the chamber, but 
instead increase the fluid density to block the flow at the valve locations (Medvitz et 
al., 2007).  
2.4.1.2 ) Continuous flow VAD (CF-VAD) modelling 
Most of the recent VAD simulations have been conducted on the CF-VADs 
as they are the majority of the pump types under development. The fluid model, 
which is the computational domain of pump simulation, is normally divided into the 
stationary part and the moving part; the stationary domain comprises the fluid 
around the static surfaces like the inlet pipe, volute casing and outlet diffuser, while 
the moving or rotational domain reflects the movement of the fluid surrounding the 
pump rotor; however, some authors also further divide the stator and rotor into 
smaller subdomains for easier mesh generation and to reduce skewness (Selgrade, 
2010; Selgrade & Truskey, 2012). The surfaces between the domains are specified 
as "domain interfaces" which provide connections between the domains (ANSYS, 
2009). 
2.4.2 Meshing scheme 
The governing equations of the fluid flow and heat transfer in CFD are in the 
form of partial differential equations which are only available for the calculation of 
very simple cases. Therefore, the computational domains are divided into small 
subdomains with which the governing equations can be discretized and solved. 
These small subdomains are called elements while the collection of elements in the 
whole domain is called a mesh. The accuracy of a CFD simulation is strongly 
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dependent on the number of elements and increasing the number of elements will 
generally improve the accuracy of the computational solution. However, the trade-
off of an increase in accuracy is the demand of computational power which is 
limited by the hardware performance and the calculation turnover time.  
Consequently, it is suggested that the mesh should be refined where the flow 
conditions change abruptly, while coarse meshes are used for the less complex 
regions for balancing the accuracy and the required resources (Tu, Yeoh, & Liu, 
2013). 
Aside from the element density in the domain, the solution accuracy is also 
influenced by the mesh quality. The type of mesh is one of the most important 
factors that affects the mesh quality and accuracy of the results as well as the 
computational resources required for the simulation. 
2.4.2.1 ) Classification of mesh 
The type of mesh can be categorized by either connectivity between the 
elements or the structure of the elements.  
I. Connectivity-based classification 
If it is classified based upon the connectivity, the mesh type can be either 
structured, unstructured or a hybrid mesh. The structured meshes are characterized 
by the regular connectivity between the elements, hence creating a uniform pattern 
of elements in the domain. A good alignment of the grid helps the solver to 
converge more easily, but it is not possible to fit this grid type onto some complex 
geometry. 
The unstructured mesh is the type that has an irregular connectivity which 
has the advantage of better flexibility to fit onto most geometries and allows 
automated generation but it usually requires more cells and takes more time to 
converge. In addition to these mesh types, it is possible to apply the hybrid or mixed 
mesh which is a combination of both the structured and unstructured meshes. The 
structured meshes are normally applied to regular shaped geometries such as the 
inlet pipe or the diffuser while the unstructured meshes are used on the more 
complex areas such as the impeller blades (Kido et al., 2006).  
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Figure 2-15: Structured mesh (top) and unstructured mesh (bottom) in 2D domain 
(Tu et al., 2013). 
II. The element-based classification 
Meshes of the CFD simulation could be generated in either 2-dimensional 
(2D) or 3-dimensional (3D) space depending on the type of the solving domain. For 
the 2D mesh, the elements are commonly formed in quadrilaterals or triangles. In 
the 3D element form, the common structures are hexahedral, tetrahedral, square 
pyramid and extruded triangles, as shown in Figure 2-16. 
 
Figure 2-16: Common 3D mesh type for CFD analysis. 
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Much of the commercial CFD software has a module or function for mesh 
generation but limited to only the tetrahedral element type on either unstructured or 
hybrid cells that allows some degree of control over the element sizing, while there 
are some specialized grid generation packages that are specifically designed for 
turbo machinery application and could provide the structured meshes with a better 
mesh quality for the pump (Katharine H. Fraser et al., 2011). Both types of mesh 
generation tools could provide accurate results under the appropriate configurations.  
Currently, unstructured and hybrid mesh with tetrahedral and hexahedral elements 
has tended to become the more common option for CFD simulation in recent pump 
research for its flexibility and conformability to the complex geometry (Burgreen et 
al., 2004; Kido et al., 2006; Legendre et al., 2008; Taskin et al., 2010a; Zhou, Zhao, 
Lee, & Winoto, 2003). Good quality mesh can be generated without a requirement 
for manual control over the grid generation which is a time consuming process, 
especially for design comparison or selection that is usually involved with mesh 
generation and simulation of several different models at a time (Katharine H Fraser 
et al., 2012; Taskin et al., 2012). 
2.4.3 Physical setup and boundary conditions 
In order to accurately simulate the flow process in CFD, it is imperative to 
specify the physical parameters such as the fluid properties and flow environments. 
The items in the flowchart in Figure 2-17 highlight the various flow physics that 
often are considered for the simulation setup. 
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Figure 2-17: Flowchart of physics for the CFD configuration (Tu et al., 2013). 
In the CFD application these physics items can be specified to the solver via several 
configuration options such as the frame of reference, fluid modeling, wall 
conditions, and boundary conditions. 
2.4.3.1 ) Boundary conditions 
Boundary conditions are the set of parameters applied to the domain surfaces 
to define the flow condition entering and leaving the domain, as well as the border 
of flow geometries such as the surrounding walls and internal obstacles within the 
domain (Tu et al., 2013).  
For the heart pump application the inlet and outlet boundaries are often set to 
either flow velocity or pressure when the value of these parameters are set to mimic 
the flow condition of either the left or right heart support function, but the steady 
flow condition is commonly assumed for the inlet and outlet boundaries instead of 
applying time varying boundary conditions to simulate the pulsatility of the inflow 
blood. The boundary conditions of VAD simulations by different authors are 
summarized in Table 2-1. 
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Table 2-1: Boundary settings and turbulence models used by different authors in 
CFD simulation of CF-VADs. 
Author and year Pump Type Application Flow boundary conditions 
Turbulence 
Model 
Tsukamoto et al., 
2000 Centrifugal LVAD 
Inlet : Q = 5.0 l/min,  
Outlet : P = 300 mmHg k-ε 
Apel et al., 2001 Axial LVAD Inlet = Constant velocity,  Outlet = Static pressure  k-ε 
Morsi, Yang, Witt, 
Ahmed, & Umezu, 
2001 
Centrifugal LVAD Inlet : Q = 6.0 l/min k-ε 
Song, 
Throckmorton, 
Wood, Antaki, & 
Olsen, 2003 
Centrifugal LVAD Q = 6.0 l/min, H = 100 mmHg k-ε 
Song, Wood, Day, & 
Olsen, 2003 Centrifugal LVAD 
Inlet : Q = 6.0 l/min 
Outlet = Static pressure k-ε / k-ω 
Burgreen et al., 2004 Centrifugal LVAD Q = 3, 7, 10 l/min - (Laminar) 
Song, 
Throckmorton, 
Wood, Antaki, & 
Olsen, 2004 
Centrifugal LVAD Q = 6.0 l/min, P = 100 mmHg k-ε 
Song, Wood, & 
Olsen, 2004 Centrifugal LVAD 
Inlet : Q = 2-10 l/min,  
Outlet: P = 20,000 Pa (150 
mmHg) 
k-ε 
Untaroiu et al., 2005 Axial LVAD Q = 2-10 l/min, H = 80-160 mmHg  k-ε 
Kido et al., 2006 Centrifugal LVAD Inlet : Q = 0.5-3l/min,  Outlet: P = 0 Pa  SST k-ω 
J. Zhang et al., 2006 Centrifugal LVAD Q = 1, 3, 5, 7 l/min - (no information) 
Throckmorton & 
Untaroiu, 2008 Axial LVAD 
Inlet : Constant velocity (Q = 
0.5-4 l/min) 
Outlet : P  = 20,000 Pa (150 
mmHg) 
k-ε 
Masuzawa, Ohta, 
Tanaka, Qian, & 
Tsukiya, 2009 
Centrifugal LVAD Q = 3, 5, 7 l/min k-ε 
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Medvitz, Boger, 
Izraelev, Rosenberg, 
& Paterson, 2011 
Centrifugal LVAD Q = 6 l/min - (Laminar) 
H. Wu, Wang, & Lv, 
2011 Axial LVAD Q = 6 l/min, H = 100 mmHg  k-ε 
J. Wu et al., 2012 Axial (Paediatric) LVAD Q = 1.5 l/min SST 
Selgrade & Truskey, 
2012 Centrifugal LVAD Q = 4, 7 l/min SST k-ω 
2.4.3.2 ) Fluid modelling 
For the CFD simulation, it is necessary to specify the accurate properties of 
the working fluid so that the solver can accurately calculate the flow behaviour 
including the interaction of the fluid to the surrounding boundaries. The basic 
properties of the fluid that typically need to be determined before conducting the 
simulation are phase, density, viscosity and compressibility, while other additional 
properties such as conductivity, specific heat and vapour pressure could be required 
depending on the level of details that are considered for the problem such as heat 
transfer, phase change or cavitation simulation. Therefore, the properties of human 
blood, which is a working fluid, for the heart pump need to be reviewed to 
accurately model the simulation.  
Human blood is a complex fluid comprised mainly of liquid plasma which is 
the fluid matrix of blood making up about 55% of total blood volume. The main 
components of plasma are water, proteins, ions, and dissolved nutrients. 
Erythrocytes or so called red blood cells (RBCs) is the second major component in 
blood that accounts for about 45% of volume while the remainder (<1%) are 
leukocytes or white blood cells and platelets. RBCs have a biconcave disk shape 
containing enzyme and hemoglobin. The cell wall is a soft membrane that allows 
the cell to be remarkably flexible and able to compress into various shapes and 
squeeze through narrow capillaries during circulation. There are an estimated 5 
million RBCs in a microlitre of blood, but the amount of RBCs is commonly 
expressed as a percentage of cells in total blood volume called hematocrit and is 
estimated in a typical range to be 40-54% for a human male (Silverthorn, 2014).   
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Figure 2-18: Human Blood Composition (Marieb & Hoehn, 2007). 
From the fluid mechanics point of view, blood is a non-Newtonian 
compressible fluid which, nevertheless, expresses Newtonian behaviour when the 
exerted shear rate is above 100 s-1 (Wells & Merrill, 1961, 1962; Woodcock, 1976) 
and, as most of the CF blood pumps generate a higher shear stress than this 
threshold, it is commonly defined as incompressible in the CFD simulations. In 
addition, blood in modelling is normally simplified and assumed to be a pure 
substance to avoid the complexity of the blood composition. The density and 
viscosity are typically considered as bulk properties referring to the value of real 
blood with estimated ranges of 1,040 – 1,060 kg/m3 and 0.0030 - 0.0036 Pa,  
respectively (Behbahani et al., 2009; Carswell et al., 2013; Kido et al., 2006; 
Masuzawa et al., 2009; Medvitz et al., 2011; Selgrade & Truskey, 2012; Song, 
Throckmorton, Wood, Antaki, et al., 2004; J. Wu, Paden, Borovetz, & Antaki, 
2010). 
2.4.3.3 ) Flow modelling 
In fluid dynamics, the fluid flow can be categorised based on the velocity 
distribution and the motion path into laminar and turbulent flow types. At the low 
Reynolds number flow where the inertia forces in fluid flows are smaller than the 
viscous force, the disturbances that occur during the flow are overcome by viscous 
forces and dissipated away which allows the flow to be smooth without disturbance. 
This type of flow and is called laminar flow. The laminar flow is simple and smooth 
so its flow properties can be simply described using the continuity and momentum 
equations. However, at a high Reynolds number, the inertia forces can lead to a 
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large disturbance that becomes dominant and influences a random and chaotic flow 
motion described as turbulence flow. This type of flow is much more complex and 
harder to predict as it associated with a random swirling flow motion called eddies 
or vortices that cause random velocity fluctuation.  
In the rotating pump, the flow regime can be identified by the Reynolds number 
calculated from the equation: 
   ܴ݁ ൌ ߩ߱ܦ
ଶ
μ  [2-7] 
Where:  Re = Reynolds number 
   ρ = Fluid Density 
   ω = Angular velocity of the impeller 
   D = Outer diameter of the impeller 
   µ = Fluid viscosity  
For the rotating pump the transition from laminar to turbulence flow occurs 
around Re = 105 (Song, Throckmorton, Wood, Allaire, & Olsen, 2004) . The nature 
of the rotating blood pump involves a high impeller speed which causes high 
disturbance to the flow, and hence turbulence flow is typically assumed for the CF 
blood pump (May-Newman, 2010). 
I. Navier-Stokes equations 
The Navier-Stokes equations developed by Claude-Louis Navier and George 
Gabriel Stokes are a set of governing equations that are most commonly used to 
describe the motion of viscous fluid. The foundation of these equations is the 
conservation laws, specifically the conservation of mass, momentum and energy. It 
is useful for describing many flow applications in scientific and engineering 
interests as it could provide a description of the chaotic nature of turbulence flow, 
although it would require a large computational effort or some special technique for 
complex flow problems. 
The main continuity equations in the stationary frame can be written as 
follows: 
Conservation of mass  
 ߜߩߜݐ ൅ ׏ ∙ ሺߩܷሻ ൌ 0 [2-8] 
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Conservation of momentum 
 ߩ݃ െ ׏ߩ ൅ ׏ ∙ ߬୧୨ ൌ ߩ ܷ݀݀ݐ  [2-9] 
Conservation of energy  
 ߩ ݄݀݀ݐ 	ൌ 	
݀ܲ
݀ݐ ൅ ߘ ∙ ሺ݇ߘܶሻ ൅ ߶ [2-10] 
Conservation of scalar quantities 
 ߲ሺߩ߶ሻ߲ݐ ൅ ߘሺߩ߶ܸሻ ൌ
݀ܲ
݀ݐ ൅ ߘ ∙ ሺ݇ߘܶሻ ൅ ߶ [2-11] 
In addition to these main equations, fluid flow can be fully described with 
other additional equations in which the number or type of the equation needed 
depends on the required information, which may include the boundary data, heat 
flux, conservation of mass or an equation of state.   
II. Reynolds average equations  
There are several approaches to solving the Navier-Stokes equations for the 
simulation of turbulence flow. The method known to be the most accurate flow 
simulation and with the simplest concept is the Direct Numerical Solution (DNS) 
which directly solves the Navier-Stokes equations without using approximating or 
averaging parameters other than numerical discretizations (Ferziger & Peric, 1996; 
Tu et al., 2013). However, solving complex Navier-Stokes equations requires a 
large amount of computational power so it is not a practical approach for most 
applications.  
Another method for modelling the turbulence is called the Large Eddy 
Simulation (LES) method, which focuses on solving the large scale eddy that is 
more dominant in turbulence flow. This method is much less costly than the DNS 
method but still too demanding for complex geometry and high turbulence flow (Tu 
et al., 2013). 
In most engineering applications, only a few quantitative flow properties are of 
interest and need to be accurately identified. The high accuracy approaches like 
DNS and LES would waste more resources than necessary. Therefore the Reynolds-
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averaged method that produces less information but sufficient engineering 
approximation values is often considered to be a more flexible option for the 
complex flow and hence has been the most popular approach for the turbulence 
simulation. 
In this method, the time averaging of all the variables is used in the 
calculation to avoid the fluctuations in the flow properties. The Reynolds 
decomposition technique is used for this averaging calculation under the assumption 
that any flow property (߶ሻ can be written as the sum of a time-averaged value (߶തሻ 
and a fluctuation about that value (߶ᇱሻ (Ferziger & Peric, 1996): 
 ߶ሺݔ௜, ݐሻ ൌ ߶തሺݔ௜ሻ ൅ ߶ᇱሺݔ௜, ݐሻ [2-12] 
 
Where  ߶തሺݔ௜ሻ is the steady flow described as: 
 ߶ሺݔ௜ሻ ൌ lim் →∞
1
ܶන ߶ሺݔ௜, ݐሻ
்
଴
݀ݐ [2-13] 
 
For the unsteady flow, the averaged variables are described as: 
 ߶തሺݔ௜, ݐሻ ൌ lim் →∞
1
ܰ෍߶ሺݔ௜, ݐሻ
ே
௡ୀଵ
 [2-14] 
Where:  t = unit of time 
   T = the averaging interval 
   N = the number of the members of the ensembles (must 
be large enough to eliminate the fluctuations) 
With the Reynolds decomposition in equation [2-12] the instantaneous 
velocity ݑ௜ሺݔ, ݐሻ can also be expressed as the sum of the mean velocity and a 
fluctuation part (Figure 2-19) so that: 
 ݑ௜ሺݔ, ݐሻ ൌ ௜ܷሺݔሻ ൅ ݑ௜ᇱሺݔ, ݐሻ [2-15] 
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Figure 2-19: Velocity plot of turbulence flow compared to the steady mean velocity 
component (Tu et al., 2013).  
Applying these averaged velocity components of the Navier-Stokes 
equations to the conservation of mass and momentum under the assumption of an 
incompressible and constant property flow yields the equation called a Reynolds-
averaged Navier-Stokes (RANS) equation: 
 ߩ డ௎೔డ௧ ൅ 	ߩ ௝ܷ
డ௎೔
డ௫ೕ 		ൌ െ
డ௉
డ௫೔ ൅
డ
డ௫೔ ሺ߬௜௝ െ ߩݑᇱఫݑᇱపതതതതതതത ) [2-16] 
Where: ߬௜௝ = Viscous stress. 
The term ߩݑ′ఫݑ′పതതതതതതത in equation [2-16] has a fluctuating contribution to the non-
linear acceleration terms and acts as though it was a stress, hence it is called the 
"Reynolds stress tensor" (George, 20013). Introducing this term results in six 
unknown quantities and, along with the pressure and three velocity components, 
there are a total of ten unknowns. However, the available equations are only the 
mass conservation and the three components of the RANS equation (equation 
[2-16]), which sum up to four equations in total. This  means there are currently 
more unknowns than the available equations and the system is not closed or 
unsolvable (David C. Wilcox, 1998) . In normal problems, a straightforward 
solution would be to develop an extra partial differential equation (PDE) for each 
term from the original NS equations, but for this case it will introduce more 
correlations for the unknowns (Saad, 2011). Therefore, an alternative approach is to 
introduce an approximation to the Reynolds stress term, which is called the 
"turbulence model". 
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2.4.3.4 ) Turbulence model 
There are several types of turbulence modelling to close the equations; one 
of the common approaches for CFD applications is the "eddy viscosity model" 
which assumes that turbulence consists of small eddies and the Reynolds stresses 
have a proportional relation to the mean velocity gradients, and the stress at a point 
of an interested  time is the result of velocity everywhere from the past time to that 
certain point (Davidson, 2003; George, 20013). Therefore, the transport equations 
need to incorporate nonlocal and flow history effects of the eddy viscosity (μ௧ሻ; 
hence the  turbulence kinetic energy, k, was chosen for the velocity scale in the 
energy equation (David C. Wilcox, 1998). 
The eddy viscosity is described as: 
 ߤ௘௙௙ ൌ ߤ ൅ ߤ௧ [2-17] 
Where:   ߤ௘௙௙ = Local effective viscosity 
  μ = Local molecular viscosity 
  ߤ௧  = Local turbulent viscosity  
The turbulence kinetic energy relationship to the velocity scale is given as: 
Turbulence energy equation 
To form the equation of turbulence energy, the Boussinesq eddy viscosity 
assumption was used to approximate the momentum transfer caused by the 
turbulence eddy. This assumption states that the Reynolds stress tensor, 	߬௜௝,  has a 
proportional relationship to the strain rate tensor, ߪ௜௝ , as follows:  
 ߬௜௝ ൌ 	2μ௧ߪ௜௝ ൅ ଶଷ ߜ௜௝ߩ݇  [2-19] 
For the compressible flow ߪ௜௝ = 0, hence the equation is reduced and contracted to 
	߬௜௜ ൌ 	െ2݇.   
 ݇ ൌ 	12 ݑ′పݑ′పതതതതതതത ൌ
1
2 ሺݑᇱ
ଶതതതത ൅ ݒᇱଶതതതത ൅ ݓᇱଶതതതതതሻ [2-18] 
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According to these assumptions, the equation of the turbulence energy and 
eddy viscosity was developed on the basis of the RANS equation in the following 
form: 
 ߲ߩ߲݇ݐ ൅	 ௝ܷ
߲ߩ݇
߲ݔ௝ ൌ 	ߩ߬௜௝
߲ ௜ܷ
߲ݔ௝ െ ߩߝ ൅
߲
߲ݔ௝ ቈ൬μ ൅
μ௧
ߪ௞൰
߲݇
߲ݔ௝቉ [2-20] 
Where: ε = Eddy dissipation rate 
  ߪ௞ = Closure coefficient.  
The experiment results suggests ߪ௞ ൌ 1.0 (David C. Wilcox, 1998). 
This equation is known as the "turbulence energy equation" which is an 
important equation that is used as a basis for all turbulence energy equation models.  
The variable "ε" in this equation is the turbulence eddy dissipation which is 
defined as the dissipation rate of k. It could be assumed as: 
 ߝ ~ ݇
ଷ ଶൗ
݈  [2-21] 
Where: l = Turbulence length scale; describes the size of large eddies 
There are two unknown parameters in this equation which are ε and l. The methods 
of approximating these variables are provided with the turbulence models.   
In the eddy viscosity turbulence models, the method available for 
approximating the unknowns in the RANS equation could be categorized by the 
number of the additional PDEs that are used for closing the equations, which range  
from the zero-equation model which introduces no additional PDE to the  two-
equation model that adds two PDEs for solving the unknowns.  
I. Zero-equation models (algebraic models) 
As the name suggests, this approach does not employ any additional PDEs 
to describe the transport equation; instead, the turbulent viscosity or so called eddy 
viscosity is calculated as a global value from an algebraic equation as a product of a 
turbulent viscosity scale,	 ௧ܷ, and a turbulence length scale,	݈. 
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 ߤ௧ ൌ ߩ ఓ݂ ௧ܷ݈ [2-22] 
Where ఓ݂ is a proportionality constant and the length scale is calculated from the 
formula: 
 ݈ ൌ
൬ ஽ܸ
ଵ ଷൗ ൰
7൘  
[2-23] 
Where: ஽ܸ = Volume of the fluid domain. 
Solving the transport equations using the zero-equation models requires the least 
computational effort, but it is not recommended as it does not adequately 
incorporate the physical foundation of the system, and hence is not accurate enough 
for use in general flow problems, except only for simple flow geometries or as an 
initial computation for the more complex methods (ANSYS, 2009). 
II. One-equation models 
Prandtl's (Prandtl & Wieghardt, 1947) model is one of the most widely 
known original one-equation turbulence models. It solves the transport equation for 
a turbulent quantity using the turbulence dissipation, ε, which is the function of 
turbulence kinetic energy, k, and the length scale that is described as an estimated 
function in equation [2-21], but the closure coefficient,	ܥ஽, was introduced for the 
approximation as follows:  
 ߝ ൌ ܥ஽݇
ଷ ଶൗ
݈  [2-24] 
Where:  ܥ஽ = Closure coefficient. The empirical data estimate this value 
between 0.07 and 0.09 (David C. Wilcox, 1998). 
  ݈  = Turbulent length scale. 
The eddy viscosity is then described as: 
 μ௧ ൌ ݇ଵ ଶൗ ݈ = ܥ஽݇ଶ/ߝ [2-25] 
Therefore, the turbulence energy equation from equation [2-20] can be written as 
follows:  
 ߲ߩ߲݇ݐ ൅	 ௝ܷ
߲ߩ݇
߲ݔ௝ ൌ ߩ߬௜௝
߲ ௜ܷ
߲ݔ௝ െ
ߩܥ஽݇
ଷ
ଶ
݈ ൅
߲
߲ݔ௝ ቈ൬μ ൅
μ்
ߪ௞൰
߲݇
߲ݔ௝቉ 
[2-26] 
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Where:   ߪ௞  =  1.0 
III. Two-equation models 
In this approach the transport equations are derived from two scalar 
parameters, the first value often relies on the turbulence kinetic energy while the 
second value could be turbulence length scale or another equivalent. The two-
equation models that are often used in CFD simulation are the k-ε and k-ω models 
in which the second values are turbulence eddy dissipation (ε) and specific rate of 
dissipation (ω), respectively. 
k-ε model 
As mentioned above, in the k- ε model, the turbulence kinetic energy and the 
turbulence eddy dissipation are used to derive additional transport equations by 
relating to the turbulent viscosity (μ௧ሻ	as follows: 
 μ௧ ൌ ߩܥஜ ݇
ଶ
ߝ  [2-27] 
and expressed to the turbulent kinetic energy equation given in Equation 
[2-26].  
 ߲ߩ߲݇ݐ ൅	 ௝ܷ
߲ߩ݇
߲ݔ௝ ൌ 	ߩ߬௜௝
߲ ௜ܷ
߲ݔ௝ െ ߩߝ ൅
߲
߲ݔ௝ ቈ൬μ ൅
μ௧
ߪ௞൰
߲݇
߲ݔ௝቉ [2-28] 
The second equation is written in terms of the dissipation rate as:  
 ߲ߩߝ߲ݐ ൅	 ௝ܷ
߲ߩߝ
߲ݔ௝ ൌ 	ܥఌଵ
ߝ
݇ ߩ߬௜௝
߲ ௜ܷ
߲ݔ௝ െ ܥఌଶߩ
ߝ
݇
ଶ
൅ ߲߲ݔ௝ ቈ൬μ ൅
μ௧
ߪఌ൰
߲ߝ
߲ݔ௝቉	 [2-29] 
Where the closure coefficients suggested by Wilcox (David C. Wilcox, 
1998) are as follows: 
ܥఌଵ = 1.44, ܥఌଶ ൌ 1.92,   ܥஜ = 0.09, ߪ௞ = 1.0,  ߪఌ = 1.3  
The k-ε model is one of the most widely used turbulence models for CFD 
simulations in various fields of study, including the CF heart pump simulation 
(Table 2-1), with many successful results with validations. It is known for its 
robustness, ease of implementation and being computationally cheap. However, the 
major weakness of this model is the lack of sensitivity to the adverse pressure 
gradient and strong flow separation as well as low performance in analysing the 
viscous sublayer (Davis, Rinehimer, & Uddin, 2012; Florian R Menter, 1993; F. R. 
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Menter, 1994). With these pros and cons, the k- ε model is suitable for design 
comparison and optimization which are involved with comparing several conditions 
or geometries, while it should be avoided for implementation on an application with 
a drastic pressure gradient.       
k-ω model 
The standard k- ω model was originally developed by Wilcox (David C 
Wilcox, 1988; David C. Wilcox, 2008) . As well as the k-ε model, it attempts to 
predict turbulence by two PDEs and also solve the turbulence kinetic energy, k, as a 
first parameter, but it introduces ω which is described as "the rate of dissipation of 
energy in unit volume and time" (David C. Wilcox, 1998) or the so called specific 
dissipation rate or turbulent frequency as the second parameter in the model. 
The relation of k and ω with the eddy viscosity is written as:  
 ߤ௧ ൌ ߩ ݇߱ [2-30] 
For this model, the turbulence eddy dissipation is related to the specific 
dissipation rate, ω, as follows: 
 ߝ ൌ ߚᇱ݇߱ [2-31] 
Therefore, the turbulence kinetic energy equation [2-26]) can now be written 
as:  
 ߲ߩ߲݇ݐ ൅	 ௝ܷ
߲ߩ݇
߲ݔ௝ ൌ ߩ߬௜௝
߲ ௜ܷ
߲ݔ௝ െ ߩߚ
ᇱ݇߱ ൅ ߲߲ݔ௝ ቈ൬μ ൅
μ௧
ߪ௞൰
߲݇
߲ݔ௝቉ [2-32] 
And the second equation to describe the specific dissipation rate is:  
 ߲ߩ߲߱ݐ ൅	 ௝ܷ
߲ߩ߱
߲ݔ௝ ൌ ߙ
߱
݇ ߩ߬௜௝
߲ ௜ܷ
߲ݔ௝ െ ߚߩ߱
ଶ ൅ ߲߲ݔ௝ ቈ൬μ ൅
μ௧
ߪఠ൰
߲߱
߲ݔ௝቉ [2-33] 
Where the model coefficients are given as (ANSYS, 2009): 
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β' = 0.09, α = 5/9, β = 0.075, ߪ௞ = 2.0,  ߪఠ = 2.0  
This model performs better in predicting the complex boundary layer flows under 
an adverse pressure gradient, so it is suitable for external aerodynamics and 
turbomachinery with a large pressure difference. However, implementation is 
slightly more complex and more computationally costly as it requires a fine mesh 
resolution near the wall; moreover, the prediction of separation tends to be early and 
overestimated.  
SST k-ω model 
The SST k-ω model is a variation of the k-ω model developed by Menter 
(Florian R Menter, 1993). It is the combination of the k-ε and k-ω by employing the 
k-ω formulation in the viscous sub-layer and switching to the k-ε in the free stream.  
The k-ε, k-ω and SST k-ω models have been used in VAD studies and have 
all been reported to have successfully predicted the flow in the pump, but yet there 
is no study that conducts a full investigation or provides the standard to compare the 
accuracy between these models. Song et al. (Song, Wood, et al., 2003) suggested 
that the flow visualization plot from the k-ω model in the near-wall regions has 
better agreement with the particle image velocimetry results than what is observed 
from the k-ε model. However, Throckmorton et al. (Throckmorton & Untaroiu, 
2008) later made a suggestion, based on their verification data of a miniature axial 
blood pump, that the bulk flow parameters from the k-ε model correlated more 
closely to the experimental results than the SST k-ω model.   
2.4.4 Unsteady Flow and the Moving Domain 
In the operation of CF-VADs, the change of flow rate and pressure including 
the rotation of the impeller causes the flow and hydraulic forces variations to the 
pump. These variations of the in-flow properties can be simulated by either applying 
the time varying boundary conditions in the transient analysis or using the average 
flow condition in the steady state simulation. 
The motion of the CF-VAD impeller is generally limited to the rotation 
about the axis and there are two approaches available for the calculation of the 
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moving domain; these are the multiple frames of reference (MRF) and sliding 
mesh methods. The MRF method does not physically move the grid of the moving 
domain but instead approximates the impeller motion using the relative velocity 
between the static and rotating domains under the assumption of constant velocity; 
therefore, this method is used on the steady state simulation. The sliding mesh 
method has a different approach for solving the rotating domain by updating the 
mesh position periodically based on the defined time step, so it is used for modeling 
the transient effects (Katharine H. Fraser et al., 2011).  
In order to find the necessity of the transient settings in the CF-VAD 
simulation, Song et al. (Song, Throckmorton, Wood, Allaire, et al., 2004) conducted 
a series of simulations comparing between a steady state simulation and three 
transient simulations in the first of which the condition simulated blade rotation 
under the average inlet flow using a sliding interface technique on the rotor 
(Transient Rotational Sliding Interfaces - TRSI) , while in the second the condition 
incorporated a time varying inlet volumetric flow rate (time varying boundary 
condition - TVBC) over one heart cycle, and, finally, in the third the condition 
combined both the TRSI and TVBC so that it simulated the closest condition to the 
VAD operation in the heart pulse environment. The results showed that the 
disturbance of the flow and forces caused by the varying inlet flow rate were 
insignificant, however the effect of blade rotation in the TRSI setting was much 
greater and shows a significant influence over the results. 
Despite the large effect of the flow variation from the impeller rotation, there 
are very few studies which have adopted the transient model for CF-VAD 
simulations (Burgreen et al., 2004; Chua, Song, Lim, & Zhou, 2006; Curtas et al., 
2002; Morsi et al., 2001; Yamane, Miyamoto, Tajima, & Yamazaki, 2004) as most 
of the VAD studies use a CFD simulation as a preliminarily overview of the pump 
geometry designs and the steady state could provide sufficient information with 
lower computational resources.   
2.4.5 Blood damage model 
As previously discussed, blood damage is one of the major concerns for 
pump design that should be optimised during the design and evaluation phase of 
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development; it is, however, one of the most difficult factors to assess because of 
the large biological diversity and chemical properties that could easily be affected 
by a small variation in the test conditions or handling during blood preparation, and 
hence the test results are almost non-reproducible. Moreover, the blood damage 
generation of the devices is typically evaluated in the test loop that needs a large 
volume of testing fluid to operate, and human blood would be ideal for obtaining an 
accurate result; however, it rarely is available in a large enough quantity for the 
experiment, hence animal blood, such as bovine, is often the preferred option for 
most studies (Katharine H Fraser et al., 2012; Goubergrits & Affeld, 2004; Gu & 
Smith, 2005; Song, Throckmorton, Wood, Antaki, et al., 2004; T et al., 2003; 
Taskin et al., 2012; T. Zhang et al., 2011). However, the blood of different animal 
species has difference rheological properties and RBC membrane fragility (Jikuya, 
Tsutsui, Shigeta, Sankai, & Mitsui, 1998) which could cause a large variation or 
error in the results. Therefore, there have been several attempts to govern the 
transport equation to predict the breakage of RBC for the CFD simulation to 
compare the damage during design optimization without having to undertake the 
complications in the experiment.  
The first model for damage calculation in artificial organs, which was 
widely accepted and became the foundation of many later developed models, was 
proposed by Giersiepen et al. (Giersiepen, Wurzinger, Opitz, & Reul, 1990). It was 
a power law established on empirical data obtained by Wurzinger et al. (Wurzinger, 
Opitz, & Eckstein, 1986) under the assumption that blood damage is only dependent 
on shear stress and exposure time, and it is formulated as: 
 ܦ ൌ ݀ܪܾܪܾ ൌ ܥ ߬ఈݐఉ [2-34] 
 
Where :  D = Damage fraction 
  dHb/Hb  = Ratio of plasma free hemoglobin to total hemoglobin 
  τ  = Shear stress  
  t  = Exposure time 
 C, α, and β denote constants which have the values originally proposed by 
Giersiepen as C = 3.65 x 10-5, α = 2.416 and β = 0.785. This set of constants has been 
widely used but is also thought to be overestimated (Grigioni et al., 2004), hence it has been 
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replaced several times by some investigators for different applications and conditions; one 
of the most widely used sets is proposed by Heuser et al. (Heuser & Opitz, 1979) with the 
values of 1.8 x 10-8, 1.991 and 0.765 that are available for t < 0.6s and τ < 700 Pa. However, 
Wu et al. (J. Wu et al., 2010) conducted a simulation and experiment on centrifugal blood 
pumps comparing Giersiepen and Heuser's constants and found that both models yield no 
significant difference and could closely estimate the value of hemolysis generated by the 
heart pump. 
In CFD simulation of VADs, this power law is also widely implemented for 
the estimation of blood damage generated from the devices via the post processing 
techniques. The implementation of a blood damage model can be categorized by the 
frame of reference in either Lagrangian or Eulerian coordinates. The Lagrangian 
method relies on calculating the shear stress exerted on each individual blood cell 
particle as it flows through the device, while the Eulerian method considers the 
damage over the whole domain at a certain point of time.  
I. Lagrangian method 
The blood damage estimation using the Lagrangian method could be done 
by the particle tracking technique which releases particles at the inlet of the pump 
and integrates the damage function along the pathlines; then, the total blood damage 
is calculated from the average damage to the individual particles. Since each blood 
cell particle could have a large variation in the shear stress and exposure time due to 
the various numbers of trajectory paths in many different flow channels, the 
accuracy of this method is dependent on the number of the tracked particles where 
the more particle numbers could cover more possible trajectories of the cell and 
hence more accuracy of the result. In a recent study, it was found that an estimated 
1,100 particles are sufficient for the calculation in the blood pump (Taskin et al., 
2012) ,but this number could be varied with different sizes of the device.   
According to Giersiepen's power law model in Equation [2-34], the total 
damage along the pathline from the inlet to the outlet of the device can be calculated 
as follows: 
 ܦ ൌ	׬ ܥ௢௨௧௟௘௧௜௡௟௘௧ ∙ ݀ݐఈ ∙ ߬ఉ = ∑ ܥ ∙ ߂ݐ௜ఈ ∙ ߬௜ఉே௜ୀଵ  [2-35] 
Where:  N  = Number of observation points along the pathline. 
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  ݐ௜  = Time that the particle spent from the starting point to reach 
the ݅th observation point. 
This equation has been adopted by several authors with various sets of 
constants (W. K. Chan, Wong, Ding, Chua, & Yu, 2002; Mitoh et al., 2003; Pinotti 
& Rosa, 1995; Song, Throckmorton, Wood, Antaki, et al., 2004; T et al., 2003; J. 
Wu et al., 2012; Y. Zhang et al., 2008). However, Grigioni et al. (Grigioni et al., 
2004; Grigioni, Morbiducci, D’Avenio, Benedetto, & Gaudio, 2005) suggested that 
the method of summing the individual damage along the pathline with Equation 
[2-35] could not reflect the cell with sub-lethal damage that may later be destroyed 
under the sustaining shear stress. Therefore, Equation [2-36] which could add up the 
damage contribution as the erythrocyte moves along the pathline was proposed:  
 ܦ ൌ 	෍ܥܽ ቎෍߬ሺݐ௝ሻ௕/௔߂ݐ
௜
௝ୀଵ
቏
௔ିଵ
߬ሺݐ௝ሻ௕/௔߂ݐ
ே
௜ୀଵ
 [2-36] 
The accuracy of these 2 equations was compared by Fraser et al. (K. H. 
Fraser, Taskin, Zhang, Griffith, & Wu, 2010) using both the centrifugal and axial 
types of blood pump and using Taskin's constant set. The results from the 
centrifugal pump simulation showed that Equation [2-35] yields less than a 10% 
error compared to the experimental results while Equation [2-36] over-predicted the 
hemolysis for this pump. It is unfortunate that the results from the axial pump in this 
study were not clearly reported, thus it is not possible to verify whether the 
hemolysis prediction was accurate for the different shear range.  
Another hemolysis estimation method on the Lagrangian frame that takes 
the shear loading history into account was proposed by Goubergrits et al. 
(Goubergrits & Affeld, 2004). This method modified Giersiepen’s power law model 
(Equation [2-34]) by dividing the pathline into small increment time steps, so that 
the shear stress can be assumed to be constant in each step. The damage index D 
along the pathline can then be given by: 
 ܦ	ሺݐ ൅ ߂ݐሻ ൌ ܥ ∙ ൫ݐ௘௙௙ ൅ ߂ݐ൯ఈ ∙ ߬ሺݐ ൅ ߂ݐሻఉ    [2-37] 
Where ݐ௘௙௙ is defined as a virtual time step which can be calculated as: 
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 ݐ݂݂݁ ൌ ൬ ܦሺݐሻܥ ∙ ݐሺݐ ൅ ߂ݐሻߚ ൰
ߙ
 [2-38] 
The C, α and β constants in this model were based on the original 
Giersiepen’s constant; however, the experiment by Taskin et al. (Taskin et al., 2012) 
shows that it considerably over-predicted the damage on both the axial and 
centrifugal pump while Heauser's constant set yielded closer results but they were 
still slightly lower than those obtained from the actual experiment.  
The accuracy of this method depends on the number of particles that are 
released to the pump but it takes more computational power as more particles are 
tracked.  
II. Eulerian method  
In the Eulerian approach, the damage index is calculated by an integration of 
the damage function over the entire fluid domain which is usually done by 
transforming the equation from the Lagrangian to the Eulerian frame. This approach 
generally requires less computational power than the Langrangian method as it is 
not required to calculate the particles’ trajectories, and the accuracy of damage 
prediction is hence relying on the mesh structure. 
Garon and Farinas (Garon & Farinas, 2004) proposed the hemolysis 
estimation method based on Giersiepen’s empirical model in Equation [2-34] with 
the original constant set, by proposing the linear damage (DI) as follows: 
 ܦூ ൌ 	ܦଵ/଴.଻଼ହ ൌ ሺ3.62 ݔ 10ି଻ሻଵ/଴.଻଼ହ ߬ଶ.ସଵ଺/଴.଻଼ହ	ݐ [2-39] 
This equation was formed from the experimental results of blood exposed to 
different levels of constant shear stress and exposure time. Therefore, it could be 
simplified by the time derivative to remove the time dependency and thus the 
equation could be transformed from the Lagrangian to the Eulerian frame under the 
assumption of incompressible fluid, resulting in the average linear damage 
generated by the device (ܦഥூሻ : 
 
 
78 Mechanism Design of Ventricular Assist Device 
 
 ܦഥூ ൌ
1
ܳ නߪ ܸ݀
௏
 [2-40] 
Where: V  = Finite volume 
  ߪ   = Scalar shear stress 
In the Eulerian frame, the damage D from the device is then given by: 
 ܦ ൌ ሺ ܦഥூሻ଴.଻଼ହ  [2-41] 
This study also gives the relation of the damage function D and the 
normalised index of hemolysis (NIH) which is available when the quantity of 
plasma-free haemoglobin is small in relation to the amount of total haemoglobin by 
reducing Equation [2-4] to: 
  ܰܫܪ ൌ ܪܾ ൈ ܦ ൈ 100  [2-42] 
This hemolysis calculation approach was employed by several research 
groups for blood pump developments (Medvitz et al., 2011; J. Zhang et al., 2006), 
and yields close results to the experimental measurement of hemolysis conducted by 
Taskin et al. (Taskin et al., 2012).  
The calculation of blood damage with this approach is conducted in the post-
processing, therefore it can be done without adding to the computational load 
required during the simulation process. However, the drawback is it that it cannot 
identify the location of the damage source because it only provides a global index 
over the whole device. 
Another hemolysis estimation method in the Eulerian frame is proposed by 
Taskin et al. (Taskin et al., 2010b) which introduced a scalar function of plasma-
free haemoglobin ሺ߂ܪܾ′ሻ that is defined as: 
 ߂ܪܾᇱ ൌ ߂ܪܾଵ/ఈ [2-43] 
And the scalar transport equation is formulated as follows: 
 ݀ሺ߂ܪܾᇱሻ
݀ݐ ൅ ݒߩߘ ሺ߂ܪܾ
ᇱሻ ൌ ܵ [2-44] 
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Where S in the above equation is the source term which is defined as: 
 ܵ ൌ ߩ ሺܪܾ ∙ ܥ ߬ఉሻଵ/ఈ [2-45] 
Along with the new hemolysis model, Taskin et al. also obtain a new set of 
constants from the experiment on the shearing device from bovine blood as C = 
1.21 x 10-5, α = 0.747 and β = 2.004. The damage index (D) of the device could 
then be calculated from the mass-weighted average of Hb at the outlet divided by 
Hb. 
This hemolysis model calculated the post-processing process as well as 
Garon and Farinas' model, but its advantage is that it can directly provide localized 
information on the high hemolysis regions which is valuable information for the 
design optimization of the devices. However, the validation of this model on the 
experimental results that was later conducted by Taskin et al. (Taskin et al., 2012) 
with three different set of constants found that it had made a considerable over-
prediction. Fraser et al. (Katharine H Fraser et al., 2012) later optimized this model 
by suggesting a new set of constants: C = 1.745 x 10-6, α = 1.963 and β = 0.7762 
which could greatly improve the accuracy of the hemolysis prediction for both the 
centrifugal and axial pump designs. 
Comparison of Lagrangian and Eulerian approaches  
The comparative investigation and experimental validation of the three 
Lagrangian and two Eulerian approaches reviewed here were conducted by Taskin 
et al. (Taskin et al., 2012) with three different sets of constants (proposed by 
Giersiepen's, Heauser's and Zhang's constants) on an axial blood flow shear device 
that was designed based on the Jarvik 2000 heart pump and the Centrimag heart 
pump. However, for the Garon and Farinas' model, the authors used the nonlinear 
damage form (equation [2-39]) in the Langragian frame in the study; hence, the 
result of the Eulerian model (equation [2-40]) was not confirmed. 
According to the results, Giersiepien's model (equation [2-34]) tends to 
predict the highest hemolysis value  compared to the other models in both pump 
designs, while the rest of the models (equations [2-35], [2-36], [2-37], [2-39] and 
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[2-44]) give smaller difference values between the models. The accuracy of the 
blood damage prediction in this study was greatly affected by the constant used with 
the model. Giersiepen's constants overestimated the damage as well, as was seen in 
other previous studies, while Heauser's constants have overall results slightly closer 
to the experiments than Zhang's set of constants. 
All the available damage models presented too large a percentage of errors 
to be viable options for the damage prediction of the device, as the minimum error 
from the Lagrangian method was 57% while it was as high as 91% in the Eulerian 
method. Furthermore, the prediction results from these studies also show a different 
percentage of error compared to the model validation in other studies (K. H. Fraser 
et al., 2010; Gu & Smith, 2005; Song, Throckmorton, Wood, Antaki, et al., 2004), 
which could be caused by variation of the blood handling and the testing procedures 
that are uncontrollable (Goubergrits & Affeld, 2004); moreover, currently there is 
no standard procedure available for the blood shear test.  However, it is still possible 
to use these simulation methods for the relative prediction of hemolysis in the 
comparative studies such as the design optimization or ranking the damage 
generation of different heart pumps.  
2.5   REVIEW SUMMARY 
The number of heart failure patients has been increasing and has become one 
of the greatest global healthcare concerns, while the effective treatment for severe 
cases is still limited to the heart transparent which is greatly restricted by the 
availability of donor hearts. The VADs have become an alternative option to relieve 
the requirement for heart replacement with the flexibility to support both sides of 
ventricle failure, although use as a biventricular support still faces complications as 
it requires two devices to be implanted. Long-term clinical trials have confirmed the 
advantages of VADs over medical therapy for sustaining patients in temporary 
support for the BTT and BTR while having the potential to become the preferable 
option for use as a permanent support or DT in the near future. 
The recent development of VADs has been focusing on improving the 
reliability and hemodynamic capability to increase the device’s life span while 
attempting to reduce the pump size to be implantable in the small body of a 
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paediatric patient. The review has included the essential design concerns that need 
to be considered for heart pump development, starting with the mechanical 
durability which has improved from the pulse generation mechanism used at the 
dawn of VAD development to a more reliable rotating impeller and, eventually, a 
magnetically levitating impeller that completely removes the mechanical wear and 
that has been in development and is in clinical trials at present. The hemolysis or 
blood damage generation from the pump is also a major concern as it is still a major 
contributor to the problematic incidents that reduce the survival rate of long-term 
patients. It is caused by the exposure of RBC to the excessive shear stress over the 
period of time. In the CF pump this shear stress generation is related directly to the 
blade design and the impeller’s rotating speed, so the high risk regions, such as the 
leading edge of the impeller and the volute tongue, must be carefully designed and a 
design with a lower specific speed would be more preferable. Another 
hemodynamic concern is thrombosis or blood clot that is likely to form in the 
recirculation and stagnation region of the pump and could cause a performance drop 
or mechanical failure and could be lethal if the clot breaks free into the blood 
stream; hence, flow visualizations are typically employed to ensure that 
recirculation and stagnation are not present in the pump. 
This literature review included a comparison between two common designs 
of the current generation of CF VADs, the axial flow and centrifugal pumps. The 
axial flow pump has a more compact design but the trade-off is a lower capacity and 
performance, so that it requires a much higher pump speed than the centrifugal 
pump to deliver the same head and flow rate. This also leads to a higher risk of 
mechanical wear if the pump has a contact surface or bearing, and also increases the 
chance of shear stress induced hemolysis; so, the centrifugal pump tends to be a 
more preferable option for the design of a VAD that is aimed for long-term support. 
In the development of the heart pump, CFD has proved to be a powerful tool that 
provides the detailed results that cover most of the design aspects from 
hydrodynamic estimation to hemolysis and thrombosis prediction, as well as design 
selection and optimisation. Employing CFD for heart pump development could help 
to save costs and time by reducing the number of prototypes required for initial 
evaluations; hence, the latter part of this literature review outlined the current use of 
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CFD for VAD design and the simulation techniques for heart pumps to effectively 
obtain significant information from the CFD simulation.  
The CFD analysis of VADs starts with creating the fluid model that reflects 
the fluid domain within the pump. For the CF-VADs, the model is typically divided 
into the rotating domain, which is the fluid within and around the impeller hub, and 
the stationary or other areas in the pump. The domain is then subdivided into 
smaller elements with the mesh generation process to simplify the model for the 
numerical calculations. The unstructured mesh offers better flexibility over the 
complex geometries and allows automatic generation with some degree of control 
over the element size, so it is often preferred for the VAD simulation, but some 
prefer the hybrid mesh for better element quality.  
The pre-processing or simulation setup is one of the most important stages 
that greatly influence the accuracy of the simulation results. The physics set up for 
the flow problems could be done via the configuration of boundary conditions, fluid 
properties, turbulence model and frame of reference. From the literature review, 
most of studies have been focusing on LVAD simulation, and the boundary 
conditions are typically set to the BEP of the pump while some also included the 
off-design conditions by varying the flow rate and pump speed. The properties of 
blood in the simulation are usually assumed to be incompressible according to the 
high shear stress within the pump, and are considered as a pure substance for 
simplicity.  
The rotation of the impeller in CF-VAD causes high disturbance to the fluid 
flow, hence the turbulence flow nature is common in most pumps. The Navier-
Stokes equations that are commonly used to describe the flow could also predict the 
turbulence flow model with a great amount of detail. However, solving the 
equations in a 3D frame within the complex geometry of a heart pump is a huge 
computational demand and hence impractical. Consequently, the Reynolds-averaged 
method is typically employed to obtain the approximated value of the relevant 
parameters which could reduce the computational load with the trade-off of a lower 
accuracy but which is still sufficient for the engineering applications. However, this 
approach leads to the situation where the equations could not be closed as there are 
more unknown variables than the available equations. To resolve this problem, the 
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turbulence models technique has been used for calculation of the unknown 
Reynolds stress term. The type of models has been classified by the number of 
additional transport equations introduced for the calculation. This review discussed 
the turbulence models with emphasis on the two-equation model as it can 
sufficiently describe the physics of flow and has many verification studies which 
support the accuracy of the calculation. The k-ε model is commonly used for heart 
pump simulation because of its robustness and ease of implementation, while the 
limitation of this model is that the drastic change in pressure gradient does not 
impose on the low pressure head in the heart pump. Another model discussed in this 
section was the k-ω; this model, and its variations, was also implemented in some 
studies for its strength in the accuracy of the near-wall region but it requires higher 
computational power for the near-wall mesh resolution. The weakness of this model 
lies in the prediction of the flow separation regions which tend to be overestimated. 
The pulsatile nature of blood flow and the fluctuation from impeller rotation could 
affect the solution results. The transient simulation with a time varying boundary 
condition could closely simulate the flow effect at a high computational cost, so the 
magnitude of the effect from different configurations of the transient simulation was 
compared against a steady state simulation. The review supports the use of the 
sliding mesh method of transient simulation with the steady state, as the effect of 
fluctuation from the blades appears to be significant to the results. However the 
steady state is more widely used for its lower computational resources despite the 
lower accuracy.    
The method of hemolysis estimation has been thoroughly discussed as it is 
one of the major design concerns that are difficult to accurately predict. The damage 
models are established on either the Lagrangian or Eulerian frame of reference, 
where the Lagrangian method computes the blood damage from the shear stress 
exerted on the sample particles that flow through the pump while the Eulerian 
method focuses on the calculation of shear stress on the elements over the whole 
domain. With several results for comparison and validation, both methods still 
present a large error as neither could reflect the actual damage from the pump, but 
the calculation methods are still valuable for design comparison and optimization to 
reduce the risk of damage generation from the heart pump. 
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2.6 CONCLUSION 
According to the literature review, it is clear that a VAD is a strong alternative for 
CHF patients as it is more effective than the optimal medical treatment and more 
flexible than heart transplantation. Improvements in mechanical reliability and 
hemocapability could reduce the limitations of the current long-term blood pump.    
CFD is an important tool to achieve the objectives of new heart pump design 
and development and helps to predict the design issues, so it is possible to create 
several pump designs and use the information from CFD to select the best optimum 
design that suits the requirements without having to produce several working 
prototypes for actual comparison. The selected design can then be further analysed 
in greater detail for further optimisation to obtain the best hydraulic performance 
and minimise the risk of hemolysis and thrombosis before making a prototype for 
experiments. 
From the literature review, it is notable that the VADs are commonly 
designed for the left ventricle support function, although some are capable of 
providing the right ventricle support by lowering the pump speed, and there are very 
limited studies on the BiVAD as a single module. It could prove to be useful if the 
pump is carefully designed to equally support both sides of the ventricles with the 
assistance of CFD simulation to provide an insight into the pump geometry.  
To complete the development process, the human mock circulation loop is 
still required for the verification of the final pump design which is the final stage in 
the scope of this research. Beyond this stage it will involve the development of the 
driving, controlling and suspension mechanism before in vitro tests in animals and 
clinical trials which are the last stage in the VAD development cycle. 
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 Design and Development of the 
VAD  
This section is about the design concept and optimisation of the BiVAD and 
the CFD simulations to predict the hydrodynamic and hemodynamic performances 
for the design of a working pump ready for verification and the evaluations within 
the human mock circulation loop. 
3.1 INTRODUCTION  
Turbo machinery has long been used in industrial and general pump 
applications. However, the development of these pumps focuses only on the 
hydraulic performance aspects such as improving the efficiency at the pump 
operating point. The requirements are different for ventricular assist devices which 
have more factors to consider, including hemocompatibility which is highly 
significant as the blood is a sensitive fluid with complex properties that could affect 
the patient's circulatory system. To achieve the hemodynamic requirements, the heart 
pump needs to be carefully designed to avoid causing high shear stress that could 
damage the red blood cells and cause blood trauma, which is not a major concern in 
general pump design.  Damage to blood may lead to thrombus formation and could 
be fatal to patients if it breaks free into the blood stream and migrates to vital organs. 
The variation in pump operating conditions is also an important factor which 
makes the design of a VAD more complicated. In general application, pumps are 
usually designed to operate at the best efficiency point (BEP) where they have the 
highest efficiency while also being least prone to failure. The VAD operating 
condition, however, is hard to determine as it is greatly varied by many 
uncontrollable functions.  These variations are caused by flow variation due to the 
pulsatility nature of the heart’s cycle, or the degree of heart failure which requires a 
different level of support for each individual patient. The requirement is also caused 
by the physiological requirements of basic daily activities such as sleep, rest or 
exercise. In some cases, the heart condition of a patient with VAD support could 
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worsen, and the pump would need to be able to be adjusted to provide sufficient 
support for the patient’s perfusion needs. Meanwhile, if the patient’s heart recovers, 
the pump also needs to be able to respond to the changes and reduce the level of 
support accordingly. Aside from these variations in operating conditions, the VAD 
design aims to cover a wide range of operations to function as an LVAD and RVAD 
to be able to support both the left and right ventricle with the same pump model or to 
function as a BiVAD which supports both sides at the same time. 
The VADs that are designed for long term support such as bridge to 
transplantation (BTT), bridge to recovery (BTR) or destination therapy (DT) are 
expected to be implantable so that the patients can carry on their daily activities 
while under the support of the device. Therefore the size of this type of pump needs 
to be small enough to fit into the patient's pericardial cavity or abdomen; meanwhile, 
it also needs to have a strong structure and a reliable mechanism that could extend 
the pump’s life expectancy without requiring any internal maintenance of the pump.    
With all these sensitive requirements, it usually takes a long time for the 
development of the pump and requires a lot of expense to carry out the heart pump 
development. The pump’s initial design needs to be evaluated and optimized many 
times with much trial and error in the process to produce an effective prototype. The 
pump needs to pass both in vivo and in vitro tests before it could be used in a clinical 
trial. A new pump design often takes a few years of clinical trials before it can be 
approved for real clinical use and commercial production.  
CFD is a powerful tool for fluid flow analysis that could be adopted for the 
heart pump development to reduce the time and cost from design initiation to 
prototype evaluation. It can be used to provide details of the pump flow and helps the 
designer to predict the pump’s performance, compare the flow dynamics between 
difference choices of designs, and identify the flow problems that might occur in the 
pump. The information obtained from CFD simulation is not limited only to the 
hydraulic pump’s performance, but it is also possible to use it to analyse the 
hemodynamic parameters such as blood damage and thrombosis which  are design 
concerns for heart pump development. With this information, the designer can 
investigate the different design choices without having to go through the long and 
repetitive work of trial and error on real prototypes, which is a time and resource 
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consuming process. In addition to the use of CFD to establish the working prototype, 
it can also be used to provide information for the design optimization throughout the 
rest of the final stages in the development process, like making minor refinements 
that might help to improve the pump’s performance during the in vivo or the clinical 
trial stages. 
To achieve the aim of this thesis, this chapter describes the design of the 
BiVAD in aiming to achieve all the requirements of the heart pump’s functions, as 
described above, with the employment of CFD techniques to analyse the pump’s 
performance. The design was then modified to operate on the single-sided motor as a 
prototype for the performance evaluation in the test rig, by taking advantage of the 
symmetrical design of the LVAD and RVAD. This modification yields a single-sided 
pump that can work in both the left and right heart support applications, while the 
information from this evaluation could be used for the full prototype of the BiVAD 
in the future.   
3.2 STRUCTURE OF THE VAD 
3.2.1 VAD Design background 
As discussed in Chapter 2, the third and later generations of heart pumps are 
commonly built on an axial flow or a centrifugal pump as the pulse generation 
mechanism has proved to be not necessary. Each type of pump has different 
advantages that need to be considered for the design of the VAD.  The axial flow 
pump structure offers the advantage of compact size with the same performance; 
however, the trade-off is a very high impeller rotating speed which could cause 
excessive shear stress and thus blood damage. The life span of the pump is also 
shorter because of the mechanical wear if there is any contact with the surface or seal 
(Kafagy & Gitano-Briggs, 2013b). For all these reasons, the centrifugal pump is a 
more preferable choice for long term usage for the heart pump which is required to 
be durable and to generate minimum blood damage.  
The design of the centrifugal VAD is based on the general centrifugal pump; 
however, the pump’s requirements are not only dependent on the hydrodynamic 
performance like the net positive suction head (NPSH), radial or axial thrust, but also 
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on the hemodynamic effects such as shear stress induced blood damage and 
recirculation, and the pump size needs to be carefully considered.  
3.2.2 Centrifugal VAD structure  
The VAD design in this study is based on the BiVAD concept structure 
previously designed by Jianping Yuan1, as shown in Figure 3-1. The pump has been 
redesigned to incorporate the driving mechanism as well as optimised to suit the 
making of the prototype pump and further evaluation in the human mock circulation 
loop. The structure of this pump, including the design choices and decisions, is 
discussed below: 
 
Figure 3-1: BiVAD concept design schematic. 
I. Inlet pipe 
The inlet pipe of the VAD is the part which connects to the ventricle via the 
inflow cannula and guides the blood to the impeller eye. The common design of the 
inlet pipe is a basic straight pipe that guides the flow directly to the centre of the 
impeller eye; this is the most effective and has low boundary layer losses. However, 
some designs would slightly shift the inlet pipe position due to the restriction of the 
impeller shaft or bearing placement.  
                                                 
 
1 This BiVAD concept was designed by Prof. Jianping  Yuan when he was a visiting research fellow at 
QUT in 2012 
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The original concept design of this pump has a 90ᵒ elbow structure to reduce 
the space required in the implantation and to be suitable for the placement of 
cannulas. Right after the elbow corner, there is a flow straightener that helps to 
eliminate disturbances in the incoming flow before entering the impeller area.   
II. Impeller 
The impeller is the rotating part that transfers mechanical energy to fluid 
energy and thereby increases the flow velocity and pressure. The fluid flow into the 
impeller at the centre, known as the eye of the impeller, is pushed away from the 
centre with centrifugal force through the blades or shrouded vanes on the impeller. 
The number of blades or vanes is an important factor for the performance of a 
centrifugal pump as a large number of blades generate more centrifugal force and, 
thus, a higher head pressure. However, there will be fewer volute spaces between the 
vanes and, hence, a reduced flow capacity of the pump. Therefore, the design of the 
blade numbers in a VAD is significant for balancing between a sufficient flow rate to 
meet a patient’s perfusion while also generating enough head to compensate for the 
pressure loss from the weakened ventricle.  
The design of the impeller can also be classified by the way that the impeller 
blades are attached to the hub, as follows:  
i) Open impeller  
The open impeller type only has blades attached to the cylinder hub. This type of 
impeller has a low performance as the fluid can leak from both above and below the 
impeller blades. However, the open structure allows easy cleaning and there is a 
larger flow channel compared to other types, so that it is suitable for fluids with large 
particle as there is a lower chance of blood clot formation.  
ii) Shrouded impeller 
The shrouded impeller has shroud plates attached on both sides which enclose the 
impeller blades within. This structure can eliminate leakage across the vanes, and it 
improves the performance of the pump significantly. However, the small clearance 
above the shroud allows leakage from the inlet pipe and risks generating shear stress 
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and the formation of recirculation flow, as the centrifugal force might not work 
effectively to wash out this area without the guide vanes.    
iii) Semi open impeller 
The semi-open impeller only has a circular plate attached to the bottom side of 
the blade; thus, the leakage flow can occur only above the impeller, and the 
performance is in between the shrouded and open type of impellers. The only major 
concern of this impeller as a VAD design is the clearance under the impeller that 
could cause a recirculation flow and leads to stagnation without a proper flow design.   
The semi-open impeller design was considered to be the most suitable for this VAD 
design. In order to achieve the highest performance, 5 designs of impeller with 
common hub structures but different blade configurations were created for a 
comparison between the effect of the blade numbers and the twisted / cylindrical 
blade alignment, as follows: 
 
Figure 3-2: Five impeller designs for the performance evaluation. 
Figure 3-2 shows the different impeller designs for evaluation. Impeller II 
and impeller IV have a normal cylindrical blade alignment, the only difference being 
that impeller II has 6 blades while impeller IV has the blade number reduced to 4 to 
increase the flow capacity. 
Impellers I and III have 6 and 4 blades, respectively, but incorporate the 
twisted blade alignment design.  
Impeller V has a unique structure among the designs as it has 3 cylindrical 
blades and 3 smaller splitter blades.    
The impeller of this pump is to be driven by the magnetic force between the 
stator coil and the permanent magnet embedded at the base of the impeller hub. The 
permanent magnets (shown in red in Figure 3-1) also added to the impeller eye, inlet 
support, and around the impeller hub, help to suspend the impeller and levitate it 
within the chamber. 
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Figure 3-3: Side view of the impeller with the extended part to accommodate the 
magnet for the driving and suspending the mechanism. 
III. Volute casing and chamber 
The blood flow from the impeller vanes is collected in the volute casing which 
gradually reduces the flow velocity and gains the dynamic pressure along the 
expanding cross-sectional area in the process known as velocity diffusion. A good 
volute design must be able to conduct this velocity conversion with minimum losses. 
There are many volute designs of centrifugal pumps available depending on the 
application; however, the common designs of VAD are single volute, double volute 
and circular volutes.  
i) Single volute 
The single volute is the most basic and common design of a centrifugal pump 
for its simplicity and good efficiency. However, the disadvantage of this type of 
volute is the considerable radial force when operated at a flow rate lower or higher 
than the best efficiency point (BEP) due to the imbalance in the pressure distribution 
around the impeller. The excessive radial force could cause fatigue on an internal 
structure such as a bearing or shaft and thus reduce the life time of the pump. 
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Figure 3-4: Circular and spiral volute 
The variations of the single volute type are the circular volute and spiral volute. 
The circular volute is a type of concentric volute casing around the periphery of the 
impeller. It can provide better pump efficiency compared to the spiral volute design 
at specific speeds below 600 rpm; however the efficiency is lower at a higher 
specific speed (Lobanoff & Ross, 2013). Some of  the VADs that use the circular 
type of volute are NEDO BVAD(Nosé et al., 1999) and BiVACOR (Daniel Timms et 
al., 2008).    
ii) Double volute 
The double volute design has a similar structure compared to the single volute 
but it has a dividing rib to split the flow before exiting to the outlet diffuser. This 
volute design provides a lower radial force on the impeller so it is often used in 
applications or pump designs with a high radial force that could cause an excessive 
shaft and bearing load. However, the small structure of the splitter rib could cause 
some difficulty in production, especially for a small VAD design.  
 
Figure 3-5: Double volute 
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The original concept design of this pump is made on a single spiral volute 
design with a 30 mm volute basic circle diameter. Underneath the impeller there is a 
small clearance of 0.5 mm that allows the rotor to levitate within the chamber by 
means of magnetic suspension without touching down or rubbing on the internal 
chamber surface. This area, however, has a risk of creating recirculation flow which 
could cause blood coagulation; therefore, a small passage was created as a link 
between the chambers that generates the small flow from the LVAD to the RVAD 
side. This secondary flow is designed to create a washing effect to wash the small 
clearance area along the side and underneath the impeller and eliminate all 
recirculation flow; in addition, it could also provide the hydraulic bearing effect that 
reduces the axial thrust on the impeller. The issue of this concept structure is the 
leakage flow that could reduce the efficiency of the LVAD; in addition, it also allows 
the oxygen rich blood to flow into the RVAD that leads to the pulmonary system. 
Therefore, the amount of the leakage flow must not be too large to disrupt the 
pulmonary function while the flow needs to be sufficient to effectively wash out the 
stagnation or recirculation flow.   
IV. Outlet diffuser 
The outlet diffuser in the VAD is the part from the volute throat that guides the 
outflow from the volute to the outlet port. The static pressure of fluid is gradually 
increased in this part as the cross-section area is expanding along the flow path 
toward the outlet port.  
The key design parameters of this pump are summarized in the Table 3-1. 
Table 3-1: Design parameters of the BiVAD pump 
Diameter of impeller inlet Di 11 mm 
Diameter of impeller hub Dh 4 mm 
Diameter of impeller outlet D2 26 mm 
Width of impeller outlet b2 3.5 mm 
Number of impeller blades Z 4 or 6 
Wrap angle of impeller blades ϕ 110ᵒ 
Diameter of volute basic circle D3 30 mm 
Width of volute inlet b3 5 mm 
Diameter of volute outlet D 10 mm 
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3.3 VAD DESIGN CRITERIA AND REQUIREMENTS 
3.3.1 Hydrodynamic requirements 
The average mean aortic and pulmonary pressure of a healthy adult are 
estimated at 93 and 15 mmHg, respectively, and the average flow rate is 5 l/min 
(Marieb & Hoehn, 2007). As the pump needs to be able to support different degrees 
of failure of the ventricle, including the need to overcome the variation of vascular 
resistances, the design operation point was set to be higher than the average pressure 
at 100 mmHg (1.36m) for the LVAD and 20 mmHg (0.68m) for the RVAD. 
Another design problem for the heart pump is the variation of the flow rate that 
passes through the pump and which is influenced by many factors such as age, 
severity of the CHF condition, and physical activities of the patients. As these factors 
are uncontrollable, the pump must be able to deliver the required head pressure with 
a wide range of flow rate to maintain perfusion for the patients.  
This evaluation was done in the CFD simulation software along with the 
impeller design selection. As the left and right side of the BiVAD design are 
identical and they work independently, it was safe to consider the configuration as a 
single pump that operates under different conditions. Therefore, the pump evaluation 
was done independently to find the optimum rotation speed that could deliver the 
head pressure under the variation of flow rate.    
3.3.2 Hemodynamic requirements 
As previously discussed in Chapter 2, the major hemodynamic concerns of the 
heart pump are shear stress induced damage and thrombus formation from the 
recirculation flow.  
Although blood damage generated by the pump is an important factor that 
affects the pump’s lifetime for supporting patients, there is no clear standard for the 
acceptable blood damage caused by a heart pump. Nosé (Nosé, 1998) suggested the 
blood damage threshold of a heart pump by categorizing the clinical needs of  the 
heart pump into 3 categories: 2-day pumping, 2-week pumping, and longer than 6 
months. The short term support pumps for 2 days and 2 weeks are required for 
cardiopulmonary bypass and post-cardiotomy heart failure support, respectively, 
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while the 6-month pump is intended for long term support such as bridge to 
transplant. Nosé recommended that the pump which was considered to have anti-
traumatic property should have a normalised index of hemolysis (NIH) less than 0.01 
g/100L for the long term or 2- week pumps that operate under a flow rate 5 of L/min 
and head pressure 100 mmHg. It was also recommended that the pump should have a 
lower NIH than 0.004 g/100L to reduce the chance of  the red thrombus that could 
form during a patient's bioadaptation on the first 2 days of operation and to be 
considered as antitraumatic for short term operation support; however, this is 
generally not a requirement for clinical practice (Behbahani et al., 2009). These 
standard values have later been used as a design reference and development targets 
for several heart pump developments (Bock et al., 2007; Carswell et al., 2013; C. H. 
H. Chan et al., 2015; Farinas, Garon, Lacasse, & N'Dri, 2006) 
Aside from shear stress, the flow dynamics within a pump need to be carefully 
designed to avoid stagnation and recirculation which could cause thrombosis that 
leads to pump failure or breaks off into the blood stream and causes an ischemic 
attack.  
3.4 INITIAL SINGLE-SIDED VAD SIMULATION 
The initial simulation was conducted on the Ansys CFX 12.1 software to 
confirm availability of the impeller design in delivering the required head pressure 
and briefly investigate its efficiency. In this stage, the simulations was conducted on 
the simplified model of the independent single-sided pump of all five impeller 
designs under different flow rates at the nominal designed pump speed.  
After this initial simulation a more detailed simulation on the full model of the 
BiVAD would be conducted in the next step to find the optimum rotating speed for 
each impeller design and provide a detailed analysis of pump performance. The most 
suitable impeller design would be selected, for further development and the 
information was also used in further optimization for creating a pump prototype. 
3.4.1 Fluid model 
The CFD analysis was performed on the simulation domain which in this case 
is the simplified fluid model of the pump that was created for the initial simulation to 
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study the efficiency of each impeller design. The fluid domains of the centrifugal 
pump and VAD simulation can be divided into two types: the rotating domain which 
is the fluid in the vanes and around the impeller area, and the static domain which in 
this study comprises three parts: the inlet pipe, side chamber or ring diffuser, and 
volute, as shown in Figure 3-6. A total of 5 impeller models were placed in the static 
domain for each simulation. 
 
Figure 3-6: Fluid assembly model of the single-sided VAD. 
3.4.2 Meshing method 
Mesh creation is a method to subdivide the computation domain to a number of 
small elements for finite calculation methods. The mesh generation of this model was 
done in Ansys 12.1 ICEM using the CFX-mesh method. The process of meshing was 
done separately between the stationary domain and the impeller so that all the 
simulation could be done on the same stator.  
The mesh type selected for the simulation was the unstructured tetrahedral-
shaped element for its ability to effectively generate a valid mesh on the model with 
small angles such as for the blade tips without highly skewed element angles. The 
element size was controlled by the face spacing method that allows control over the 
mesh size on each surface area via the specification of the angular resolution, the 
range of edge length, and the expansion factor. The angular resolution is an option to 
control the edge length to vary over the face curvature; the smaller value for this 
setting allows a smaller edge length and finer elements. The range of edge length is 
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specified by the minimum and maximum length that allows for the element 
generation, and it is applied with the angular resolution to control the mesh size. As 
these functions were applied to constrain the mesh size on the local surfaces, the 
expansion factor was used to specify the rate at which the mesh length scale returns 
to its global value as the elements moved away from the surface. The large expansion 
factor allows the mesh to coarsen more rapidly from the specified surface.        
 By utilising this face spacing feature, the constraints were set to generate a 
finer mesh near the walls, on the side chamber, on the volute tongue and on the 
impeller, especially near the blade surface area which requires a more accurate 
calculation of the results, and is coarser on the area with a more uniform flow at the 
inlet port and outlet diffuser.  
With the specified method and constraint configurations, the total number of 
mesh elements generated on the static domain is 532,615 elements, while the 
impeller is composed of an estimated 544,000 - 785,000 elements depending on the 
design structures. The mesh structures on the static and rotating models are shown in  
Figure 3-7 and Figure 3-8 respectively, while the number of elements is summarized 
in Table 3-2. 
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Figure 3-7: The tetrahedral meshes generated on the stator model. 
 
 
Figure 3-8: Meshes of single sided VAD impeller. 
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Table 3-2 : Number of elements on each part. 
Fluid Model Number of Elements 
Stator 532,615 
Impeller I 785,597 
Impeller II 709,286 
Impeller III 626,164 
Impeller VI 544,316 
Impeller V 715,965 
3.4.3 Material properties 
Blood is known to be a non-Newtonian fluid, however it behaves as a 
Newtonian fluid when the shear rate is above 100 s-1; therefore, the pumping fluids 
of VADs are often modelled as Newtonian due to the high shear rate nature of the 
blood pump and aorta (Wells & Merrill, 1961, 1962) and this assumption has been 
experimentally validated in several research studies (Steven W. Day et al., 2001; 
Steven W Day et al., 2002; J. Zhang et al., 2006).    
Therefore, to simulate the blood flow through this blood pump, the fluid was 
assumed to be Newtonian and the properties were specified to replicate the blood 
density at 1,056 kg/m3 and the viscosity at 0.004 Pa.s. 
3.4.4 Boundary conditions  
The boundary conditions for this initial simulation are specified by aiming to 
find the efficiency for each impeller design over a variety of flow rates. Therefore, 
the volumetric flow rate was varied from 0.15 to 0.42 m3/h over a designed pump 
speed of 4,000 rpm. This flow rate was converted to flow velocity (v) by the 
equation, v = A/Q, where Q is the flow rate and A is the cross-sectional area of the 
inlet pipe, and is applied to the pump inlet as the normal velocity profile. The 
boundary type of the outlet pipe is specified as the "opening" which has no 
restriction on the flow direction; and, since the flow rate between the inlet and the 
outlet are equal, the Cartesian velocity components were used to specify the flow 
velocity at the outlet boundary based on the same flow rate at the inlet pipe to direct 
the flow out of the pump in the normal direction to the outlet diffuser.  
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The standard k-ε turbulence model was chosen for this simulation and specified 
as an initial turbulence boundary for both the inlet and outlet of the pump. The 
turbulence kinetic energy was calculated from the equation: 
 ݇ ൌ 0.05ݑଶ [3-1] 
where  k  = Turbulence kinetic energy (m2/s2) 
  u  = Flow velocity (m/s) 
The initial turbulence eddy dissipation (ε) was specified by the function: 
 ߝ ൌ ܥஜ
଴.଻ହ݇ଵ.ହ
0.07ܦ  [3-2] 
where   ε  =  Turbulence eddy dissipation rate (m2/s3) 
  Cµ  = Constant parameter for k-ε model, = 0.09  
  D = Pipe diameter (m) 
The connecting surfaces of the impeller and volute model (Figure 3-9) were 
specified as the general connection domain interface to allow the fluid flow to pass 
through between the models, and the mixing model on these interfaces was specified 
as the "frozen rotor" which is the calculation option for the quasi-steady state 
simulation without changes in the relative position between the components across 
the interface (ANSYS, 2009). Other surface areas were specified as no slip, and 
smooth wall. 
 
Figure 3-9: Interface at the connecting surface between rotating and stationary 
domain. 
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The boundary conditions for this initial simulation are summarised in Table 
3-3. 
Table 3-3: Boundary conditions of single-sided VAD simulation. 
Boundary Conditions 
Inlet 
Boundary type Inlet 
Boundary Detail Normal Speed: ‘Flow Velocityinlet’ m/s 
Initial Turbulence k-ε 
Outlet 
Boundary type Opening 
Boundary Detail 
Cartesian Velocity Components: 
u = 0 m/s 
v = ‘Flow Velocityoutlet’ m/s 
w = 0 m/s 
Initial Turbulence k-ε 
Impeller Speed 4000 
 
3.4.5 Solver control 
The solver control was set to the high resolution advection scheme to obtain 
better accuracy for the current unstructured meshes. The convergence criteria were to 
reach either 2,000 iterations or to reduce the RMS residual below 1 x 10-5. This 
solver control setting was also used in all the simulations in this study. 
3.4.6 Initial simulation results and discussion 
With the method explained above, the simulations were conducted on 5 
impeller designs under 6 flow rates, so that a total of 30 simulation cases were 
completed in this initial simulation. 
The performance parameters considered for this initial simulation are head 
pressure, hydraulic power, and hydraulic efficiency. The comparison of these 
parameters across the impeller designs are shown in Figure 3-10, Figure 3-11 and 
Figure 3-12.  
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Figure 3-10: The predicted pump head vs. flow rate across the impeller designs. 
 
Figure 3-11: The predicted hydraulic power vs. flow rate across the impeller designs. 
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Figure 3-12: The predicted hydraulic efficiency vs. flow rate across the designs. 
According to the performance plots, impeller numbers I and II which have 6 
blades are the best design which could generate the highest head and hydraulic power 
and, hence, better efficiency compared to the designs with 4 blades and the short 
splitter blades design. Design V is the third best design but the efficiency is about 8% 
lower than designs I and II under the whole flow range in this simulation. Designs III 
and IV have close performances to design V at a flow rate lower than 0.24 m3/h, but 
the head pressure drops more rapidly above the designed flow rate. At the design 
flow rate (0.3 m3/h), both designs I and II could deliver the estimated head pressure 
up to 1.42m while other designs generate a significantly lower head at the same flow 
rate for all the conditions and could not achieve the LVAD required head of 1.36 m 
(100 mmHg) at this designed speed; however, this could be achieved by optimizing 
the rotation speed of the pump in later stages.  
 In addition to the performance parameters, the pressure, velocity and shear 
stress distribution contour within the pump at the designed flow rate (0.3 m3/h) are 
shown in Figure 3-13. According to the pressure contour in this Figure, the pressure 
is distributed almost equally between the vanes. The rate at which the pressure is 
raised is higher in the designs with six blades and the splitter blades compared to the 
four blade designs, which is in agreement with the higher head pressures from 
designs I, II and V. However, designs I, II and V present a large low velocity region 
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in the diffuser area, as shown in the velocity contour, which could not be observed in 
the four-blade designs. The high shear stress region was found at the tongue and 
leading edge of the impellers, especially on the splitter blades of impeller V, but the 
effect of this shear stress needs to be investigated further to explain whether it affects 
the red blood cells (RBC). 
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Figure 3-13 : Pressure, velocity and shear stress contours of each impeller. 
In conclusion, all the designs show no significant problem at this stage of the 
initial evaluation. In the next section, all the impellers will be evaluated as a BiVAD 
under the designed flow rate to find the operating speed that could deliver the desired 
head pressure for the LVAD and RVAD environments. There will also be further 
investigation of the low flow region and the effect of the generation of shear stress.  
3.5 BIVAD SIMULATION 
As stated in previous sections, the simulation of the BiVAD at this stage is 
aimed at acquiring information on the operating speed, performance specification, 
and possible design problems for the impeller selection and the development of the 
prototype pump. 
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3.5.1 BiVAD fluid model 
The fluid model of the BiVAD was created on the same principles as the 
single-sided VAD but with inter-connection details of the BiVAD’s internal 
structure. The model comprises 8 parts, with 3 parts for the stationary domain (inlet 
pipe, side chamber, and volute) on each side and 2 rotating domains that represent 
each impeller. This fluid model is shown in Figure 3-14 and the solid model in 
Figure 3-15. 
 
Figure 3-14: Fluid Model of BiVAD. 
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Figure 3-15: BiVAD solid concept model. 
3.5.2 Meshing model 
The mesh generation for this BiVAD simulation was still based on the face 
spacing method. However, due to the larger model size, the elements scale has been 
adjusted to keep the number of elements close to the previous simulation to maintain 
the reasonable computational power and the simulation time. The high density mesh 
was maintained on the sensitive areas such as near the blades’ region, the tongue and 
the wash-out hole between the chambers, while reducing the mesh density on the 
straight flow areas such as the inlet pipe and the outlet diffuser.  
The stator model contains a total of 822,505 elements while the impellers, 
which have an identical structure, contain an estimated 190,000 - 215,000 elements 
in total, or about 40% of the total elements on the model, depending on the impeller 
design. The meshed models on the rotor (impeller I) and stator are shown in Figure 
3-17 and Figure 3-16, respectively. 
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Figure 3-16: Meshed model of BiVAD rotor (Impeller I)  
 
Figure 3-17: Meshes on the BiVAD stator. 
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Mesh independence test was conducted to ensure that the element density is 
sufficient to obtain the accurate solution and the accuracy of the result is independent 
on the element size. The test was done by varying the number of elements from 
approximated 250,000 to 1,500,000 elements while maintaining the mesh ratio 2:1 
between stator to rotors. Head pressure was used to represent the result from 
simulation and the relation between head pressure and the number of element is 
shown in Figure 3-18. According to this result, the head pressure is tend to be steady 
when the number of element is above 700,000. Consequently, the current mesh 
density is verified to be sufficient for this study.      
 
Figure 3-18: Head pressure vs. number of element. 
3.5.3 Simulation settings and boundary conditions 
In this simulation, the pump is set to operate at the design conditions with 
variable pump speed to find the specific speed that could deliver the required head 
pressure. The flow rate on this simulation is thus set to the designed condition at 5 
L/min by specifying the outlet boundary as a Cartesian velocity components, while 
the static pressure is used as the inlet boundary condition. The inlet pressure was set 
to 20 mmHg which is the estimated filling pressure from atrium in case of congestive 
heart failure. 
3.5.4 Simulation Results and discussion 
By varying the pump speed of the simulation condition as specified above, a 
series of simulations were conducted and the relationships between the pump head 
(H) and rotation speed (n) of all the impeller designs were plotted, as shown in 
Figure 3-19.  
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Figure 3-19: The plot of the head pump vs. pump speed. 
Since the required head pressures for the LVAD and RVAD are 1.36 m and 
0.68 m, respectively, the required rotation speed was derived from the plot, as shown 
in Table 3-4.  
 
Table 3-4: The required rotation speed for each impeller design. 
 
Impeller rotation speed (rpm) 
Impeller I Impeller II Impeller III 
Impeller 
IV Impeller V 
LVAD 4062 4000 4298 4283 4196 
RVAD 3111 3054 3336 3304 3181 
 
I.      Hydraulic efficiency 
With these specified speeds, a total of five simulations were made. The 
hydraulic performance of each side of the pump and the total performance are 
summarized in Table 3-5.  
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Table 3-5: Predicted hydraulic performance of heart pump from the Simulation. 
  Parameters  Case I Case II Case III Case IV  Case V
LVAD 
݊௅(rpm)  4062 4000 4298 4283  4196 
ܳ௅ି௢௨௧௟௘௧(݉ଷ/݄ሻ 0.29 0.29 0.29 0.29  0.29 
ܪ௅ሺ݉ሻ  1.367 1.357 1.359 1.359  1.358
௛ܲ(W)  1.149 1.141 1.144 1.143  1.142
ߟ௛௅  0.529 0.551 0.514 0.522  0.509
RVAD 
݊ோ(rpm)  3090 3054 3336 3304  3181 
ܳோି௢௨௧௟௘௧(݉ଷ/݄ሻ 0.29 0.29 0.29 0.29  0.29 
ܪோሺ݉ሻ  0.682 0.681 0.676 0.679  0.678
௛ܲ(W)  0.574 0.573 0.569 0.571  0.570
ߟ௛ோ  0.511 0.532 0.487 0.501  0.496
BVAD  ܳ௚௔௣(݉
ଷ/݄ሻ  0.0037 0.0027 0.0025 0.0041  0.0046
ߟ௛ோ  0.523 0.545 0.505 0.515  0.504
 
According to Table 3-4 and Table 3-5, the simulation results of this BiVAD 
are in good agreement with the results from the initial simulation on the single-sided 
pump. Impeller II requires the lowest speed to deliver the required head pressure to 
both sides of the pump at 4,000 rpm for the LVAD and 3,054 rpm for the RVAD. 
Impeller I required a slightly higher speed at 4,062 and 3,090 for the left and right 
sides, respectively, while impellers II and IV need the highest speeds among the 
designs to generate the required head.  
The hydraulic power of the pump generated from the impeller is relatively 
close on both sides and show no significant difference in these simulation conditions. 
However, Impeller II shows the highest efficiency among the cases, 55.1% on 
LVAD, 53.2% on RVAD, and overall of 54.5% for the whole pump, which is 
slightly higher than Impeller I with 52.3% efficiency and approximately 5% better 
efficiency than the rest of the designs. 
With the design of the washout hole between the left and right chambers, some 
of the blood was allowed to leak from the LVAD to the RVAD to generate a washing 
effect to prevent stagnation under the impeller. The fluid transfer rate from the left to 
the right side of the pump is shown in Table 3-5 as the volumetric flow rate “Qgap”. It 
can be observed that approximately 0.003-0.004 l/min of the oxygen rich blood from 
the systemic circulation leaks to the pulmonary system. At this pump flow rate, the 
leakage is considered to be a small amount at approximately only 1.5% of the pump 
flow and should not cause any problem to a patient’s circulatory system. The 
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effectiveness of the washing effect is to be considered and discussed based on the 
flow visualisation in the next section.   
II.      Hydraulic force 
The magnitudes and direction of the hydraulic forces on the impeller are 
critical to the magnetic suspension design of the pump to avoid contact between the 
impeller and the internal surface of the chamber which could cause wear and reduce 
the pump’s lifetime. Therefore, an accurate prediction of the radial and axial thrusts 
in the simulation phase of the pump development could help reduce time and cost in 
the prototype’s evaluation. From the information gathered in this simulation, the 
radial force (Fr), is calculated from the accumulated force between Fx and Fy and can 
be identified by the equation:  
 ܨ௥ ൌ ටܨ௫ଶ ൅ ܨ௬ଶ [3-3] 
 
The direction of Fr can be obtained as follows: 
  ൌ ݐܽ݊ିଵ ܨ௬ܨ௫ [3-4] 
The radial force (Fr), axial thrust (Fy), and the torque (߬ሻ about each axis that 
are applied on the impeller and the whole pump are summarized in Table 3-6. 
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Table 3-6: Hydraulic forces and torques on the BiVAD. 
 
 
According to the results from Table 3-6, the axial thrust is the dominant force 
in all cases for both the LVAD and RVAD sides. The axial thrust is estimated to be 
200 - 250 times greater than the radial forces, which is the result of the inflow that 
passes directly onto the impeller's rotating axial. The results from this simulation 
show that the impellers with a higher number of blades have a larger axial force 
compared to those with fewer blades, while the twisted-blade designs have a slightly 
larger axial force compared to the cylindrical blades structure. The design that has 
the largest axial force is impeller I which has 13.80 N on the LVAD and 12.89 N on 
the RVAD. This is followed by impeller II which has the same number of blades, and 
impeller III that also has a total of 6 blades but 3 of them are the shorter splitter 
blades. Impellers III and IV have an estimated 30% lower axial forces applied on the 
impellers compared to the same structure with more blades. 
The radial force on the rotors is very small compared to the axial thrust. The 
largest radial force is observed on the RVAD side for impeller IV with a magnitude 
of 0.090 N. The smallest force among all the cases is 0.038 N which is observed on 
the left impeller of impeller III. The directions of these radial forces are variable. By 
comparing the radial forces’ direction to the volute diagram shown in Table 3-6, it 
Case Location Fr(N) (°) Fz(N) Tx (N.m) Ty (N.m) Tz (N.m) 
I 
LVAD Rotor 0.054 304.05 13.80 -0.00027 -0.00027 -0.00511 
RVAD Rotor 0.085 282.15 -12.89 -0.00261 0.00032 0.00347 
Stator 5.741 182.37 -0.59 0.00476 0.10998 -0.00902 
II 
LVAD Rotor 0.061 300.75 11.89 -0.00034 -0.00019 -0.00494 
RVAD Rotor 0.067 284.37 -11.00 -0.00202 0.00047 0.00336 
Stator 5.765 182.13 -0.62 0.00413 0.10996 -0.00899 
III 
LVAD Rotor 0.038 320.49 9.76 -0.00018 0.00029 -0.00494 
RVAD Rotor 0.089 265.11 -8.90 -0.00265 -0.00035 0.00334 
Stator 5.748 182.30 -0.63 0.00521 0.11092 -0.00901 
IV 
LVAD Rotor 0.046 309.17 8.42 -0.00024 0.00026 -0.00489 
RVAD Rotor 0.090 269.74 -7.67 -0.00268 -0.00028 0.00329 
Stator 5.727 182.46 -0.55 0.00517 0.11002 -0.00878 
V 
LVAD Rotor 0.052 300.30 10.53 -0.00039 -0.00029 -0.00511 
RVAD Rotor 0.082 294.08 -9.66 -0.00212 0.00074 0.00345 
Stator 5.747 182.48 -0.61 0.00518 0.10878 -0.00940 
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can be seen that impellers I, II and III have the same direction of force at 
approximately 300ᵒ on the left impeller and 280ᵒ on the right side. They are all in the 
fourth quadrant and near the diffuser area of the volute; meanwhile, the radial forces’ 
direction of impellers III and IV, which have 4 blades each, are also placed in the 
fourth quadrant for the left impeller but slightly backward to the third quadrant for 
the right impeller.    
The highest torque on this BiVAD is the torque about the z-axis which is the 
result of the difference in pump speed on the left and right sides and the placement of 
the outlet diffuser. Since the magnitude of this torque is very small, it is considered 
insignificant and negligible.   
III.      Flow visualisation 
Figure 3-20 through Figure 3-24 present the distribution streamlines and 
contours of the turbulence kinetic energy, velocity, pressure and shear stress, 
respectively. Since all the impeller designs show a relatively close flow distribution, 
the information presented in these Figures is depicted from the BiVAD with impeller 
II only. More simulation results of other cases are shown in Appendix 3-1.  
Streamlines: Streamlines of the fluid flow through the pump are plotted in 
Figure 3-20. It was found that blood can flow smoothly through the inlet pipe of both 
the LVAD and RVAD side, although the flow speed is reduced at the 90 degree 
elbows but there is no sign of recirculation. The fluid then flows through the 
straighteners to the impeller without any major disruption to the stream flow. Inside 
the chamber, the flow is distributed to each vane and accelerated out to the volute 
and outlet port. The flow in the outlet port is not fully uniform especially on the 
RVAD side where it can be seen that the stream circulates around the outlet pipe 
while flowing toward the outlet. This flow motion leads to losses in the pump’s 
performance and increases the residence time of the blood which might increase the 
blood damage. The angle and dimension of the outlet port can be further optimized to 
improve the pump’s performance. 
The streamlines also show some of the fluid flow paths that leaked and 
circulated down along the impeller hub in the same direction as the impeller rotation 
of the LVAD. This leakage allows the fluid from the LVAD side to flow through the 
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washout hole to the RVAD side. The characteristic of the fluid flow through this 
washout hole will be further discussed in the later part of this section with additional 
information from other flow parameters.      
 
Figure 3-20: Streamlines through the BiVAD. 
Turbulence kinetic energy: The turbulence kinetic energy (TKE) is the kinetic 
energy associated with the eddy and can be used to identify vortices in the pump 
flow. According to Figure 3-21, the TKE is relatively low in the inlet pipe, which 
indicates a uniform inflow to the impeller and outflow from the pump despite having 
to flow through the 90ᵒ elbow and the top bearing of the impeller. The only high 
TKE regions can be observed in the impeller vanes, blade tips and near the volute 
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tongue which is a common effect of turbulence from the flow separation caused by 
the rotating impeller. The TKE is reduced in the gap behind the impellers and the 
diffuser area, which means that the flow becomes more uniform before exiting the 
pump.     
 
 
Figure 3-21: Turbulence kinetic energy distribution gradient in section view of the 
LVAD, RVAD and across the whole pump with Impeller II. 
Flow velocity: According to the velocity contour plot (Figure 3-22), the velocity of 
the fluid is highest at the area of the blade tips and gradually reduces near the volute 
wall and the outlet diffuser while the pressure is raised in these areas. The low 
velocity region is near the wall of the inlet elbow and the outlet diffuser; however, it 
shows that the uniform velocity distribution and the turbulence kinetic energy in 
these areas are relatively low. The flow is expected to be uniform and not likely to 
have any stagnation or formation of coagulation in these areas. However, the 
performance of the pump can be improved by optimising the inlet elbow for better 
flow distribution to the impeller. 
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Figure 3-22: Velocity contour in section view of the LVAD, RVAD, and across the 
whole pump with Impeller II. 
Pressure: The pressure distribution is uniform in the bend section of the inlet 
pipe and increases as the flow exits the vanes to the volute and diffuser area, which is 
the same trend as observed in the initial simulation of the single-sided VAD. In the 
gap around and underneath the impeller the pressure is slightly reduced, but it can be 
noticed that the overall pressure in this area of the LVAD is higher than in the 
RVAD, and this difference in pressure pushes the blood to flow through the flow 
passage.   
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Figure 3-23: Pressure distribution gradient in section view of the LVAD, RVAD, and 
across the whole pump with Impeller II. 
 
Shear stress: Shear stress is distributed similarly between the LVAD and 
RVAD, as shown in Figure 3-24, but the regions of high shear stress are slightly 
larger on the LVAD side due to the higher speed. The regions with high shear 
stresses are above 125 Pa and can be observed on three small areas: at the inlet 
magnet support parts which are above the impellers, on the leading edges of the 
impeller, and at the volute tongue. The information of this shear stress can be used 
for the blood damage calculation for the pump which will be discussed in the next 
section. 
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Figure 3-24: Shear stress distribution gradient in the transverse-mid plane view of the 
LVAD, RVAD, and across the whole pump with Impeller II. 
Washout passage flow: The flow through the connecting passage can be 
observed from the streamlines in Figure 3-25. The leakage of blood from the LVAD 
rotates with the impeller movement down along the gap between the impeller and the 
chamber. This flow path is induced by the effect of the pressure difference between 
the LVAD and RVAD, as presented in the pressure distribution contour in Figure 
3-26. At the bottom of the chamber, blood continues to swirl to the centre of the 
rotation, where it then pushes through the flow passage and continues to swirl in the 
same direction until the end of the passage. At the end of the passage on the RVAD 
side, the swirling direction of the blood then turns in a counter-direction to move 
along with the right impeller upward to the volute region. This flow passage could 
generate the washout effect smoothly without any recirculation observed on the 
streamlines; however, there are small regions underneath both impellers that have 
low flow velocity, as shown in blue colour in Figure 3-27. These areas may have the 
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risk of stagnation formation and should be optimized further before making the 
prototype.  
 
Figure 3-25: Streamlines of the blood flow from the LVAD to the RVAD. 
 
Figure 3-26: Pressure distribution in the flow passage. 
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Figure 3-27: Velocity gradient in the section view of the flow passage between the 
the LVAD and RVAD. 
IV.      Hemolysis estimation 
The shear stress induced hemolysis, which is the breakage of red blood cells, 
providing high shear stress over the time period. In reality the damage is assessed by 
the amount of haemoglobin released to the plasma by the damaged cells, but for the 
CFD simulation it could be predicted by the damage threshold which is a function of 
the shear stress and the exposure time of RBC. 
The Eulerian method introduced by Garon & Farinas (Garon & Farinas, 2004) 
was used for the predicting blood damage in this simulation. In this method the blood 
damage was considered to be time independent and the total blood damage from the 
device can be calculated by the function of the average linear damage over the whole 
calculation domain. The NIH is then calculated and the benchmark against Nosés 
anti-traumatic threshold for a long term and short term blood pump at 0.01 and 0.004 
g/100L, respectively (Nosé, 1998), the comparative results are shown in Figure 3-28. 
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Figure 3-29: NIH prediction of all the impeller designs compared to the anti-
traumatic limit. 
According to the blood damage calculations, although all the impellers could 
pass the clinical threshold for long term use for a blood pump at 0.01 g/100L, 
impeller V is the only design that causes higher blood damage than the short term 
anti-traumatic threshold. The design of the impeller that generates the lowest blood 
damage is impeller II which has an NIH value of 0.00302 g/100l, while impeller I 
causes slightly higher blood damage with an NIH value of 0.00308g/100l. Impellers 
III and IV which have the 4-blade structure also generate lower damage than the 
limit at 0.357 and 0.00372 g/100 L, respectively. 
3.5.5 BiVAD simulation conclusion 
The comparison of the simulation results among the five impeller designs has 
presented a similar flow profile across the pump. The flow passage design could 
generate a smooth wash-out effect from the LVAD to the RVAD without a vortex or 
recirculation. Improvement to the design could be done in the low velocity region 
under the impeller which has the risk of forming thrombosis, and the 90ᵒ inlet elbow 
can be improved to deliver a more uniform flow velocity to the impeller which could 
improve the overall performance of the pump. 
The performance analysis shows that the 6-blade designs (Impellers I and II) of the 
pump have better performance compared with the 4-blades (Impellers III and IV) and 
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the splitter blades design (Impeller V) while also requiring a lower operating speed to 
achieve the required head on both sides of the pump. Aside from the number of 
blades, the cylindrical blade design has a slightly higher efficiency than the twisted 
blade design in this simulation condition.  
Impeller II is also the best design in terms of hemodynamic efficiency as it 
generates the lowest blood damage and could achieve the anti-traumatic property 
along with impellers I, III and IV. Impeller V, although it could not be designated as 
an anti-traumatic short-term blood pump, is still clinically acceptable for both short 
and long term use on patients.  
According to the hydrodynamic and hemodynamic efficiency from the 
simulation results, impeller II was the best design that could outperform the other 
designs in most aspects. Therefore it was adopted for further development of this 
blood pump.  
3.6 DESIGN OPTIMISATION AS A SINGLE-SIDED VAD 
This BiVAD concept requires a specifically designed motor which is 
unavailable in this stage of development. Therefore, the pump was split in half and a 
study was conducted on an individual side of the pump. This was possible because 
the pump has a symmetrical design between the LVAD and RVAD sides and the 
only difference is the impeller’s rotating speed. This analysis was to provide insight 
information on the pump in a systemic and pulmonary circulation operating 
environment, which would be used in the design optimization before the pump could 
be combined together as a full BiVAD once the driving mechanism design is ready. 
However, splitting the pump for individual analysis meant that the washout 
mechanism for removing stagnation underneath the impeller needed to be redesigned 
as the flow passage between the chambers was no longer available. To solve the 
stagnation problem a new flow passage was introduced in the middle of the impeller. 
In this design, the centrifugal force generated from the rotating impeller will generate 
a secondary flow that can eliminate the stagnation by drawing the leakage of blood 
from the gap around the bottom of the impeller hub and then push out the primary 
flow at the outlet passage on the top of the impeller hub between the impeller blades.  
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Two designs for the passages were evaluated against the control design in this 
simulation to verify the change in the pump’s efficiency and the fluctuation of the 
radial force which is significant for the magnetic suspension design. The first design 
has a single outlet port and the second design has two outlet ports in opposite 
directions. The fluid model of the passage designs is shown in Figure 3-30.  
 
Figure 3-30: The design of the flow passage on the LVAD. 
This new design of the passage, especially the single outlet design, introduced 
an asymmetrical structure to the impeller which could cause fluctuation of the radial 
force due to the outflow stream. This fluctuation needs to be closely examined as an 
excessive radial force could cause damage to the internal structure of the pump. In 
addition, the investigation of the radial force is also important for the design of the 
magnetic suspension system which could be implemented in this pump in the future. 
Therefore, the transient simulation was employed to examine the pump’s operation. 
3.6.1 Simulation setup 
In the simulation the impeller speed was set to the design point at 4,000 rpm, 
the inlet and outlet boundaries are at a pressure of 780 mmHg, and the flow rate is 
0.3 m3/h; which these were the designed working conditions of the pump that were 
used in the previous simulation on the LVAD side. 
 
 
125 
 
To apply the transient simulation, the transient rotor stator was used as a 
mixing model on the domain interfaces. The time frame was set to 0.015 s and a total 
of 120 time steps were processed within the selected time frame which is equal to 
one revolution of the impeller. The simulation was initiated by a steady state result 
obtained from the initial simulation, then the solver allowed the impeller to run for 3 
consecutive revolutions to reach a stable condition before starting to record the 
results.   
3.6.2 Simulation results and discussion 
I. Hydraulic force 
The relationship between the pump head and impeller positions of the three 
cases is shown in Figure 3-31. It can be noticed that all the cases display the same 
head pattern over time. The amplitudes in the graph exhibit an increase cyclically of 
the head pressure when the impeller vanes move across the diffuser port. There is a 
small shoulder in the signal during the decline of the head pressure as the trailing 
edge of the blades approach the volute tongue.  Both of the designs with the washout 
holes express a slight loss on the head pressure, presumably due to the leakage flow 
through the washout hole; however, the loss is very small as it is less than 1% for 
both designs and, thus, it could be considered as not significant. 
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Figure 3-31: Head vs. impeller angular position of 3 washout hole designs 
A similar cycling pattern can also be seen in the change in the pump’s 
efficiency over time (Figure 3-32). There is a small fluctuation in the efficiency of 
the designs with a washout hole, and the leakage flow through this passage also 
reduces the pump’s efficiency slightly. The average efficiency predicted from the 
simulation on revolution is 56.37%, 56.26% and 55.84% for designs I, II and III, 
respectively.  
 
Figure 3-32: Pump efficiency vs. impeller angular position 
The outflow from this new washout hole affects the magnitude and direction 
of the radial force, as shown in Figure 3-33 and Figure 3-34. The reference design 
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without a washout hole presented an almost steady cyclical pattern of force when the 
impeller rotates. This force is disrupted by the outflow from the washout hole and 
causes more fluctuation to the force direction, as clearly seen on the polar coordinate 
plots. However, the magnitude of force is very small compared to the other forces on 
the impeller. 
 
Figure 3-33: Radial force vs. Impeller angular position 
 
Figure 3-34: Radial force trajectories on the polar coordinates. 
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Figure 3-35: Head pressure vs. Impeller angular position 
Figure 3-35 shows the axial forces (FZ) of all designs and they are relatively 
large compared to the radial forces. The unbalanced design of the washout hole did 
not cause any significant fluctuation on the axial forces as it did on the radial 
coordinate. However, the force exerted on the impeller for both designs with a 
washout hole is lower due to the counter-direction force from the retrograde flow in 
the passage. According to the results, the axial force of Design III is slightly lower 
than Design II with average forces of 13.007N and 13.016N, respectively, while the 
average axial force of the reference design is relatively high at 13.459N. 
II. Washout passage flow  
The streamlines distribution in Figure 3-36 depicts the flow pattern under the 
impeller area and inside the washing hole. In the reference design, the fluid circulate 
in this region at high velocity near the edge of the impeller and at very slow velocity 
near the center of the rotation without making any progress upwards and back to the 
top region of the impeller. This stagnant and recirculation flow pattern could cause 
platelet deposition which leads to a high risk of thrombus formation in this area. The 
washout passage in design II and design III overcomes this problem by creating 
leakage flow from this clearance gap upwards to the region of the blades; according 
to the flow pattern, blood could swirl through this passage towards the outlet near the 
leading edge of an impeller without a vortex being observed in the flow field. 
Considering the flow profile in the passage of Design II, blood continues swirling 
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throughout the passage, while the streamlines of the fluid flow in design III become 
more uniform after the separation of the passage. 
 
Figure 3-36: Streamlines comparison in each washout hole design 
Figure 3-37 displays the velocity contour in the cross-section view of the pump at 
different impeller positions. The blue regions’ appearance near the passage outlets of 
design III indicate possible stagnation areas which were not washed out during the 
rotation of the impeller. Stagnation was not found in the washout hole of design II as 
the single-hole design creates a larger pressure difference across the passage, as 
shown in Figure 3-38, and thus makes a slightly higher flow rate through the 
passage, which helps wash out the stagnation flow. The average flow rate through the 
hole for design I and design II during one revolution is 0.00577 m^3/h and 0.00496 
m^3/h, respectively, which is considered to be only about 2% of the blood flow rate 
through the pump. 
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Figure 3-37: The section view of velocity contour within the washout hole at 
different angular position of impellers. 
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Figure 3-38: Pressure distribution in the vertical-section view of the pump 
III. Hemolysis 
The hemolysis of this simulation was calculated from the shear stress 
information at each time step and plotted against the impeller angular position as 
shown in Figure 3-39. 
 
Figure 3-39: NIH vs. impeller angular position 
Considering the comparison of the above cases, all the cases can achieve the 
required hemolysis specification. The reference design and the single hole design 
generate almost the same level of blood damage with the NIH of 0.001831g/100l and 
0.001287, respectively, while design III causes the highest damage to the blood cells. 
However, the difference between the cases is so small that it can be considered as not 
significant and all the designs are acceptable in terms of hemolysis. 
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According to the simulation results, Design III which has double washout holes 
presents a slightly lower efficiency than the single hole and the reference designs. 
Moreover, from the velocity contour in Figure 3-37, there are low velocity regions 
present on the surfaces within the holes. These regions have a risk of forming 
thrombosis as the simulation result of the different impeller positions shows that 
these stagnations could not be washed out by the rotation of the impeller. Therefore, 
Design II with a single hole was selected as the prototype due to its better 
hemodynamic performance. 
3.7 FINAL REFINEMENTS AND SIMULATION FOR THE PROTOTYPE 
The design optimisation at this stage was conducted by aiming to produce the 
final prototype of the working product by considering the machine capability and 
available resources as the main priorities.  
3.7.1 Pump structure 
I. Driving mechanism 
With the lack of a proper pump driving mechanism that requires a specifically 
designed magnetic pump control system, the magnetic levitating function of the 
impeller cannot be accomplished for the current development. The design for the 
prototype and in-vitro evaluation were continued based on a single-sided pump by 
running on the motor of a commercial magnetic drive pump Iwaki MD-10-230GS0 
which is a small 30W DC pump for general application. Therefore, the external 
structure was redesigned to be able to fit on the motor’s structure while the impeller 
hub was adjusted to accommodate the new ferrite ring magnet for the driving 
mechanism. 
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Figure 3-40: Iwaki MD-10-230GS0 motor for the VAD 
 
II. Bearing and Shaft design 
The magnet of this motor can provide the driving force for the impeller but it is 
not strong enough to create the magnetic bearing suspension; therefore, the support 
bearing needed to be redesigned to control the axial position of the impeller while a 
shaft needed to be added to restrict the radial movement. To solve these problems, a 
pivot bearing was introduced to support the top of the impeller by adding a truncated 
cone-shaped tip on top of the impeller which can fit on the female socket that is 
embedded on the flow straightener to work as a pivot joint, as shown in Figure 3-41. 
At the bottom of the chamber, 6 small static blades were added to support the 
impeller and help regulate the blood to flow smoothly to the passage at the impeller's 
centre (Figure 3-42). 
To control the radial position, a small pin was added in the centre at the bottom 
of the chamber to function as a shaft that restricts the radial movement. The position 
of the bending angle in the washout hole was moved down towards the pin, as shown 
in Figure 3-43, so the centrifugal force could effectively pull the vortices that might 
form at the tip of the pin.  
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Figure 3-41: An impeller with a truncated cone tip as a pivot bearing. 
 
Figure 3-42: Bottom support part of the impeller with static blades. 
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Figure 3-43: Section view of the pump structure. 
III. Inlet pipe 
As the pump now functions as a single pump, the 90ᵒ elbow which was 
originally designed to provide the same inlet direction to save space in the BiVAD is 
no longer required. The inlet was changed to a straight pipe which helps avoid the 
low flow region experienced in the elbow inlet corner and also provides a more 
uniform flow to the impeller which could improve the overall pump efficiency.  
IV. Chamber 
The pump was produced by a CNC milling machine as it could produce a 
highly accurate prototype at low cost which is suitable for further refinements if any 
minor change needs to be made in the pump design. However, there are several 
positions in the original pump design that could not be machined by this method such 
as the internal volute of the pump or the tiny impeller supports at the bottom of the 
pump for which there is not enough open space to enable the milling cutter to reach 
the surfaces. Therefore, the chamber was split into 4 parts, as shown in Figure 3-44, 
while the outlet pipe was also separated to an individual part that can slide to fit on 
the outlet diffuser to lock the two top parts of the chamber together.  
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Figure 3-44: Components of the pump chamber. 
The complete prototype model of the pump after design optimization is 
shown in Figure 3-45. 
 
Figure 3-45: Final model for the pump prototype. 
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This design was based largely on the limitation of materials and the 
manufacturing capability process. In the final commercial product of this pump, the 
manufacturing could be changed to a more effective method such as molding 
injection or 3D printing that is capable of creating a chamber as a single piece 
without requiring screws and seals to assemble the parts together.  
3.7.2 Simulation setup 
The simulation of this pump was conducted as a final confirmation to ensure 
that the new pump design could achieve the required performance before producing 
the prototype; therefore, the pump was evaluated under the off-design conditions and 
more analytical analysis was done to ensure that the pump performed as intended and 
also to gather more information for future improvement. The simulation in this stage 
was conducted with the updated ANSYS 14.0 version.  
I. Fluid model 
The fluid model of this new pump design was adjusted according to the 
changes of the pump’s components, as shown in Figure 3-46. It included the new 
pump design structure which has a straight inlet pipe and a new washout hole 
structure including the shaft, pivot bearing, and static blades to support the bottom of 
the impeller. 
 
Figure 3-46: The transparent fluid model shows the impeller and the internal flow 
passage. 
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II. Meshing model 
The meshing continued to be conducted by the ICEM CFD using the 
unstructured tetrahedral mesh and the mesh size is controlled by the face sizing 
method on the areas that require fine meshes. The stator model of this VAD contains 
1,160,059 elements which is close to the number of elements of the previous 
simulations. However, on the rotating domain the number of elements was increased 
to 1,013,883 elements which is almost a 1:1 ratio with the stator elements because of 
the more complex areas at the bottom support of the impeller, the region around the 
shaft, and along the washout passage; these areas comprise many small parts and 
gaps which required a high density of elements to accurately simulate the near wall 
flow effect. The mesh models of the stator and rotor of this VAD are shown in Figure 
3-47 and Figure 3-48, respectively.  
 
 
Figure 3-47: Meshes on the stator. 
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Figure 3-48: Meshes on the rotor. 
III. Boundary conditions 
As was discussed earlier that the current design of the pump could function as 
both the LVAD and RVAD by adjusting the pump speed to deliver the required head 
pressure, the simulation in this stage also needs to be conducted to verify the 
performance of this prototype design on both pump functions. 
In order to improve the accuracy of this simulation for the actual pump within 
the human body, the boundary conditions have been slightly adjusted to reflect the 
pump’s working environment in the systemic and pulmonary circulations, as follows: 
Inlet: At the inlet, the boundary was specified by the Cartesian velocity 
component of the flow, which is related to the volumetric flow rates that varied 
between 0.15, 0.18, 0.24, 0.30, 0.36 and 0.42 m3/h, to find the pump characteristics 
under the different flow rates. The k-ε model was still used as a turbulence model for 
this simulation. 
Outlet: The outlet boundary is specified using static pressure; for the LVAD, 
the outlet of the pump has to be connected to the aorta for the systemic circulation 
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arterial, thus the mean arterial pressure (MAP) was defined for the outlet boundary 
pressure. Similarly for the RVAD, the right pump is connected from the right 
ventricle of the patient to the pulmonary venous system; therefore, the mean 
pulmonary artery pressure (MPAP) (McNeil, Dunning, & Morrell, 2003) was used as 
the RVAD outlet boundary.   
Impeller rotation speed: A series of simulation was conducted to find the new 
pump speed for this modified pump design to achieve the required head pressure. It 
was found that the speed has to be slightly increased to compensate for the additional 
loss of the impeller support fans and the washout hole. Therefore, the pump speed for 
this simulation was set to 4020 rpm on the LVAD and 3070 for the RVAD to 
generate the required head pressure. 
Table 3-7: Boundary condition of the single sided VAD prototype simulation. 
Location    LVAD  RVAD 
Inlet 
Boundary type  Inlet  Inlet 
Boundary Detail  Normal Speed: 
‘Flow Velocityinlet’ m/s
Normal Speed: 
‘Flow Velocityinlet’ m/s 
Turbulence Model  k‐ε  k‐ε 
Outlet 
Boundary type  Outlet  Outlet 
Boundary Detail  Static Pressure 
100 mmHg 
Static Pressure 
50 mmHg 
Impeller  Speed  4020 rpm  3070 rpm 
 
3.7.3 Simulation results 
The simulation results are shown and discussed in this section for the current 
pump’s performance and the possibility of future development. However, as the 
impeller position is almost fully restricted by the shaft, pivot and base supports, the 
radial and axial force acting on the impeller is thus not considered for this design.   
I. Hydraulic efficiency 
The hydraulic efficiency shown in the relationship of the flow rate to the head, 
hydraulic power and hydraulic efficiency are shown in the graphs from Figure 3-49 
to Figure 3-51. 
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Figure 3-49: The plot between pressure head vs. flow rate on the LVAD and RVAD 
operating speed 
 
 
Figure 3-50: The plot between hydraulic power vs. flow rate on the LVAD and 
RVAD operating speed 
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Figure 3-51: The plot between Hydraulic Efficiency vs. Flow rate on the LVAD and 
RVAD operating speed 
In the real operational environment of the pump the LVAD would operate at 
the estimated flow rate of 5 l/min (0.3 m3/h) while the RVAD would provide a 
pulmonary flow at an estimated 4 l/min (0.24 m3/h). These flow rates were set for the 
pump operation point although there would be some variation between the conditions 
of heart failure and physical activities. According to the simulation results, the pump 
could generate the LVAD with the required head pressure of 1.36 m at a flow rate of 
0.3 m3/h and at a speed of 4,020 rpm while the RVAD head of 0.68 m was achieved 
by the pump at a speed of 3,070 rpm at the designed flow rate of 0.24 m3/h. The 
pump also shows the best efficiency at these operating points with 50.50% and 
49.47% for the LVAD and RVAD, respectively. 
Comparing these parameters with the levitating impeller in the previous 
BiVAD concept simulations, the efficiency of this design is reduced by 4.6 % for the 
LVAD and 3.7 % for the RVAD under the same flow rate. 
II. Overview of the pump and passage flow at the design condition 
The inflow streamlines in Figure 3-52 represent the overview of the flow 
distribution within the pump under the design condition of the LVAD. It can be seen 
that the stream flow in the inlet pipe is distributed uniformly in the design condition. 
Some of the flow could leak down the impeller-chamber gap to the washout hole and 
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swirl around the shaft and through the washout passage back up to merge with the 
primary flow stream in the impeller vanes. The estimated flow rates through this 
passage on the LVAD and RVAD are 0.0010 - 0.0015 m3/h and 0.008 - 0.001 m3/h, 
respectively.  
According to the streamlines plots in Figure 3-52 and Figure 3-53, there is no 
recirculation of the blood flow observed in this design condition; however, the 
streamlines show that the flow is not fully uniform when exiting the outlet port. This 
leaves some possibility for an improvement in the future optimization.  
 
 
Figure 3-52: Flow streamlines from the LVAD at flow rate 0.3 m3/h 
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Figure 3-53: Streamlines of the flow from the bottom region of the impeller through 
the washout hole 
III. Pressure distribution 
The contour plots of pressure on the transverse-mid plane and vertical plane 
Figure 3-54 to Figure 3-57) show similar distribution patterns between the LVAD 
and RVAD with a larger magnitude on the LVAD side in response to the higher 
pump speed. On the transverse-mid plane (Figure 3-54 and Figure 3-56), the pressure 
is distributed almost equally in each vane, with a higher pressure on the pressure side 
of the blades, and it is gradually raised when blood flows toward the vane exit and 
the outlet port, while there is also observed high pressure in the near wall region of 
the volute casing when the pump operates at the above design points. On the vertical 
plane (Figure 3-55 and Figure 3-57), it can be seen that there is a pressure difference 
between the higher pressure in the bottom area of the impeller and the negative 
pressure induced by the centrifugal force at the impeller eye and within the washout 
passage, which creates a suction force that draws the blood flow through the washout 
passage and creates a secondary flow within the pump, as previously shown in the 
streamlines plots. 
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Figure 3-54: Pressure contour plot of the LVAD under different flow rates on the 
transverse-mid plane 
 
Figure 3-55: Pressure contour plot of the LVAD on the vertical plane 
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Figure 3-56: Pressure contour plot of the RVAD under different flow rates on the 
transverse-mid plane 
 
Figure 3-57: Pressure contour plot of the RVAD on the vertical plane 
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IV. Velocity distribution 
LVAD 
The velocity distributions of the LVAD at the transverse-mid plane and the 
vertical plane at different flow rates are displayed in Figure 3-58 and Figure 3-60, 
respectively. On the transverse-mid plane at the design condition, it can be observed 
that the velocity is distributed almost symmetrically on each vane where the high 
velocity is present near the compression side of the blades and the lower velocity is 
on the suction side. At the mid-section of the blades on the suction side there are 
small regions which show slightly lower flow rates at 0.4 - 0.8 m/s, but the velocity 
vectors plot (Figure 3-59) indicates a smooth flow through these areas. The flow 
speed is highest in the region around the impeller, especially near the volute tongue 
where the velocity is above 3.6 m/s, and it gradually decreases as the blood flows 
toward the outlet. There are boundary layers of low velocity flow observed at the 
near wall area in the outlet diffuser; this is due to the wall friction effect of the no-
slip wall boundary and these grow in a symmetrical shape to reach the centre at the 
end of the outlet port.  
At a flow rate above 0.3 m3/h, the velocity distribution pattern in the impeller 
region and volute is similar to that observed in the centre condition but low velocities 
are located at the trailing edges instead of at the middle of the blades. The overall 
flow velocity is raised along with an increase of the flow rate through the pump, but 
it is notable that the distribution becomes more uniform since the velocity above 3.6 
m/s is no longer present, while the regions of velocities of 2.0-2.8 m/s expand over a 
larger part of the volute area. A large low velocity boundary layer is observed in the 
diffuser at the tongue side while the higher velocity is shifted to the opposite side. 
 In the low flow conditions (0.15, 0.18 and 0.24 m3/h), large low velocity 
regions could be observed in the impeller vanes and their size increases when the 
vanes move toward the diffuser region. The flow in these regions, as shown by the 
velocity vector plots (Figure 3-59) has a jet-wake structure which is a separation of 
the streamlines between the flows regions and which develops a recirculation pattern 
within the area.  Under the flow rates of 0.18 and 0.24 m3/h, the jet-wake presented a 
clear separation of different flow velocities but the flow is still properly guided out of 
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the vanes without any recirculation observed, while at a flow rate of 0.15 m3/h, the 
areas of low flow become larger with a lower velocity.  
In the lowest pump flow condition, the mass flow through the vanes is not 
enough to provide sufficient momentum to effectively eject the blood to merge with 
the main flow circulating in the volute casing; thus, the flow from the volute could 
flow back into the volute regions and develop separations with two large 
recirculations at the end of the impeller passages. The size and intensity of these 
vortices increases in the locations where the cross-sectional area of the volute 
expands near the diffuser. However, these recirculation regions would continue to 
wash away when the vanes move past the tongue where there is smaller resistance to 
the flow and allow the blood to fully discharge out of the blades’ passage. This 
washout occurs repeatedly with every revolution of the impeller, so the recirculation 
cannot persist long enough to form thrombosis within the pump, but it could increase 
the residence time of the blood which exposes the RBC to shear stress for longer and 
causes more blood damage.  
The velocity distribution contour in the outlet diffuser under low flow 
conditions showed low flow regions along the pipe at the opposite side of the tongue. 
The velocity vector plots showed that the flow could pass through this area in the 
condition with the flow rates of 0.18 and 0.24 m3/h despite a flow separation with a 
much larger intensity of separation when the pump flow rate is lowered to 0.15 m3/h 
and where the flow near the wall region starts to recirculate and form vortices that 
dominate a large area in the diffuser. The recirculation in this area could not be 
washed out by normal pump operation under this flow rate; thus, there is a high risk 
of forming both thrombosis and hemolysis if the pump is left to operate under this 
condition for long enough and it also causes loss of energy which reduces the pump’s 
efficiency. Therefore, the angle or dimension of the outlet diffuser should be 
optimized to cover a wider range for the pump’s operation.     
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Figure 3-58: Velocity contour plot of LVAD under different flow rates on the 
transverse-mid plane 
 
Figure 3-59: Velocity vector fields of LVAD below design flow rate conditions 
The contour plot on the vertical plane (Figure 3-60) shows that the boundary 
layers of the lower flow velocity formed at the near wall regions of the inlet pipe; 
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this is caused by the effect of wall friction on the uniform velocity flow that was set 
as an inlet boundary. However, the flow could pass through the pipe without any sign 
of stagnation or recirculation at all the flow rates. The region that is at risk of 
forming thrombosis in this pump, as observed from this vertical-section view, is in 
the area behind the flow straightener bars. Currently there are 4 of these bars built on 
the top part of the chamber, and each has a thickness of 1 mm which is relatively 
large compared to the cross-sectional area of the inlet pipe; thus, there could be a 
blockage of some flow and a cause of stagnation, as shown in the blue region of this 
Figure. However, with the limitation of the current manufacturing process and the 
strength of material for the prototype, the size and shape of the straightener could not 
be reduced or optimized further in this stage but they should be adjusted in the future 
optimization of this pump. 
 
Figure 3-60: Velocity contour plot of the LVAD on the vertical plane 
RVAD 
When the pump is operating under the RVAD conditions the overall flow 
velocity is lower than the LVAD under the same flow rate, as shown in Figure 3-61. 
At the design flow rate (0.24 m3/h) the pump presented a similar distribution to that 
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previously observed in the design condition of the LVAD (0.3 m3/h) where small 
flow separations are found at the middle of the blades on the suction side. The 
separation intensity is increased below the design conditions but the velocity vector 
field plots in Figure 3-62 show that the recirculation was not formed in the vanes, 
while the diffuser region also developed a well-uniform distribution without any 
separation.   
The flow separation in the diffuser of this RVAD is instead found in a higher 
flow rate than the design condition at 0.3 m3/h near the middle area of the outlet 
diffuser on the tongue side. The separation intensity in this condition is not high 
enough to generate recirculation and it disappeared when the flow rate was increased 
to 0.36 m3/h. However, the separation is observed again at the flow rate of 0.42 m3/h, 
starting from the volute tongue with very high intensity. The velocity vector plot 
(Figure 3-63) shows that the separation in this area is caused by the main flow that 
hits the tongue at a high contact angle on the volute side, so the flow does not fully 
cover the tongue on the diffuser side and leaves the low pressure behind the impact 
region, thus creating a suction force that forms the recirculation in the area.  
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Figure 3-61: Velocity contour plot of the RVAD under different flow rates on the 
transverse-mid plane 
 
 
Figure 3-62: Velocity vector fields of RVAD below design flow rate conditions 
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Figure 3-63: Velocity vector field of RVAD above design flow rate 
 
Figure 3-64: Velocity contour plot of the RVAD on the vertical plane 
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From the vertical plane plot (Figure 3-64), the velocity distribution is similar to 
the LVAD; boundary layers are also observed in the inlet pipe for all the flow rates. 
The low velocity is found behind the straightener bars and risks forming stagnation 
in these RVAD operating conditions. 
V. Turbulence kinetic energy 
LVAD 
The intensity of the turbulence kinetic energy (TKE) is found to be relatively 
high at the vane on the suction side of the blades in most conditions, while the same 
or a slightly higher TKE level is also observed behind the trailing edge of the blades 
due to the wake turbulence; this is common for the flow within the centrifugal pump 
and could be observed in all the simulation conditions and also in the previous 
simulation results. 
During low flow there is an increase of the TKE intensity around the tongue 
region but the distribution is still similar in pattern for the flow rates of 0.24 and 0.18 
m3/h. However, when the flow rate is reduced to 0.15 m3/h a very high intensity of 
TKE, roughly above 0.6 m2/s2, is found at the end of the vanes that move near the 
tongue.  This value of TKE is more than 100% higher than those observed on the 
same region with a higher flow rate which indicates strong turbulence in the area. If 
comparing this plot to the velocity contour plot, the high turbulence is found to 
match the location of the large vortices where the back flow was previously observed 
at the tip of the impeller vanes. Therefore, it is reasonable that strong turbulence 
could develop in these areas. 
For the above design flow rate conditions, the TKE is raised all over the 
impeller and volute areas. The left side of the diffuser where the flow separation 
occurs tends to have more turbulence than the other side where the flow passes 
through more smoothly. These turbulences observed in the diffuser have no direct 
impact on the hemodynamic properties of the pump, but an improvement to the 
design to eliminate these turbulences could reduce the energy loss and improve the 
pump’s performance.  
An additional observation on the vertical plane is a small amount of TKE 
found at the inlet of the washout passage and at the end of the shaft where blood 
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starts to swirl around in order to flow through the passage but the intensity is lower 
than that at the impeller and volute areas. 
 
Figure 3-65: Turbulence kinetic energy of the LVAD under different flow rates on 
the transverse-mid plane 
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Figure 3-66: Turbulence kinetic energy contour plot of the LVAD on the vertical 
plane 
RVAD 
The TKE in the RVAD shown in Figure 3-67 with the design flow rates (0.15 
and 0.18 m3/h) are better distributed than those in the LVAD and there is no sign of 
strong turbulence being formed at the pump in both flow rates. However, turbulence 
is starting to form in the middle of the outlet diffuser at the above design flow rate of 
0.36 m3/h with an estimated energy of 0.07-0.14 m2/s2 and it becomes highly intense 
and dominating mostly at the diffuser area when the flow rate is increased up to 0.42 
m3/h; this results in a large recirculation near the tongue area similar to that 
previously observed in the velocity vector plots.   
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Figure 3-67: Turbulence kinetic energy of the RVAD under different flow rates on 
the transverse-mid plane 
 
Figure 3-68: Turbulence kinetic energy contour plot of the RVAD on the vertical 
plane 
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VI. Shear stress  
The shear stress within the pump is generally found to be high in the region of 
flow diversion or separation; in this case the tongue and leading edge of the blades 
were found to have the highest shear stress in most of the flow conditions. The level 
of shear stress is reduced when the flow is directed into the impeller vanes but is still 
relatively high at the region where turbulence occurs near the suction side of the 
blades and along the wake turbulence region behind the trailing edges.  
The contour plot on the vertical plane reveals that the shear stress could be 
increased on the flow straightener at the inlet when the flow rate is increased. The 
additional shear stress of this design was also found to be generated at the inlet of the 
washout passage where the flow starts to swirl in, and also at the outlet of the 
passage which currently has a sharp exit corner. This high shear stress at the exit of 
the flow passage could be improved by adding a small radius to provide a better 
transition when the blood merges with the main flow and to reduce the stress exerted 
on the RBC in this area. 
The shear stress plot of the bottom plane (Figure 3-73) depicts extra shear stress that 
is introduced to this design at the leading and trailing edges of the static support 
blades. However, the magnitude of the shear stress at this region is lower than at the 
blades’ area due to the lower flow speed. 
LVAD 
When the pump operates at below the flow rate in the LVAD, there is an 
increase in the shear stress intensity on the left side of the tongue and at the wake 
turbulence region formed behind the trailing edge of the blades. The shear stress 
greatly increases at the flow rate of 0.15 m3/h where this wake turbulence flows back 
into the vane regions and contacts with the pressure side of the next blade that moves 
in. This effect was found to cause high shear stress, which is estimated at above 240 
Pa, and increased the risk of causing RBC damage as the recirculation also occurs in 
the same area.   
The shear stress was found to be generated in the outlet diffuser in the same 
region where the turbulence was formed when the pump operates above the design 
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point. The level of shear stress in this region was the same as the average stress 
found at the volute casing area but covers a larger area when the turbulence exists in 
the pipe. 
RVAD 
The overall shear stress level in the RVAD is only slightly increased at the 
level below the design flow rate and there was no significant problem from this shear 
stress level except for a slight increase in the blood damage level.  
The high shear stress that forms in the RVAD is only observed in the tongue 
and diffuser area which previously saw a large turbulence and a retrograde flow. 
Although the shear stress observed in this area is much lower than that found in the 
critical regions of the LVAD, the recirculation could increase the exposure time and 
eventually damage the RBC. 
 
Figure 3-69: Shear stress of the LVAD under different flow rates on the transverse-
mid plane 
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Figure 3-70: Shear stress contour plot of the LVAD on the vertical plane 
 
Figure 3-71: Shear stress of the RVAD under different flow rates on the transverse-
mid plane 
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Figure 3-72: Shear stress contour plot of the RVAD on the vertical plane 
 
Figure 3-73: Contour plot of the shear stress distribution in a bottom plane of LVAD 
(left) and RVAD (right) at the design flow rate 
 
VII. Hemolysis estimation 
The blood damage assessed from the simulations is shown as the NIH index in 
Figure 3-74. The pump tends to generate a smaller amount of damage at the BEP 
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flow rate for both the LVAD and RVAD which has a good agreement with the shear 
stress that was observed in each flow condition.  
 
Figure 3-74: NIH index of different flow rates on the LVAD and RVAD functions 
At the design operating condition of this pump under the flow rate of 0.3 
m3/h, the NIH index from the simulations is 0.00628 g/100L. This number increased 
significantly from the previous simulations due to the additional shear stress 
introduced to the pump with the additional support components. These included the 
impeller support structure on both the top pivot bearing and the static blades at the 
bottom, and the extra shear stress at the outlet of the washout passage, as shown in 
the Figure 3-72 and Figure 3-73.This value of the NIH is higher than the anti-
traumatic limit of a short term support pump for cardiopulmonary bypass support; 
however, it is still within the acceptable clinical range and could be used for both the 
LVAD and RVAD applications. 
The graph in Figure 3-75 represents the hemolysis index of several heart 
pumps both on trial and commercially available under the standard operating 
condition at a flow rate of 5 L/min and head pressure of 100 mmHg. This pump at 
the current stage could operate at the required condition while generating 
significantly lower blood damage than the clinical limit and maintaining its 
competitiveness with other pump models at the same generation. This result suggests 
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that the blood damage generated from this VAD design is at the acceptable level, and 
this pump should not cause blood damage problems in the long term support.   
 
Figure 3-75: NIH comparison across the pumps (Gräf, Finocchiaro, Laumen, Mager, 
& Steinseifer, 2015; James, Wilkinson, Lingard, Meer, & Woodard, 2003; Johnson Jr 
et al., 2011; Lin et al.; Throckmorton & Kishore, 2009; J. Zhang et al., 2006) 
3.7.4 Conclusion 
According to the simulation results, the distribution profile of all the 
parameters on the contour plots are similar to the results previously observed in the 
BiVAD simulation, which means that the design refinements did not cause any 
significant impact on the flow in the volute and impeller areas.  
The off-design simulation confirmed that the pump could provide sufficient 
head pressure over the wide range of flow rates with good efficiency for both the 
LVAD and RVAD applications, and could achieve the hemodynamic requirements to 
be used as both a short term and long term blood pump to support cardiopulmonary 
operations or CHF patients. 
The pump still has a risk of forming thrombosis from the recirculation when 
operating at the flow rate of 0.15 m3/h and below on the LVAD application, and at 
the flow rate 0.42 m3/h and above on the RVAD application. The structure of this 
pump should be further optimized in a future study to achieve a wider operational 
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range for the pump. The limitations of the pump also need to be confirmed in a test 
with real blood to study the actual time at which thrombosis could be formed within 
the pump when operating under the off-design conditions. 
In addition to the items that need to be further studied, there are also some structures 
in the pump that have potential for minor improvements such as the shape of the flow 
straightener that could be optimized to prevent stagnation behind it, and the high 
shear stress at the washout hole which could be reduced by adding a small radius for 
better transition of the outlet flow.  
3.8 DESIGN SUMMARY 
The availability of the pump design has been confirmed by the simulation 
results and revised based on manufacturing requirements; therefore, the pump design 
is summarised, as shown in Figure 3-77 to Figure 3-79. The pump prototype for 
design verification was produced on these models and drawings.  
 
Figure 3-76: Exploded view of the VAD design. 
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Figure 3-77: Rendered view of the VAD concept model 
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Figure 3-78: Assembly drawing of the VAD design. 
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Figure 3-79: The section view drawing of the VAD design
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Figure 3-80: VAD exploded sketch with bill of parts 
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 Design and Construction of VAD 
Test Loop 
This Chapter focuses on the design and construction of the test loop for an in-
vitro evaluation of the VADs known as the Human Mock Circulation Loop (MCL). 
In order to achieve all the aspects of evaluation, the MCL must be able to simulate 
the basic physiological conditions of a normal heart and the heart functions of CHF 
which mainly are characterized by the pulsating flow, the compliance of the venous 
and arterial system, and resistance of the blood vessels.  
4.1 DESIGN REQUIREMENTS 
The main objective of the MCL design is to create an apparatus for evaluation 
of the VAD prototype and verify the simulation results. The structure is mainly 
focused on replicating the pulsatile environment and resistance of the systemic 
circulation to observe characteristic of the pump under the unsteady flow. Therefore 
the MCL must be able to simulate the flow condition of a healthy adult as a reference 
condition, while also capable of reducing the physiological condition to simulate the 
condition of a heart failure patient.  
4.2 PHYSICAL PARAMETERS 
In order to mimic the flow characteristics of the human circulatory system, 
several physical parameters need to be studied and properly selected to achieve, as 
much as possible, the condition that is close to what really happens within the human 
body. These parameters include the flow circulation paths, heart functionality, 
pressure and flow distributions, and compliance and resistance to the flow. 
4.2.1 Human Circulatory System 
The human heart is a double pump each of which has its own circulation loop 
encompassing a set of vessels, namely the arteries, arterioles, capillaries, venules and 
veins. Figure 4-1 shows the human circulatory system where the left part of the heart 
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pumps blood through the systemic circulation and the right part of the heart pumps 
blood through the pulmonary circulation.  
 
Figure 4-1: Human circulatory system (Brazier, 1988) 
 The systemic circulation functions in distributing oxygen-rich blood 
containing nutrients and other substances needed to all the body tissues and organs, 
while also carrying away the carbon dioxide and organic waste from the cell 
metabolism back to the heart via the vena cavas. This return blood enters the heart at 
the right atrium which functions as a weak primer pump to regulate the venous blood 
to the right ventricle before pumping to the pulmonary circulation.    
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The pulmonary circulation is a shorter circuit. It carries oxygen-poor, carbon 
dioxide-rich dark red blood from the end stage of the systemic circulation to the air 
sacs called alveoli in the lungs to exchange the gas and enrich the oxygen level to the 
blood cells. As the gases are exchanged, the blood turns bright red and circulates 
back to the left atrium via the pulmonary veins to enter the systemic circulation 
again.   
4.2.2 Heart Functionality 
I. Cardiac Cycle   
The human heart pumps blood by the contraction of the heart wall that reduces 
the volume of the heart cavity during the systolic phase and thus increases the 
pressure to the blood and propels the blood flow through the heart valves, before the 
heart muscle is relaxed and allows the blood to fill in the cavity for the next ejection 
in the diastolic phase. Heart valves have a vital role in regulating the blood flow 
during the cardiac cycle where they function as non-return valves to prevent 
backflow to the heart chambers. There are a total of 4 valves in human heart 
chambers (Figure 4-2); the atrioventricular valves (mitral and tricuspid valves) 
control the flow from the atriums to the ventricles, while semilunar valves (aorta and 
pulmonic valves) control the outlet flow of the ventricles.  
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Figure 4-2: Schematic of the human heart (Nordqvist, 2014) 
The full cycle of the cardiac function consists of five phases. Figure 4-3 
shows the pressure and volume of a heart over two complete cycles, while Figure 4-4 
outlines the events of the cardiac cycle.   
 
Figure 4-3: Pressure and volume of heart during systolic and diastolic phases (J. E. 
Hall & Guyton, 2011). 
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Figure 4-4: Heart events and left ventricle volume during the cardiac cycle (Brazier, 
1988). 
Phase 1: Ventricular Filling  
During the filling stage, the artrioventricular (AV) valves are open, while the 
semilunar valves are closed. Blood flows into the heart and about 70% of the 
ventricle is passively filled in this phase.    
Phase 2: Arterial Systole  
In this stage, the arterials’ contraction forces the blood to flow through the 
tricuspid and mitral valves to the ventricles. The inertia still keeps the blood flowing 
into the heart while preventing backflow to the veins.  
Phase 3: Isovolumetric Contraction 
There are 2 stages in the ventricular systole. At the beginning of the phase the 
aortic valve is closed, and the ventricular muscle starts to contract and reduce the 
volume; therefore, the pressure is sharply increased until the ventricle pressure is 
raised above the aortic pressure and pulmonary pressure at an estimated 80 mmHg 
and 10 mmHg, respectively. The aortic and pulmonary valves then open while the 
ventricle continues to contract and thus the pressure is raised further at a slightly 
lower rate. 
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Phase 4: Ventricular Ejection  
The volume ejection begins as the aortic and pulmonary valves open. The 
high flow rate starts at an early phase due to the high ventricle pressure and then 
slows down as the systole progresses. The aortic and pulmonary pressures at the end 
of this ejection phase could slightly exceed the ventricle pressures but the momentum 
keeps the blood flow forward without a retrograde flow. 
The estimated peak pressures in the aorta and pulmonary artery are about 120 
and 25 mmHg, while the cardiac output is around 70 to 90 mL per stroke at resting 
condition, which is an ejection fraction of about 65% of the end-diastolic ventricular 
volume.  
Phase 5: Isovolumetric Relaxation 
The ventricular pressure continues to drop rapidly while the aortic and 
pulmonary valves close to prevent the backflow (Barrett, 2010). 
II. Heart Rate  
Heart rate is the measure of the heart cycle per unit of time which generally is 
measured as beats per minute (bpm). The heart rate can be varied depending on the 
physical needs of the oxygen and carbon dioxide exchange; therefore, the heart rate 
could have a large variation from 60-80 bpm for a normal adult during rest to above 
180 bpm during intensive exercise.  
This mock circulation loop is capable of varying the heart rate between 60-120 
bpm. The heart rate of 60 bpm is set for the normal heart function, while 90 bpm is 
used for the heart failure condition to simulate the increase of the heart rate in 
attempts to compensate for the loss of cardiac output. 
4.2.3 Distribution of Flow and Pressure 
I. Pressure in the Heart Chambers 
The contraction of the heart chambers makes the pressure varied throughout 
the cardiac cycle. The pressure distribution and the range of an average healthy adult 
during rest is shown in Table 4-1 
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Table 4-1: Pressure distribution in heart chamber 
 
   
The left ventricle has the highest diastolic pressure among the chambers as it 
pumps blood through the systemic circulation. The maximum left ventricle pressure 
is estimated at 120 mmHg which is equal to the pressure in the aorta at the same 
phase of the heart cycle, while the pressure is lowest during the filling phase at about 
10 mmHg and the aortic pressure is around 80mmHg. Blood from the systemic 
circulation then returns to the heart via the right atrium at a very low pressure 
ranging from 0-4 mmHg. The blood from the right ventricle is then pumped through 
the pulmonary circulation by the right ventricle in the same manner as the left 
ventricle does in the systemic circulation but at a significantly lower pressure, which 
is about 25 mmHg during the systolic phase and 4/10 mmHg during the diastolic 
phase in the right ventricle and pulmonary, respectively. The pressure in the left 
atrium, which receives the blood returned from the pulmonary circulation, slightly 
varies with respiration from 8-10 mmHg.       
II. Stroke Volume 
The amount of blood volume pumped during one contraction is called stroke 
volume. It can be calculated by measuring the difference in the blood volume in the 
ventricle at the end of the diastolic phase and at the end of the systolic phase: 
 ܸܵ ൌ ܧܦܸ െ ܧܸܵ [4-1] 
 
Heart Chamber  Pressure (mmHg) 
Right Atrium  0‐4 
Right Ventricle  25/4 
Pulmonary Artery  25/10 
Left Atrium  8‐10 
Left Ventricle  120/10 
Aorta  120/80 
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where EDV is the end-diastolic volume and ESV is the end-systolic volume. The 
EDV of the left ventricle for normal people is about 120 ml and the ESV is 50ml; 
therefore, the estimated stroke volume (SV) is about 70 ml or around 60% of the 
blood volume in the chamber. However, the actual value of the stroke volume can 
range from 55-100 ml depending on the activities and physiological condition of 
normal people. Figure 4-5 shows the relation between the left ventricular volume and 
the stroke volume during one cardiac cycle. 
 
Figure 4-5: Left ventricular stroke volume (Brazier, 1988). 
III. Cardiac Output 
The cardiac output (CO) refers to the volume of blood pumped by the left or 
right ventricle. It can be calculated by the following equation: 
 ܥܽݎ݀݅ܽܿ	ܱݑݐ݌ݑݐ ൌ ܪ݁ܽݎݐ ݎܽݐ݁ ݔ ܵݐݎ݋݇݁ ܸ݋݈ݑ݉݁ [4-2] 
Normal cardiac output is approximately 5L/min which is generally the same 
for both ventricles. During exercise, the reflex mechanism increases the cardiac 
output by either increasing the heart rate, stroke volume, or even both at the same 
time to pump enough blood volume to meet the required perfusion for the tissues and 
organs. These mechanisms may raise the CO rate up to 30-35 l/min (Brazier, 1988; 
Marieb & Hoehn, 2007). 
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IV. Arterial Pressure  
The contraction of the heart during the systolic phase ejects blood into the aorta 
at high pressure. For an average healthy adult, this arterial pressure is typically as 
high as 120 mmHg and 25 mmHg for the left and the right ventricles, respectively. 
This peak pressure is called the systolic pressure ( ௦ܲ௬௦ሻ. 
During the diastole, after the aortic valve closes, the aortic pressure drops to 
the lowest level at approximately 80 mmHg for the left ventricle and 10 mmHg for 
the right ventricle for a healthy adult. This pressure is referred as diastolic pressure 
( ௗܲ௜௔௦ሻ. The difference between systolic and diastolic pressure is defined as the 
arterial pulse pressure (PP). This relationship is shown in Equation [4-3]: 
 ܲܲ ൌ ௦ܲ௬௦ െ ௗܲ௜௔௦ [4-3] 
The pulse pressure is the measure of force per unit area that the heart generates 
at each contraction; therefore, it is used as a strong indication of heart problems. In 
normal people the pulse pressure is estimated at 40 and 15 mmHg for the systemic 
and pulmonary circulation, respectively. An arterial pulse pressure lower than 25 
mmHg caused by low stroke volume could be a sign of cardiovascular disease, while 
a pressure consistently greater than 40 mmHg could indicate poor heart functions 
like heart valves’ leakage. Pulse pressure is directly related to the stroke volume and 
the heart rate, thus it increases during exercise as the systolic pressure is increased 
with a stronger ventricle contraction while the diastolic pressure remains about the 
same. 
V. Mean Arterial Pressure 
Due to the fluctuation of pressure according to the nature of pulse flow, an 
average pressure is often used as a reference for the studies and calculations of 
arterial pressure. However, as the diastolic phase is normally longer than the diastole, 
the mean arterial pressure (MAP) is calculated based on the diastolic pressure plus 
one-third of the pulse pressure. 
 ܯܣܲ ൌ ௗܲ௜௔௦ ൅ ܲܲ3  
[4-4] 
 
 
178 Mechanism Design of Ventricular Assist Device 
 
The typical value of mean arterial pressure for a healthy adult, whose systolic 
pressure is 120 mmHg and diastolic pressure is 80 mmHg, is calculated as follows: 
ܯܣܲ ൌ 80 ൅	ሺ120 െ 80ሻ3 ൌ 93.3	݉݉ܪ݃ 
The pulmonary artery pressure is approximately 7 times lower than the aortic 
pressure (Barrett, 2010); therefore, the pressure for the right system is estimated at 13 
mmHg .  
VI. Venous Blood Pressure 
Venous blood pressure is typically measured in terms of mean venous pressure 
(MVP), also known as central venous pressure (CVP), and is the pressure of blood in 
the thoracic vena cava. The value of this pressure is steadier compared to the arterial 
pressure which is pulsated by the left ventricle contraction, and has very little 
variation during the cardiac cycle. The pressure in the vena cava is only 
approximately 15 mmHg.    
4.2.4 Compliance  
Compliance or capacitance is the ability of the blood vessels and internal 
organs to expand on receiving a pulse pressure of blood flow during the systolic 
phase and the recoil on the diastolic phase is due to the elasticity of the cell 
membrane. This flow property creates a damping effect to the blood flow which 
reduces the pulse fluctuation and helps in maintaining the perfusion supply to the 
organs during the systolic phase where the flow is paused. Without this effect, the 
systemic circulation pressure would quickly drop from the systolic pressure to zero 
which would cause a pause in the perfusion and the heart workload would need to 
increase greatly to maintain a continuous blood supply to the body. Compliance can 
be described as the ratio of the change in volume (ΔV) by the change in pressure 
(ΔP), as expressed in the following equation:  
 ܥ ൌ ߂ܸ߂ܲ [4-5] 
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The compliance property is dependent on the elasticity of the organs or blood 
vessels’ walls by having an inverse relation to the stiffness; therefore, this value 
varies at different body locations. This relationship can be seen in the plot between 
pressure and volume of the arteries and veins, as shown in Figure 4-6. The graph 
suggests that the veins in the venous system are deformed more easily than the 
arteries under the same pressure; therefore, according to the description of the 
compliance, the venous system has greater compliance than the arterial system. In 
addition to the variation of compliance among the blood vessels, the compliance 
value could also gradually be changed with age as the elasticity of the arterial walls 
becomes lower and thus the compliance is reduced.  
 
Figure 4-6: Pressure - volume plot of arteries and veins (J. E. Hall & Guyton, 2011). 
As the compliance relies on the elasticity of the blood vessels, it is hard to directly 
measure the values; thus, it is commonly calculated based on the stroke volume and 
pulse pressure (Chemla et al., 1998; Stergiopulos, Meister, & Westerhof, 1994). 
VII. Arterial compliance  
Arterial compliance is the compliance of large arteries such as the thoracic aorta, 
which normally have large elasticity and, thus, small compliance. Several studies 
have been conducted and the arterial compliance has been documented, as shown in 
Table 4-2; the average values range from 1-2 ml/mmHg for the systemic arterial and 
2-5 ml/mmHg for the pulmonary arterial system. 
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Table 4-2: Compliance values from different literature. 
Literature  Arterial 
Compliance(ml/mmHg) 
Pulmonary 
Compliance(ml/mmHg) 
(Stergiopulos et al., 1994)  1.68  ‐ 
(Chemla et al., 1998)  1.46  ‐ 
(G. Ferrari et al., 2002)  1.80  4.80 
(Liu, Allaire, Wu, Wood, & 
Olsen, 2006) 
2.20   ‐                         
(Daniel  Timms, 2005)  1.12  2.98 
 
VIII. Venous compliance 
The venous compliance is estimated to be from 20 to 30 times greater than the 
arterial compliance (Berne, Levy, Koeppen, & Stanton, 1998; Gelman, 2008); 
therefore, the estimated venous compliance value of a healthy adult is about 
50ml/mmHg.    
4.2.5 Resistance 
The resistance to the blood flow is one of the significant effects on the 
circulatory system. It is mainly influenced by the blood’s viscosity, and the length 
and/or change in the size of the vessels that the blood passes through. Higher 
viscosity makes the fluid thicker and stickier as it become harder for the molecules to 
slide between one another; the high viscosity of blood compared to water makes this 
property become more significant. The longer the length of the vessels, the greater 
the resistance, and the large radius of a vessel like in the aorta means a lower 
resistance compared to the resistance in the smaller vessels such as arterioles or 
capillaries. These relationships can be expressed by the formula: 
 ܴ ൌ 8ɳܮߨݎସ  [4-6] 
The resistance also has a relationship with the flow rate and flow pressure. A 
large flow resistance causes a large pressure drop on the flow path. This relationship 
is described by the following equation:   
 ܴ ൌ ߂ܲܳ  [4-7] 
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The resistance value can be presented in different units but most commonly is 
displayed in dyne.s.cm-5 or mmHg.min/l. 
The flow resistance is predominantly encountered in the systemic circulation 
which includes the resistance of blood flow incurred by the arteries, capillaries and 
veins. These resistances are often lumped to a single parameter called systemic 
vascular resistance (SVR) or total peripheral resistance (TPR). Based on Equation 
[4-7], the SVR can be calculated from the pressure drops between the MAP and the 
mean right arterial pressure (mRAP), divided by the cardiac output (CO), as shown 
in the following Equation (Marieb & Hoehn, 2007): 
 ܴܶܲ ൌ ܯܣܲ െܴ݉ܣܲܥܱ  [4-8] 
 
According to Equation [4-8], the TPR is calculated based on the MAP of 93 
mmHg, mRAP of 3 mmHg, and the CO of 5 L/min, which yield an estimated TPR of 
1.09 mmHg.min/l. 
4.2.6 Frank-Starling Mechanism 
Frank-Starling is the circulation mechanism of the heart that increases the 
stroke volume in response to the venous blood that returns to the heart. This means 
that the heart naturally works harder to eject the excessive blood volume that is filled 
in the ventricle, leading to an increase of stroke volume and, hence, cardiac output. 
Figure 4-7 shows the Starling curve; it is the left ventricle contraction force via the 
stroke volume on the y-axis which increases, along with the end of the diastolic 
volume on the x-axis.  
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Figure 4-7: A Starling curve (Brazier, 1988). 
4.2.7 Physiological condition of CHF patients 
As described in Chapter 1, CHF is the condition in which the heart muscles, 
especially in the ventricle, are weakened, thus losing the contraction force that is 
required to pump blood in the circulation system. In the aspect of physiological 
parameters, one can see a reduction of stroke volume and, thus, of cardiac output, 
which means the ventricle cannot effectively remove the blood volume from the 
ventricle. If this occurs in the left ventricle, the excessive blood will start to 
accumulate in the pulmonary system, the right side of the heart and the lungs, thus 
increasing the MAP and LAP which leads to pulmonary edema. Meanwhile, the 
blood that is backed up in the right side of the heart will trigger the Frank-Starling 
mechanism that leads to more blood being accumulated in the lungs and left ventricle 
and causes even more edema. In addition to the pulmonary problem, the consistently 
high workload on the right ventricle due to the Frank-Starling response could induce 
the development of right-sided heart failure, and thus lead to a worsening CHF 
condition.  
4.3 LITERATURE REVIEW OF MOCK CIRCULATION LOOP 
STRUCTURE & MECHANISM  
The mock circulation loop (MCL) is a mechanical circulation system capable 
of simulating the physiological conditions of the human circulatory system. It could 
be used as a test rig for in-vitro evaluation of cardiac prosthetic devices such as heart 
valves, balloon pumps, TAH or VAD. There are several designs of MCL that serve 
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different purposes and with different components and which have the capability of 
replicating the circulation characteristics. They can vary from the basic system that 
only consists of the preload chamber and a resistance valve that can deliver a 
continuous but constant flow rate, to the more advanced versions which simulate the 
pulse flow and comprise both systemic and pulmonary circulation systems. Some of 
these advanced systems can accurately replicate other important characteristics such 
as compliance, ejection fraction, fluid inertia or the different levels of the body’s 
workload during exercise, rest or sleep. Examples of the structure of a basic and an 
advanced MCL configuration are shown in Figure 4-8. 
4.3.1 Basic structure and flow generation 
Several basic MCL systems have been developed for the evaluation of a heart 
pump as the MCL is a quick and efficient way to verify the pump’s performance. 
The common feature of the basic loop is the ability to deliver a constant flow which 
is usually achieved by a preload tank with a clamp or valve to adjust the resistance 
before it flows into the pump, while the pressure is controlled by the water level 
(Yoshino et al., 2001). However, the lack of pulsatility behaviour from this type of 
loop limits the ability to evaluate the hemodynamic performance and it is not 
possible to evaluate the fluctuation of the pump’s performance due to the variation of 
flow that occurs in a real human circulatory system. 
 
Figure 4-8: Diagrams of a basic mock circulation loop by Yoshino et al. (Yoshino et 
al., 2001) (left) and a more advanced version by Timms et al. (Daniel Timms, Hayne, 
McNeil, & Galbraith, 2005) (right) 
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The advanced mock circulation loop has been constantly developed to be 
more flexible and capable of reflecting the real physiological conditions. An 
important function of the advanced MCL is the simulation of the pulsatile flow 
environment from the artificial ventricle. Scotten et al. (Scotten, Walker, & 
Brownlee, 1979) created a left ventricle for a mitral prosthetic valve with  a cone-
shaped polyurethane sheet enclosed in a transparent hydraulic chamber. The ventricle 
is driven by a positive displacement pump that transfers the pressure to the sheet via 
the fluid within the chamber.  
Cassot et al. (Cassot et al., 1985) attempted to improve the physiological pressure, 
especially within the left ventricle, to 
simulate an accurate condition for a heart 
valve evaluation which required a higher 
detail of the flow characteristics than the 
traditional MCL could generate. The 
study focused on redesigning the 
ventricle simulator by trying to mimic 
the real shape of a ventricle using a 
flexible ventricular sac suspended within 
the top part of the transparent rigid 
chamber (Figure 4-9). The driving force 
was still delivered by means of 
hydraulic pressure like the system of 
Scotten et al. but the piston pump was replaced with a volumetric  gear pump 
running on a servomotor controlled by a synthesiser that could produce the pressure 
to regulate the flow for the  required shape, amplitude and frequency profile.     
The designs of a ventricle with a flexible membrane within the chamber were 
adopted and improved many times by several researchers to suit the requirements of 
the testing subjects with consideration about compromising between the accuracy 
and the complexity of the mechanism. One of the most common designs for this type 
of ventricle simulator is the replacement of  the hydraulic chamber with an air 
pressurised chamber fitted with a pneumatic regulator to control the pressure; this 
was used by Verdonck et al. (Verdonck, Kleven, Verhoeven, Angelsen, & 
Figure 4-9: An artificial ventricle by 
Cassot et al. (Cassot, Morvan, Issartier, & 
Pelissier, 1985) 
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Vandenbogaerde, 1992), Pentalos & Konig et al. (Koenig et al., 2004; Pantalos, 
Koenig, Gillars, Giridharan, & Ewert, 2004), Liu et al. (Liu et al., 2006) and Garcia 
et al. (Garcia, Enriquez, Dembitsky, & May-Newman, 2008), 
The simulation of the pulse flow effect can also be accomplished by means of 
a simpler mechanism, such as a piston or bellows in the displacement pumps. An 
example of a piston-driven ventricle is the mock circulation loop designed by 
Zannoli et al. (Zannoli, Corazza, & Branzi, 2009) (Figure 4-10), with a 1:20 
downscaled model of the systemic circulation system built as a simple but effective 
design for teaching and general research purposes. The piston in this system is driven 
by a simple crank and slider mechanism that operates at a constant speed of 66 rpm 
and a fixed stroke volume of 1.0 ml. To control and vary the stroke output, the 
pressure-volume relationship of the ventricle needs to be controlled, and a more 
sophisticated driving mechanism is needed. Baloa et al. (Baloa, Boston, & Antaki, 
2001) incorporated this pressure-volume relationship in their mock loop for VAD 
testing by using a voice coil actuator (VCA) which could control the speed and 
displacement of the bellows pump directly controlled by the computer program. The 
piston or bellows displacement control can also be achieved by other different means 
of driving mechanism such as a servo motor and a screw-driven mechanism 
(Colacino et al., 2008; Vosse et al., 2011).  
 
Figure 4-10: The MCL with piston-driven ventricle by Zannoli et al. (Zannoli et al., 
2009) 
Timms et al. (Daniel Timms et al., 2005; Daniel L. Timms et al., 2011) have a 
different approach to create the pulsatile flow in their complete mock loop for 
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BiVAD testing by using pneumatic actuators to compress the air directly to the 
ventricle chambers, which is an air-sealed vertical tank constructed from clear 
flexible PVC piping. This method allows the ventricle pressure to be simulated more 
efficiently as it allows the passive diastolic filling and does not induce negative 
pressure in the chamber like other mechanisms.   
4.3.2 Compliance simulation 
The compliance effect is one of the important parameters that reduces the 
fluctuation of the flow rate and pressure due to the pulsatile flow environment. 
However, as the rigid wall of tubing and other components could not reflect the 
compliance from the elastic property of the blood vessels, many researchers 
attempted to replicate this effect in their advanced loop by introducing a damping 
effect via several mechanism structures. The notable designs include the use of a 
spring, flexible membrane and air trap tank. 
One of the most widely accepted MCLs was the Pennsylvania State University 
mock circulation system (Rosenberg, Phillips, Landis, & Pierce, 1981) which was 
originally designed in 1971 and has undergone several improvements and became the 
standard used by the American National Institutes of Health in 1985. This MCL 
consists of many components that were innovative designs at the time; one of the 
important features is the application of a leaf spring-loaded bellows to a compliance 
chamber which allows the compliance to be relatively small and adjustable by 
replacing the spring with another different spring constant.  
 
Figure 4-11: The Pennsylvania State University mock circulation system. 
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The concept of this compliance was revisited by Woodruff et al. (Woodruff, 
Sharp, & Pantalos, 1997), which focused on improving the compliance mechanism 
for the required microgravity environment evaluation to study an astronaut’s cardiac 
function under weightless conditions. The Penn State mock circulation system was 
used as a base design and improvement was done by replacing the original leaf 
spring with a spring coil, resulting in a significantly smaller size and lighter weight. 
Figure 4-12 shows the design of this compliance chamber with an internal spring 
structure and a knob on the top which can be used to adjust the spring constant to 
change the compliance value of this chamber. The test was conducted in comparison 
with the original Penn State loop and the compliance was set to 0.5, 1.0 and 1.5 
mmHg/ml for the arterial compliance, and 5, 10 and 15 ml/mmHg for the venous 
compliance. The results show the limitation of the available springs that could not 
provide the exact required spring constant and thus there is some error in the actual 
compliance value. Another major drawback of the spring compliance chamber is that 
the adjustable range of spring constant was not wide enough to cover all the target 
compliance values, thus the test rig needs to be stopped for spring replacement which 
could cause an error to other parameters of the circulation loop.  
 
Figure 4-12: Compact compliance by Woodruff et al. (Woodruff et al., 1997) 
Pentalos et al. (Pantalos et al., 2004) used the spring compliance concept for the 
venous and systemic compliance chamber that was specifically designed for VAD 
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testing.  The compliance design was similar to the chamber of Woodruff et al. with a 
spring-loaded piston pressed on the roll sock diaphragm which was fitted inside the 
enclosed chamber. This compliance can be varied by adjusting the spring stiffness, 
but the value was set to 1.3 ml/mmHg to simulate the real human condition for 
assessing the MCL performance.    
The use of a flexible membrane to 
provide a compliance is incorporated in the 
basic circulation loop for artificial lung 
testing which was designed by Haft et al. 
(Haft et al., 2003). This loop has a simple 
structure design where the pulse flow is 
generated from a Thoratec LVAD instead of 
a dedicated design of a ventricle simulator 
and adjustable resistance is not  included in 
the system. A flexible polyurethane bag in 
a pressurised chamber is used as a 
compliance chamber, as shown in Figure 4-13. The compliance is adjustable by 
using the air pressure compressed into the chamber by a pneumatic compressor; in 
this test, the pressure was varied from 0 to 16 mmHg while the volume of the 
chamber also varied between 50, 100, 200, 250 and 500 ml.  
One of the most common approaches to simulate this effect is using the air 
trapped inside the chamber to replicate the elastic property of the blood vessels. This 
method  was utilised by Donovan (Donovan, 1975) on the mock circulation loop for 
VAD testing that was constructed as an acrylic tank that contains 4 internal chambers 
of which the 2 small chambers are used as the systemic and pulmonary arterial 
chambers while the larger chambers are the systemic and pulmonary venous 
chambers. The compliance was set at 10 ml/mmHg, 1 ml/mmHg, 5 ml/mmHg and 1 
ml/mmHg for the systemic venous, pulmonary arterial, pulmonary venous and 
systemic arterial chambers, respectively. The compliance was adjustable by changing 
the volume of the air trapped above each individual chamber. 
Figure 4-13:  Flexible membrane 
compliance by Haft et al. (Haft et al., 
2003) 
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Figure 4-14: Mock circulation loop by Donovan (Donovan, 1975) 
The concept of the chamber with the air trapped inside is known to be a 
simple but effective design, but the size of the tank needs to be relatively large to trap 
enough volume of air that can give the required compliance. However, as MCLs are 
often developed for laboratory use where usually the size is not a critical 
consideration in the design, the basic chamber with the air trapped inside which is 
less complicated and easier to develop is, thus, still a preferred option for many 
researchers to use in their test loop (Andrade et al., 1999; Athanassiou, Hancock, & 
Mahajan, 2005; Avrahami, Rosenfeld, Raz, & Einav, 2006; Ayre, Lovell, & 
Woodard, 2003; Bowles et al., 1991; Garcia et al., 2008; Liu et al., 2006; Daniel 
Timms et al., 2005; Vosse et al., 2011).  
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Figure 4-15: Compliance tank configurations and its equivalent electrical analog 
diagram. 
Among the air trapped inside the chamber designs, two configurations of the 
windkessel tank, as shown in Figure 4-15, have been widely used in several studies. 
While both configurations have proved to accurately replicate the human circulatory 
system, Liu et. al. (Liu et al., 2006) compared both configurations on the 
Matlab/Simulink mathematical simulation model and suggested that the 90 degree 
elbow connector between the tank and the main pipe introduces extra resistance and 
cause pressure loss from ventricle to aorta, so the configuration 1 was used in his 
complete circulation loop for VAD testing (Figure 4-16). Therefore, this 
configuration was adopted for the MCL in this thesis for the same reason. 
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Figure 4-16: The complete mock circulation loop by Liu et al. (Donovan, 1975) 
4.3.3 Resistance simulation 
Resistance is a significant basic flow property in the simulation of human 
circulation; therefore, most MCLs include a component that can both vary this value 
in the designs to mimic the ability of the body and that can vary the resistance in 
response to the physiological conditions such as the reduction of resistance during 
exercise to increase the blood circulation. 
A concept of resistance, as discussed in the previous section, is defined as the 
ratio of the pressure drop to the volumetric flow rate. Therefore, the simulation of 
resistance often relies on reducing the cross-sectional area of the pipe to generate the 
pressure drop across the pipe section. Donovan’s (1975) MCL, shown in the previous 
section (Figure 4-14), adopted this concept for the systemic and pulmonary 
resistance. The resistance module in this MCL shows an innovative design structure 
as the resistance can be varied automatically in response to the variation of arterial 
and pulmonary pressure. As shown in Figure 4-17, this resistance module is situated 
inside the aortic and pulmonary compliance chamber. The cross-sectional area of the 
flow tube is adjusted by the valve plate located on the lever arm that moves about the 
pivot connection, while another arm of the lever connected to the bellows is filled 
with water so that the water pressure can be controlled by a toggle valve and a needle 
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valve outside the chamber. As the air pressure within the tank increases above the 
water pressure, the bellows are compressed and force the water to flow through the 
valves back to the bellows’ reservoir. The contraction of the bellows pulls the lever 
arm which causes the valve plate to move about the pivot and open more of the 
cross-sectional area to the flow tube, resulting in the reduction of the flow resistance 
while also reducing the arterial pressure.  
  
Figure 4-17: Bellows-operated resistance mechanism by Donovan (Donovan, 1975) 
The Pennsylvania State University mock circulation system (Rosenberg et al., 
1981) creates a pressure drop for peripheral resistance using the same concept of 
changing the cross-sectional area of flow but with a different approach. The system 
was fitted with a resistance module containing a series of small flexible tubes 
situated between two flat plates. The plates can be clamped together by the adjusting 
nut which reduces the flow area and thus raises the flow resistance.  
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Figure 4-18: Resistance unit inside the compliance chamber by Scotten et al. (Scotten 
et al., 1979) 
The approach of Scotten et al. (Scotten et al., 1979) of simulating the 
resistance is slightly different from those directly adjusting the section area of the 
tube; instead, a cellulose fibre filter was inserted into the vertical inflow tube within 
the compliance chamber (Figure 4-18). The filter is attached to a threaded rod 
inserted into the threaded hole on top of the tank which allows the vertical position to 
be adjustable and, therefore, the active length of the filter and hence the resistance 
can be directly altered. Pantalos et al.  (Pantalos et al., 2004) used a similar method 
of simulating the resistance by filling the chamber with the open cell form in the 
sealed chamber with an adjustable compression piston to create the required flow 
resistance.   
While the resistance mechanism as shown above is reliable and capable of 
simulating the human vascular resistance, the more recent research often relies on 
simpler components such as an adjustable clamp used by Andreade et al. (Andrade et 
al., 1999), Liu et al. (Liu et al., 2006) and Vosse et al. (Vosse et al., 2011), or various 
type of valves such as Baloa et al. (Baloa et al., 2001) and Inoguchi et al. (2006) 
(Inoguchi, Tanaka, Maehara, & Matsuda, 2006).  
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A more advanced control over the resistance valve is the design of Timms et al. 
(Daniel  Timms, 2005) which incorporated a pinch valve with a proportional input 
voltage controlled under an algorithm that is capable of  varying the resistance in 
response to the change of arterial pressure in the circulation loop.        
4.3.4 Summary of Physical Parameters for the MCL  
I. Healthy - Rest 
According to the MCL literature and the calculations of physiological 
parameters that were reviewed in the previous sections, the condition of a healthy 
adult for the mock circulation loop is summarized in Table 4-3. 
II. CHF 
CHF caused by left ventricular failure which reduces the capability of the heart 
to eject sufficient blood out of the left ventricle, reduces the end-diastolic pressure, 
cardiac output, MAP and the mean circulatory pressure. Meanwhile, an imbalance 
between the flow in the systemic and pulmonary circulation causes excessive blood 
to back up in the lungs and increases pulmonary pressure.  
To reflect the weak ventricle of CHF patients, the aortic pressure is reduced by 
about 30% and the cardiac output is reduced by approximately 40%. The heart rate 
was raised by 50% to simulate the attempts of failing heart to compensate the loss of 
cardiac output.    
Table 4-3: Physiological parameters for the mock circulation loop. 
Parameters Healthy CHF 
Heart Rate (HR) (BPM) 60 90 
Stroke Volume (SV) (ml) 80 30 
Cardiac output (CO) (L/min) 5 2.5 
Left Ventricular Peak Systolic Pressure (LVPPS) (mmHg) 120 80 
Left Ventricular Peak Diastolic Pressure (LVPPD) (mmHg) 0-8 0-8 
Aortic Systolic Pressure (AOPsys) (mmHg) 120 80 
Aortic Diastolic Pressure (AOPdias) (mmHg) 80 55 
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Arterial Compliance (Cart) (ml/mmHg) 1.28 0.96 
Total Peripheral Resistance (TPR) (mmHg/ml/s) 1 1 
4.4 COMPONENTS AND FUNCTIONS 
 
Figure 4-19: The human mock circulation loop in this study. 
The mock circulation loop in this study is shown in Figure 4-19 and the 
components diagram is shown in Figure 4-20. This MCL is comprised of three main 
components: the ventricle simulator (1), the compliance tank (2) and the arterial tank 
(3). All the components are connected by 1in diameter clear vinyl tubes with 
adjustable ball valves to simulate the peripheral resistance. Two check valves are 
installed at the inlet and the outlet of the ventricle simulator to regulate the blood 
flow direction. The VAD is connected to the MCL in the secondary flow circuit 
using ½in tube fitted to an extra outlet of the ventricle simulator to the compliance 
chamber and has a valve to cut off the flow for the evaluation of the loop without the 
VAD. The test rig was placed on three large plastic containers to contain any spill or 
leakage of fluid that might accidentally occur.  
 
 
196 Mechanism Design of Ventricular Assist Device 
 
 
Figure 4-20: Diagram of mock circulation loop. 
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I. Ventricle Simulator 
The function of the ventricle simulator in this mock circulation loop is to 
simulate the pulse flow to mimic the heart pulse from the left ventricle. The structure 
of this ventricle simulator is based on a piston pump driven by a scotch-yoke 
mechanism powered by a 40W DC motor with 5:1 gear box to increase the output 
torque. The speed is adjustable via the variable speed controller to achieve the heart 
rate of different physiological conditions. The cylinder, made of structured anodized 
aluminium, has 2 parts; the larger part of the cylinder has a diameter of 100mm 
covered by an acrylic lid with 2 x 1in sockets for the inlet and outlet ports of the 
pump and a 1/2in socket connected to the VAD circuit. The smaller part of the 
cylinder has a diameter of 80mm and contains the sliding piston that pumps the fluid. 
The fly wheel of the ventricle simulator has 3 threaded sockets with different 
distances from the centre of the wheel; the ejection volume of the pump can be 
adjusted by moving the pin of the scotch-yoke mechanism to these holes (Figure 
4-21 & Figure 4-22).  
 
Figure 4-21: Ventricle Simulator. 
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Figure 4-22: Threaded sockets on the fly wheel of ventricle simulator for adjusting 
the ejection volume. 
II. Arterial Compliance Tank  
The compliance tank of this mock circulation loop is designed to simulate the 
arterial compliance effect. It is an airtight tank constructed from clear PVC with an 
inner diameter of 100mm, wall thickness of 4.5mm, and height of 645mm. The top 
lid of the tank is fitted with a ball valve and a pressure gauge for measuring and 
adjusting the air pressure according to the required compliance value. The bottom of 
the tank has two 1in sockets for the barb fittings to connect the main flow tubing, one 
1/2in port for secondary flow from the VAD and one 1/4in port for the pressure 
transducer.  
III. Atrial Reservoir Tank  
This reservoir tank serves 2 objectives; to supply the water returning to the 
ventricle simulator, and to create the preload pressure for the ventricle simulator like 
the atrium. This tank has a basic structure like the compliance tank but has a different 
size and volume. The top of the tank is fitted with a 1in ball valve for ease of filling 
the working fluid and pressure adjustment. The bottom of the tank is fitted with two 
1in connectors for the inlet and outlet and a 1/4in female threaded fitting where the 
pressure sensor is connected. The outlet of this tank is connected to the check valve 
which restricts the flow direction to return to the ventricle simulator. The tank is 
placed on an adjustable stand for a freely level adjustment of the vertical position to 
achieve the pressure and compliance of the arterial compliance tank.  
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IV. Mitral / Aortic Valves 
The mitral and aortic valves prevent the back flow of fluid to the atrium and 
ventricle and are simulated by the 1in flapper check valves which were selected due 
to their lower resistance compared to other types of non-return valves. The mitral 
valve is installed near the inlet of the ventricle simulator to prevent the back flow to 
the arterial tank, while the aortic valve is attached to the outlet of the ventricle 
simulator to regulate the output flow. 
V. Pumping Fluid 
To closely replicate the circulatory system, the pumping fluid needs to have 
similar properties to real human blood which has an estimated density of 1,040 kg/m3 
and a dynamic viscosity 0.004 Pa.s. Water-based solutions are commonly used for 
the mock circulation loop as the density of water (998 kg/m3) is close to that of real 
blood. Glycerol is often used as a mixture for the solution as it can increase the 
density to be about the same as real blood. A 40% glycerine solution was used as a 
medium solution for this mock circulation loop to mimic the density of human blood. 
The comparison of properties between fluid mixtures and human blood is shown in 
Table 4-4.  
Table 4-4: Properties of the fluid for MCL pumping medium 
Pumping Fluid Density
(Kg/m3)
Dynamic Viscosity 
(Pa.s) 
Blood  1040  0.004 
Water  998  0.001 
Saline  1025  0.001 
Glycerine  1261  0.950 
Glycerol 40%  1103  0.0039 
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VI. Measuring Equipment 
Pressure transducer:  a total of five GE UNIK 5000 pressure sensors (Figure 
4-23) were used in this mock circulation loop to measure the pressure at various 
locations. Two of these sensors were installed at the bottom socket of both air tight 
tanks to measure the fluid pressures which help in calculation of the compliance 
values; one sensor was inserted in the 1/2in tee connector next to the check valve at 
the ventricle simulator outlet to measure the aortic pressure, while the other 2 sensors 
were positioned across the VAD in the flow circuit that runs parallel to the main flow 
direction from the ventricle simulator to the compliance chamber in order to measure 
the ventricle pressure and calculate the head pressure of the pump. 
 
Figure 4-23: UNIK 5000 Pressure Transducer (left) and KROHNE IFC050C 
Magnetic Flowmeter (right). 
Flow meter:  Two KROHNE IFC050C magnetic flow meters (Figure 4-23) 
were installed on the tee fittings next to the TPR ball valve on the main circuit for 
measuring the aortic flow, and after the VAD in the secondary circuit to measure the 
pump output flow rate.  
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VII. Data Acquisition System 
Both the pressure sensors and flow meters are powered by the QJE PS3005 
power supply unit. All the modules are connected to the National Instrument Real-
Time CompactRIO NI 9207 and attached on the NI eDAQ-9172 chassis which is 
connected to the computer laptop via the USB port, as shown in Figure 4-25. The 
data acquisition module acquires sampling data from all channels, and then the data 
are processed and logged directly to the Labview 2013 software installed on the PC 
at a selected sampling rate of 100 Hz. 
The Labview processes and records 2 flow rates from the main circuit and a 
secondary circuit, and a total of 5 pressure data from the sensors which measure the 
aortic pressure, ventricle pressure, compliance tank pressure, reservoir tank pressure 
and the pump outlet pressure. The addition data which include TPR and CO are 
calculated in Labview using the acquired pressure and flow data. The front panel of 
Labview in Figure 4-24 shows the real time plot of all the signals displayed. 
 
Figure 4-24: The front panel of LabView for monitoring the sensor signals. 
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Figure 4-25: The connection diagram of controllers and data acquisition system.
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Equipment List 
All the equipment and the VAD control module of this MCL are listed in Table 4-5.  
Table 4-5: Equipment list of the mock circulation loop. 
Equipment Model Manufacturer Quantity 
40W DC Motor 5IK40GN-C GPG 1 
5:1 Gear box 5GU-5K GPG 1 
Motor Speed Controller US-52 GPG 1 
Pressure Sensor UNIK5000 GE 5 
Flow Meter IFC050C KROHNE 2 
Power Supply PS3005 QJE 1 
Compact DAQ Chassis cDAQ9172 National 
Instrument 
1 
DAQ I/O Module NI 9207 National 
Instrument 
1 
Variable Speed 
Controller 
OptiDrive E2 Invertek Drives 1 
 
4.5 COMPONENTS CONFIGURATION AND CALCULATIONS 
4.5.1 Compliance tank 
 The elastic nature of human blood vessels with the damping effect to the blood’s 
properties is called compliance. The airtight tanks in this loop are designed to 
simulate this elastic property by trapping the air above the fluid level within the 
tanks, and this compliance value can be controlled by the amount of the volume of 
air that is trapped, which can be calculated by Equation [4-9]. 
 ܥ ൌ ௔ܸ௜௥
௔ܲ௜௥
 [4-9] 
 
 Where ܥ = Compliance value of the tank (ml/mmHg) 
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 ࢇܸ࢏࢘ = Initial air volume (ml) 
 ௔ܲ௜௥ = Air pressure (mmHg) 
The total pressure at the bottom of an airtight tank is the summation of the air 
pressure and the fluid pressure which can be written as Equation [4-10]. 
 ௔ܲ௜௥ ൅ ௙ܲ௟௨௜ௗ ൌ ௧ܲ௔௡௞ [4-10] 
 
where ௔ܲ௜௥ is the pressure of air trapped in the tank (mmHg) 
 ௙ܲ௟௨௜ௗ is the fluid pressure (mmHg)  
 ௧ܲ௔௡௞ = Total pressure at the bottom of the airtight tank (mmHg) 
The fluid pressure can be calculated from the equation ௙ܲ௟௨௜ௗ = ρgh, where ݄௙ is the 
total fluid height and could also be written as: 
 ݄௙ ൌ ݄௧௔௡௞ െ ݄௔௜௥ [4-11] 
   
 ݄௙ ൌ ௧ܸ௔௡௞ െ ௔ܸ௜௥ܣ௧  [4-12] 
   
According to Equation [4-10], Equation [4-12] can be rearranged as:  
 ௔ܲ௜௥ ൅ ߩ݄݃௙ ൌ ௧ܲ௔௡௞ [4-13] 
 
 ௔ܲ௜௥ ൅ 	ߩ݃ ሺ ௧ܸ௔௡௞ െ ௔ܸ௜௥ሻܣ௧ ൌ ௧ܲ௔௡௞ [4-14] 
In the normal heart condition, the arterial compliance tank has a target compliance 
value of 1.28 ml/mmHg while an average human aortic pressure is 100 mmHg 
relative to the atmospheric pressure (absolute pressure 860 mmHg) and the fluid 
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density is 1040 kg/m3. The structural parameters of the tank are; the area (At ) = 7.85 
x 10-3 m2, the tank height (ht ) = 0.635 m, and the volume (Vtank) = 4.87 x 10-3 m3. 
According to these values, solving Equation [4-9] yields  ௔ܸ௜௥ = 1.04 x 10-3, Pair = 
1.089 x 105 Pa, and hf = 0.4867 m.  This fluid height is used in setting the 
compliance value of the tank which will be discussed in the next chapter. 
4.5.2 Total peripheral resistance valve  
In the mock circulation loop in this study, only the resistance from systemic 
circulation, as specified above, was considered. The simulation of resistance is 
achieved by adjusting the ball valve between the arterial compliance and the atrial 
reservoir tank where the resistance calculation is based on Equation [4-7] taking the 
pressure drop across the tanks divided by the maximum flow rate through the 
circulation loop.    
4.5.3 Arterial reservoir 
The arterial reservoir provides the constant preload pressure for the ventricle 
simulator, and this preload pressure is controlled by the height of the fluid in the 
tank. The required height of fluid in the tank is calculated from the equation: 
 ܲ ൌ ρgh [4-15] 
where the density of the working fluid (ρ) is 1040 kg/m3, and the target preload 
ventricle pressure (P) is 8 mmHg (1.066 kPa) for all the conditions. The average 
height of fluid (h) calculated from the above equation is 10.45 cm.   
4.5.4 Ventricle simulator 
The stroke volume or ejection volume of the ventricle simulator is adjustable 
by moving the pin of the connecting rod on the fly wheel. The stroke distances of the 
ventricle simulator are fixed at 40, 45 and 15 mm which can produce the estimated 
stroke volume of 80, 90 and 30 ml for the normal, exercise and CHF conditions, 
respectively.  
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4.6 CONCLUSION 
The literature review was conducted on the mechanisms and configurations of 
human mock circulatory systems that have been used on various applications. A 
suitable structure has been selected and modified for creating a MCL that meets the 
requirements for the testing of the new VAD that has been developed in this thesis. 
This newly designed MCL was aimed at VAD testing to verify the pump 
performance and identify problems for further optimization. As the pump in this 
study is a single-sided pump, this MCL was designed as a half circulation loop. 
This MCL has the capability of simulating the three main characteristics of the 
heart’s function, which are the pulsatile flow, compliance effect and vascular 
resistance. The pulsatile flow was simulated by the ventricle simulator which is 
based on the displacement pump design and has an adjustable stroke volume at 80 
and 30 ml/stroke for the normal heart and CHF conditions while the heart rate is 
adjustable by the motor’s speed. The compliance, which is the effect of the elasticity 
of the arteries in damping the pulse signal, was simulated by the tank with the air 
trapped inside so that the compliance value was adjustable by the ratio between the 
volume to the pressure of the air.  The vascular resistance was lumped into a ball 
valve that allows the value to be adjustable. To maintain these characteristics and 
regulate the flow direction, the swing check valves were installed to the inlet and 
outlet of the ventricle simulator. The 40% glycerol mixture was used as a pumping 
fluid in this test rig to replicate the density and viscosity of blood.  
This MCL can simulate both the normal heart function for establishing the 
baseline condition to validate the output from the loop, and the heart failure 
condition for the heart pump testing. The normal heart condition was simulated with 
the average parameters from a healthy adult while the cardiac output and aortic 
pressure are reduced by 20% and 10%, respectively, for the heart failure condition. 
The test results of this MCL on both the normal heart and CHF functions along 
with the prototype experimental evaluation will be provided and discussed in the 
next chapter. 
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 Experimentation Evaluation of 
VAD on Human Mock 
Circulation Loop 
A VAD prototype was produced based on the design shown in Chapter 3. This 
pump prototype was evaluated in the human mock circulation loop that was designed 
and constructed based on the information presented in Chapter 4. The target of the 
pump evaluation was to confirm the hydrodynamic performance of the pump design 
under the pulse flow environment, and to obtain other information for the later stages 
of development.  
5.1 EXPERIMENTAL DESIGN AND PROCEDURE 
This section provides the overview of the equipment’s preparation and the 
experiment’s configuration that were used in the evaluation of the mock circulation 
loop and the VAD performance. 
5.1.1 VAD prototype for evaluation 
The pump prototype for the experimental evaluation was created with the 
Solidworks software, as shown in Chapter 3. The 3D model of the pump was used in 
the prototype construction with the CNC machining process which was done 
internally by the QUT Design and Manufacturing Centre (DMC) workshop. PVC 
was used as the main material for this prototype, while polyether ether ketone 
(PEEK) was used for the male bearing on the top of the impeller to reduce the 
friction between the contact surfaces. The pump prototype was to be driven by a 
motor of the Iwaki MD-10-230GS0 magnetic drive pump, so the ferrite magnet from 
the impeller of this Iwaki pump was embedded into the socket in the impeller hub of 
this VAD prototype.   
5.1.2 Equipment calibrations 
The main parts of the equipment for this experiment that required calibration 
were the pressure transducers and flow meters. Each of these sensors was calibrated 
using the individual calibration sheet from the manufacturer that provided 
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information about the actual output range. All the sensors in this experiment have the 
current output, so the actual range of each sensor was converted to the gain which is 
mmHg/mA for the pressure transducers and m3/h /mA for the flow sensors. These 
gains were then used to correct the real time output data from the sensors during the 
measurement.  
5.1.3 MCL setup 
The experimentation was done in two stages. The first stage was to establish 
the baseline of the mock circulation by simulating the normal heart and CHF 
conditions. The second stage was the experiment of the VAD under the CHF 
environment of the MCL from the previous stage. 
 In the first stage, the MCL was first set to simulate the normal heart function to 
establish a baseline for the pump experiment. After that, the MCL was adjusted to 
simulate the CHF condition. 
Table 5-1: Target parameters for each MCL configuration 
Parameters Normal  CHF 
Heart Rate (HR)  60 90 
Stroke Volume (SV) 80 30 
Cardiac output (CO) 5 2.5 
Left Ventricular Peak Systolic Pressure (LVPSP) 120 80 
Left Ventricular Peak Diastolic Pressure (LVPDP) 0-8 0-8 
Aortic Systolic Pressure (AOPsys) 120 80 
Aortic Diastolic Pressure (AOPdias) 80 55 
Pulse Pressure (PP) 40 25 
Mean Arterial Pressure (MAP) 93.3 63.3 
Atrial Pressure 8-10 8-10 
Arterial Compliance 1.28 0.96 
Fluid Pressure 35.83 38.63 
Air Pressure (kPa) 7.66 2.4 
 
The target parameters for the mock circulation loop for the normal heart and 
CHF are summarised in Table 5-1, and the configuration procedures are listed as 
follows: 
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VAD Installation: Although the VAD is not used in this stage of the 
experimentation, it can be pre-installed in the secondary flow loop that is the link 
between the ventricle simulator and the compliance tank. With this setting, the VAD 
can be either included or removed from the circulation loop by turning on or shutting 
off the valves that connect the secondary loop from the main flow, as shown as 
number 4 in Figure 4-20. The VAD installed in the MCL is shown in Figure 5-1.  
 
Figure 5-1: VAD Installed on a motor that is attached to the stand and inserted to the 
MCL via the bypass flow loop 
MCL filling and operating: In this stage the pumping fluid is filled into the 
atrial reservoir tank. The TPR valve is closed to allow the fluid level in the atrial and 
compliance tanks to be adjustable independently, while all the other fluid valves and 
the air valve on the compliance tank are opened during the filling. During this initial 
filling, the ventricle simulator is turned on to about 5 rpm to remove the air bubbles 
from the circulation system, then the speed is lowered and the fluid level reaches the 
required height. With the VAD installed to the MCL, the system is turned on for a 
few seconds to purge the air. The VAD valves are then turned off to isolate the VAD 
from the circulation. 
Compliance setting: The compliance value of this MCL can be set by closing 
the air valve and continuing to pump the fluid into the compliance tank. With this 
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method, the air pressure will be raised to the required compliance effect of the MCL. 
The air pressure can be read directly from the pressure gauge installed on the top of 
the compliance tank. Labview needs to be enabled during this step to verify the fluid 
pressure. This compliance value can be adjusted by releasing some of the air through 
the air valve and opening the TPR valve slightly. When the compliance value reaches 
the required level, the reading from the pressure sensor should be equal to the mean 
arterial pressure. 
Atrial Pressure: Atrial pressure can be adjusted directly by altering the fluid 
height in the arterial reservoir tank. Additional fluid can be added to the required 
level after the compliance is set, and the atrial pressure can be verified on the 
Labview panel. 
Heart Functionality: The heart function is controlled by the stroke volume and 
heart rate. The stroke volume can be adjusted by moving the pin position on the fly 
wheel to the required perfusion of each testing condition. The heart rate is adjusted 
from the variable speed drive that controls the motor speed, and the output pulse rate 
can be read on the Labview panel. 
Aortic Pressure: Aortic pressure is measured from the pressure sensor in the 
compliance tank which reads the total pressure of the fluid and the compressed air 
pressure. With the ventricle simulator open in the previous stage, the aortic pressure 
will be raised with additional fluid being pumped into the tank. Now the TPR valve 
can now be opened and adjusted until the aortic pressure reduces to the target level. 
After completing the above steps the test rig will be ready for use. The data can 
now be recorded by the Labview program. 
 In the second stage of the experiment, the configuration of CHF from the 
previous stage is maintained. The VAD can now be included in the circulation by 
opening the secondary loop valves and setting the required speed with the variable 
speed drive.  
5.2 INITIAL EXPERIMENTAL RESULTS OF MCL 
The initial test of the MCL was conducted by simulating the normal heart and 
the CHF conditions to verify the related parameters before proceeding to the tests of 
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the newly designed VAD. During the tests without the VAD, the valves to the 
secondary loop were turned off to isolate the heart pump from the system.  
5.2.1 Normal heart configuration 
 In this test, the MCL was set to the target parameters, as previously shown in 
Table 5-1, in order to replicate the function of a healthy natural heart. The fluid was 
initially filled into the loop and pumped into the compliance tank until the pressure 
reached 35.83 mmHg, then the air valve was closed and the fluid continued to be 
pumped into the tank until the total pressure reached the target MAP at 93.33 mmHg, 
which is the required compliance. Additional fluid was then added to the arterial tank 
until the pressure reached 8 mmHg to provide the preload to the ventricular 
simulator. The speed of the ventricle was then adjusted to generate the pulse flow at 
the rate of 60 bpm, while the aortic pressure was adjusted from the TPR valve to 
maintain the range between 80 to 120 mmHg.  
 
Figure 5-2: The output parameters from the systemic circulation of a normal heart 
configuration. (LVP: Left Ventricle Pressure, AOP: Aortic Pressure, AP: Atrial 
Pressure) 
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Figure 5-3: Cardiac output from a normal heart configuration 
 
With the normal heart configuration using the above target parameters, the 
output pressure from the configuration of a normal heart is shown in Figure 5-2 and 
the cardiac output is shown in Figure 5-3. The output signals of this configuration are 
discussed as follows: 
  Ventricle Pressure (VP): According to the Figure, the pressure signal from 
the ventricle shows the cyclical pulse at approximately 1 Hz or 60 bpm which is the 
same rate as the target parameter for this configuration. There are large spikes 
observed in the signal during the end-systolic and end-diastolic phase, which are 
caused by the water hammer effect from the sudden closure and bounce of the 
flapper check valves that are used to control the flow direction. A similar fluctuation 
pattern is also found in some other MCLs such as those developed by Pantalos et al. 
((Koenig et al., 2004; Pantalos et al., 2004), Liu et al. (Liu et al., 2006) and Timms 
(Daniel  Timms, 2005). This large fluctuation indicates that the signal is 
underdamped. In this case, the lack of venous and pulmonary compliance emphasises 
this fluctuation, so the moving average signal filtering was applied to reduce the 
effect. According to the graph, the peak pressure of the systolic phase is 126.24 
mmHg, while the pressure observed in the diastolic phase is reduced to the negative 
pressure range so that the diastolic pressure ranged between -15.2 to 1.4 mmHg. The 
main cause of this negative pressure is the systole filling process that relies on the 
suction pressure to fill the ventricle chamber.  
 Aortic Pressure (AOP): According to the Figure, the aortic pressure simulated 
from this MCL is very close to the desired value at 80/120 mmHg. This loop could 
simulate the aortic pressure signal ranges between 80.44 to 119.93 mmHg and the 
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mean arterial pressure (MAP) is 93.60 mmHg. There is almost no spike observed in 
this signal because it is measured directly from the compliance tank so the signal is 
well dampened; however, there is a phase delay compared to the signal from the 
ventricle which is caused by the inertial effects and the distance between the 
chambers. The systolic ratio is not adjustable due to the mechanism design of the 
ventricle simulator, so it is fixed at 50% whereas the systolic ratio of an actual 
normal heart is approximately 40%.  
Arterial Pressure (AP): As this mock circulation loop only simulates half of 
the human circulation system, the venous pressure is assumed to be equal to the left 
atrium pressure. The arterial pressure is estimated at 8.2 mmHg with a slight 
fluctuation during the valve opening and closure.  
Cardiac Output (CO): The cardiac output measurement is limited by the 
ability of the magnetic flow meter that can only measure the total flow over a period 
of time. Consequently, it was unable to capture the pulsatile nature of the flow in the 
MCL; hence, the cardiac output is plotted as a mean value over a period of time. The 
average cardiac output in this setting is 4.99 L/min. 
The output parameters from this MCL are summarised and compared against 
an actual heart and the results from other MCLs in Table 5-2. The comparison shows 
that this MCL could closely replicate the cardiac output at 60 bpm and 5 L/min of a 
normal heart. The ventricle pressure was affected by the oscillation so the systolic 
and diastolic pressure is 126.2/-15.2 mmHg, which slightly deviates from the target 
setting at 120/80 mmHg. Nevertheless, the result is still in a similar range to the 
MCLs of Pentalos (Pantalos et al., 2004) and Liu (Liu et al., 2006) which have the 
pressure at 139/-9.3 mmHg and 12.32/-20 mmHg, respectively. The MCL designed 
by Timms (Daniel L. Timms et al., 2011) has a better result for the ventricle pressure 
setting compared to other MCLs because the ventricular contractility was controlled 
by electro-pneumatic regulators which are a more accurate and flexible method than 
the mechanism of this MCL. This pneumatic control also allows passive diastolic 
filling to avoid the negative pressure, which could not be done with the displacement 
pump of this MCL. However, this MCL could closely replicate the aortic pressure as 
the peak systolic pressure is 119.9 and the diastolic pressure is 80.4 mmHg, while 
there is also low oscillation in the signal; hence, the MAP calculated from Equation 
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[4-4] is 93.6 mmHg which is very close to the target setting. The atrial pressure is 
almost steady at 8.24 mmHg in this MCL as it acted as a reservoir to supply the 
preload to the ventricle, and this value is within the target setting range of 8-10 
mmHg.   
According to the output parameters from this MCL, it could closely replicate 
the circulatory condition of a healthy human. Therefore the CHF condition could be 
established in this configuration procedure. 
Table 5-2: Comparison of output from this MCL, a real heart, and other research 
under the normal heart condition 
 
Flow Pressure (mmHg) 
HR 
(bpm) 
Q 
(L/min) VPsys VPdias AOPsys AOPdias PP MAP AP 
Real Heart 
(Target 
settings) 
60 5.0 120 0-8 120 80 40 93.3 8-10 
(Pantalos et 
al., 2004) 80 5.0 139.5 
-9.3 – 
2.4 125.5 68 57.7 95.3 10.5 
(Liu et al., 
2006) 60 5.2 123.2 
-20 – 
5.1 125 80.1 44.9 95 8.2 
(Daniel L. 
Timms et 
al., 2011) 
60 5.15 120 7 120 80 40 98 10 
This MCL 60 4.99 126.2 -15.2 – 1.4 119.9 80.4 39.49 93.6 8.24 
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5.2.2 CHF Configuration 
 The result from normal heart simulation has shown that this MCL can simulate 
the flow condition of the human circulatory system, despite the oscillation in the 
ventricle pressure from insufficient compliance. The MCL was then set to replicate 
the cardiovascular condition of a heart failure patient which has a significantly 
decreased cardiac output and ventricle pressure to ensure that the pump tested in this 
loop could provide sufficient support for the needs of patients. The target parameters 
of this configuration are referred to in Table 5-1. 
The configuration to archive the target settings was done in the same procedure 
as described in the previous test. In this systemic CHF condition, the target aortic 
pressure was reduced to 55/80 mmHg to simulate the degree of loss in ventricular 
contractibility and the cardiac output is reduced to 2.5 L/min. The target heart rate, 
however, was increased to 90 bpm to simulate the attempt of a natural heart in 
maintaining the perfusion and to compensate for the loss of pumping pressure. The 
compliance reduced to 0.96 as a result of the decrease in the pulse pressure. The 
target atrial pressure was maintained to approximately 8 mmHg which is sufficient to 
provide preload to the ventricle simulator.  
The output pressures and cardiac output of the CHF configuration are shown in 
Figures 5-4 and Figure 5-5. According to these Figures, the pulse rate generated from 
the ventricle is 90 pulse/min and the cardiac output is 2.48 L/min. The lower 
ventricle pressure leads to lower force applied on the check valves hence lower 
oscillation is observed on the signal compare to healthy condition. Nevertheless, the 
signal spike from aortic valve still presented at the end of diastolic phase. The peak 
systolic pressure measured from the ventricle is 78.89 mmHg and the peak diastolic 
pressure is -12.09 mmHg. The peak systolic pressure is reduced to 75.72 mmHg in 
the aorta and the peak diastolic pressure is 52.82 mmHg; the calculated mean aortic 
pressure is 60.45 mmHg, and the atrial pressure is 7.95 mmHg. 
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Figure 5-4: The output parameters from the normal heart configuration. : LVP, Left 
ventrical pressure; AoP, Aortic pressure 
 
  
Figure 5-5: Cardiac output from CHF configuration 
 The results from this MCL configuration can be compared with the target 
settings and the results from other MCLs, as shown in Table 5-3. According to the 
large variation in the degree of heart failure, some parameters from each MCL may 
differ from others depending on the required application in each research and the 
structure of the MCL. In general, the output pressures of this MCL are close to the 
configuration of Liu et al. (Liu et al., 2006) which also mainly focuses on the 
systemic circulation, and has similar negative pressure ventricle filling mechanism; 
but this MCL has higher level of systolic pressures which is closer to the 
configuration of Timms et al. (Daniel L. Timms et al., 2011). The ventricle pressure 
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from this experiment is 78.89/-12.09 mmHg while the configuration of Liu et al. is 
72.2/-10 mmHg and Timms et al. is 80/16 mmHg. The peak systolic pressure is drop 
for approximately 4% due to the pipe loss so the aortic pressure is measured 
75.72/52.82 mmHg. This loss is slightly higher than Liu’s MCL that has aortic 
pressure 70.4/46.4 mmHg (2.5% loss) but less than Timms’ configuration at 75/60 
mmHg (6.25% loss). The MAP calculated from aortic pressure is 52.82 mmHg 
which is slightly lower than the target setting at 55 mmHg. The atrium pressure of 
this MCL is 7.95 mmHg, close to the target setting at 8.0 mmHg and slightly higher 
than 7.2 mmHg in Liu’s MCL; while Timms’ MCL has much higher pressure at 20 
mmHg as it is the full circulation loop that also simulate the Frank-starling response.  
Another adjustment for the CHF condition is the heart rate. The output heart 
rate is measured 90 bpm which is the same value as the target setting. This heart rate 
is the same as Timms’ configuration but this MCL has slightly higher cardiac output 
at 2.48 l/min, where the flow rate is 2.7L/min in Timms’ MCL. This heart rate 
compensation function was not included in the MCL of Liu et al. which the heart rate 
was maintained at 60 bpm, but the cardiac output was reduced to 2.0 L/min from the 
stroke volume adjustment. 
Table 5-3: Comparison of heart failure condition  
 
Flow Pressure (mmHg) 
HR 
(bpm) 
Q 
(L/min) LVPsys LVPdias AOPsys AOPdias PP MAP VP/LAP 
Target 
setting 90 2.5 80 0-8 80 55 25 63.3 8 
(Pantalos 
et al., 
2004) 
80 3.0 93 -0.9 -13.7 84 43 41 60 16.3 
(Liu et al., 
2006) 60 2.0 72.2 
-10 -
24.6 70.4  46.4 24 54.4 7.2 
(Daniel L. 
Timms et 
al., 2011) 
90 2.7 80 16 75  60 15 67 20 
This MCL 90 2.48 78.89 -12.09 – 20.76 75.72  52.82 22.9 60.45 7.95 
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The pulse characteristic and pressure parameters simulated from this MCL are 
close to the target setting for the CHF condition and similar to the output from other 
literature; hence, this configuration can be used for the experimental evaluation of 
the VAD prototype in this study. 
5.3 EXPERIMENTAL RESULT OF VAD ON THE MCL 
The VAD is connected to the MCL via a ½in tube that connects from the 
ventricle simulator to the compliance tank. In the VAD experiment the valves at the 
inlet and outlet of this connecting tube were opened to create the secondary flow 
through the VAD. This setting is similar to an actual VAD transplantation that has a 
heart pump connected from a ventricle to either the aorta or the pulmonary artery and 
generates a parallel flow path to a natural circulation. 
Steady flow experimentation  
In the first experiment, the VAD was tested in the steady condition without the 
flow from the ventricle simulator to identify the pressure head - flow rate 
characteristic of the pump. The pump speed was varied between 2,500 – 4,500 rpm 
which covered the designed speed for an LVAD at 4,020 rpm and an RVAD at 3,070 
rpm. The ball valve at the VAD outlet was tuned to vary the flow rate through the 
pump. The head pressure was recorded and plotted against the flow rate, as shown in 
Figure 5-6. 
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Figure 5-6 : Head pressure - flow rate curve of VAD at different pump speeds 
According to Figure 5-6, the head pressure from the VAD is the maximum at a 
zero flow rate or when the valve is closed. The head pressure is reduced as a larger 
volumetric flow rate is pumped through this VAD. The graph also shows that a 
higher pump speed increases the pump head and maximum flow rate through the 
pump while it also increases the maximum flow capacity that the pump could 
achieve. Under the pump speed range of this evaluation, this VAD could generate the 
maximum head pressure of 151.66 mmHg at the pump speed of 4,500 rpm, while the 
maximum flow capacity is 6.47 L/min. The lowest speed in the evaluation (2,500 
rpm) could generate a maximum flow rate of 3.5 L/min at the head pressure of 26.0 
mmHg. 
At the LVAD design speed (4,020 rpm), the maximum head pressure that the 
pump could generate is 120.06 mmHg under a zero flow rate. The maximum flow 
capacity that the pump can deliver at this flow speed is 5.75 L/min where the head 
pressure is reduced to 75.87 mmHg. The pump performance at this speed can be 
compared to the previous CFD simulated results from Chapter 3, as shown in Figure 
5-7. The plot shows the same trend between the simulated and the experimental 
results in which the head pressure drops as the flow rate is increased. However, there 
is some difference between the simulated and experimental values in that the 
maximum error is 22% at the flow rate of 5.75 L/min. This large percentage of error 
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is attributed to the lack of an efficient suspension mechanism. The current magnetic 
motor can drive the pump but it was not designed to provide the suspension force to 
the impeller, so it was not possible for the impeller to maintain its position on the 
centre of the rotating axis. This situation causes a big impact to the pump’s 
performance because it affects the gap between the impeller blades and the chamber 
so that the performance is reduced from the designed value. Therefore, the pump 
performance should be evaluated again on the prototype with a shaft-driven rotor to 
confirm the performance when the position of the impeller is fully controlled. 
Another plot in this Figure (Figure 5-7) is the RVAD design speed condition at 
3,070 rpm. In this condition the head pressure between the experimentation and 
simulation also has a similar pattern. The experimentation displays a maximum head 
pressure of 67.74 mmHg at a zero flow rate and a reduced pressure to 44.59 mmHg 
at the maximum flow rate of 4.27 L/min. The maximum error of the head pressure in 
this condition is approximately 27%. This error also is caused by the impeller 
suspension, as described in the LVAD condition above, but the loss of the pump’s 
performance in this condition also leads to insufficient pump capacity, as the pump 
could only deliver a maximum flow of 4.27 L/min, while the requirement is 5.0 
L/min. 
 
Figure 5-7: Comparison of head – flow rate from the CFD and experiment on the 
mock circulation loop (Exp) under the designed speed 
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Unsteady flow experimentation  
This second test was conducted to observe the pump response under the 
pulsatile flow, which is closest to the actual pump operation environment. The 
ventricle simulator was turned on and set to the CHF condition, as described in 
Section 5.2.2. The pump speed was then varied in the same range as the previous test 
(2,500-4,500 rpm), and the flow rate through the VAD was adjusted by the valve at 
the pump outlet. 
The average head was plotted against the average flow rate and compared with 
the steady flow result from previous test, as shown in Figure 5-8. From the plot, it 
can be observed that that the pump still operates under the same trend as the 
characteristic curve of the steady flow that has been examined previously in Figure 
5-6. However, the maximum flow rate in the pulse flow condition was reduced from 
the previous test. This was because the flow rate read from the flow meter was the 
average value; hence, the maximum flow rate shown in the plot is lower than the 
actual flow.  
 
Figure 5-8 : Head pressure – flow rate curve of VAD under the pulse flow compared 
with steady flow conditions. 
 To simulate the VAD function in supporting heart failure, the pump speed was 
adjusted to 4,020 rpm which is the speed that could raise the MAP to the normal 
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level, as shown in Figure 5-9. The comparison of the pressure signal of the CHF with 
and without the VAD support in Figure 5-10 shows that the peak systolic pressure is 
increased from 75.72 mmHg to 105.95 mmHg. It can be seen that the ventricle 
pressure signal is less affected by the oscillation, and the continuous flow from the 
pump reduces the variation of arterial pressure in the pulsatile flow. The continuous 
flow from VAD reduces the pulse pressure in the aorta (PP = Psys-Pdias) from 22.9 
mmHg to 13.8 mmHg, while the MAP is raised from 60.45 mmHg to 96.75 mmHg 
which is close to the level of a normal heart. The atrial pressure reduced slightly 
from 7.95 mmHg to 7.49 mmHg. However, the cardiac flow with the VAD support 
in this condition is 4.13 L/min which is 17% lower than the normal level (5 L/min) 
because of the performance loss from the lack or rotor suspension, as described 
earlier. More evaluation results at different flow rate and pump speed can be found in 
the Appendix 5-1. 
 
Figure 5-9: The output parameters from CHF systemic circulation with VAD support       
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(a)       (b)         (c) 
Figure 5-10: Comparison of pressure output between CHF condition and CHF with 
VAD support: (a) Ventricle pressure (b) Aortic pressure (c) Atrial pressure  
The results of the VAD test in both a steady and unsteady flow condition 
demonstrate that this pump could generate sufficient head pressure to provide 
support for the failing heart simulated from this MCL. However the pump capacity 
should be optimised by increasing it further to provide sufficient flow rate under the 
pulse flow condition.  
Nevertheless, in the current state, the capacity is also affected by the pump’s 
performance issue as it is lower than the prediction from the CFD analysis. This poor 
performance is mainly attributed to the magnetic drive motor that is not specifically 
designed for this pump; hence, the impeller is not suspended properly and this leads 
to excessive loss from friction between the rotor and the housing. Moreover, the 
pump is also susceptible to slipping between the driving magnet and the rotor at high 
load, because the magnetic drive in this motor was designed for pumping water 
which has a lower density than the glycerol mixture in this experiment. Therefore, at 
this load level, the magnetic coupling between the motor and the rotor may not be 
strong enough to prevent the slipping that could reduce the output hydraulic power 
from this pump. 
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Another issue for this experiment is the efficiency calculation. Normally, the 
pump’s efficiency could be calculated by the ratio between the output hydraulic 
power and the input electrical power of the pump motor. However, the results are not 
presented here due to a large loss of friction in the motor and the inaccurate power 
consumption measurement. The loss from the motor is caused by a large clearance in 
the motor design that allows the rotor to rub against its housing. In a normal pump 
with a shaft-driven impeller, this loss could be calculated by running the pump dry 
and calculating the excessive power to overcome the friction by comparing with the 
motor’s efficiency (Daniel  Timms, 2005). However, this method could not be 
applied to this magnetic drive pump as the dry impeller would have much more 
friction and also there would be a risk of damaging the pump. Therefore, it would 
require another pump prototype in which the power is directly transferred from the 
motor by a shaft, not the magnetic force, to properly evaluate the pump’s 
performance.   
5.4 CONCLUSION 
The mock circulation loop in this experiment could successfully reproduce the 
human circulation in both a normal heart and a failing heart condition, although it 
does not include the pulmonary system. It was sufficient for the initial experiment of 
the pump’s performance to provide the design verification and performance 
information for the prototype’s optimization until the pump is ready for an in-vitro 
trial in an animal.  
 The VAD prototype was tested in the MCL under the steady flow condition to 
identify the pump’s characteristics before testing in the pulse flow condition which 
fully simulates the CHF environment. The results of the pressure head – flow rate 
characteristics test followed the same trend as the CFD prediction but there was a 
relatively large error at a higher flow rate as the pump suffered from the lack of 
proper suspension for the rotor. However, the pump could provide enough support 
for the simulated CHF condition and also provided information for further 
experimentation and optimization. 
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 : Conclusions 
This chapter summarises the conclusion of each section in this study that leads 
to the completion of achieving the aim of this research. The results and problems 
encountered in each stage are summarised, and suggestions for their improvements 
are provided for future research. 
6.1 CONCLUSION  
This thesis is primarily aimed at developing a new VAD that can be used for 
long-term support for a heart failure patient. CFD analysis was implemented to 
evaluate the designs in different aspects in order to reduce the development costs and 
time that otherwise were needed during the design process. The literature review in 
this thesis provides both identification of the research gap and information about the 
design consideration items of the VAD development, including simulation 
techniques that can be applied to the heart pump analysis. The CFD analysis process 
in this study provides a performance comparison between the impeller designs and 
allows the design optimization to be done before producing a working prototype. The 
human mock circulation loop was developed as a testing facility for this newly 
designed pump to simulate the pulse flow environment of a heart failure patient. The 
pump’s hydraulic performance was then investigated to verify the simulation results 
and address other critical issues that were not identified during the CFD simulations. 
The conclusion of each stage of the research leads to the outcomes of this thesis. 
6.1.1 Literature review 
In the beginning of this thesis, a literature review was conducted. It covered the 
current development of CHF and the shortage of hearts for transplantation. The 
review identified the VAD as one of the promising alternative treatments; however, 
many patients in long-term clinical trials still suffer from device complications due to 
hemolysis, thrombosis and mechanism failure.  Moreover, another major problem of 
the VAD is the complication of the device during transplantation and management 
for bi-ventricular failure, where two devices are needed for each ventricle. These 
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issues point to the need for an effective and durable BiVAD that can be used in long-
term support as a bridge to transplantation or destination therapy.  
In order to effectively develop a new device, CFD analysis was reviewed and 
adopted as a primary development tool for its capability in providing critical 
information in both the hydrodynamic and hemodynamic aspects of the VAD 
development. The review highlighted the techniques that are used for the estimation 
of hydrodynamic performance and the predication of blood damage and coagulation 
which can be applied to the simulation of this blood pump.  
6.1.2 Design and development of VAD 
The development of this heart pump was established on the preliminary design 
of the BiVAD. The fluid models were successfully created on the solid design of the 
pump for the simulation. A total of five different designs of impeller were evaluated 
using these models to find the operating speed that could deliver the required head 
pressure and sufficient perfusion to the failing ventricles. The results were then 
analysed for the hydraulic efficiency and the impeller force which provide important 
information for the design of the suspension and driving mechanism. The 
hemodynamic properties were also analysed in terms of shear- induced blood 
damage and thrombosis. With these analysis data, the best design of impeller was 
successfully selected for the heart pump, and the design issues were identified for 
further optimization. 
The pump design in this stage lacks the driving mechanism which needs to be 
developed separately and is out of the scope of this study. Therefore, the pump was 
split into the individual LVAD and RVAD which can be operated on the magnetic 
drive motor of a general application pump. The necessary modifications were done to 
compensate for the loss of the washout and suspension mechanism due to the 
separation of the pump module. CFD simulation conducted on this optimized design 
confirmed its performance and availability to be used as a single-sided module, 
which can later be combined to a BiVAD once the motor design is ready.  
The pump prototype was successfully designed and created based on the 
analysis information from this section. This prototype allowed the pump’s 
performance to be verified in the human mock circulation loop.  
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6.1.3 Mock circulation loop 
A mock circulation loop designed and constructed in this study complements 
the aim of establishing a pump testing facility that could recreate the circulation of a 
CHF patient. The pulsatile pressure and flow rate are controlled by a ventricle 
simulator and the pressure is damped by the compliance effect which is configured 
by the ratio of air and fluid in the air trapped in the compliance tank. The resistance 
valve is used to simulate the vascular resistance before the fluid returns to the 
reservoir that provides the preload to the ventricle simulator. This MCL can be used 
to evaluate the efficiency of the pump prototype created in this study. 
6.1.4 Experimentation evaluation of VAD on human mock circulation loop 
The MCL test was to reproduce the flow condition of both the normal heart and 
failing heart conditions. In both conditions the MCL could closely produce the 
pressure range, flow rate, and pressure waves of a natural heart, although large 
oscillations were observed from the ventricle pressure signal at the end of the systolic 
and diastolic phases. The oscillations were found to be an effect of the bouncing of 
the non-return valves that were forced to close suddenly at high pressure. This could 
be later improved by introducing additional compliance to provide a better damping 
to the flow.  
The pump pressure head – flow rate performance was successfully identified 
under the steady condition and the pump was also tested to verify its performance 
under the pulsatile flow CHF condition. The pump could generate the head pressure 
that raises the mean arterial pressure to the normal level; however, the overall pump 
performance was affected by the unsuitable driving motor so the results are lower 
than the expectation from the CFD prediction. Nevertheless, the tests provide 
sufficient information for the current pump performance under each flow condition 
which could be used for further design refinement. 
With all the design, analysis and experimentation processes, this thesis could 
achieve its aims in providing insight analysis of the BiVAD heart pump by individual 
analysis using CFD simulation. The pump performance was verified in the 
experimentation evaluation that successfully provided the vital information for 
further development in the combination of pump modules for a complete BiVAD. 
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6.2 FUTURE RESEARCH 
The remaining items from this research and suggestions for improvement that 
may lead to expansion of future research are described as follows: 
6.2.1 Pump design 
 According to the simulation results, the pump has a risk of forming 
thrombosis at low pump speed and low flow rate in the RVAD 
function. The design of the right side of the VAD should be further 
optimized for better performance.  
 The pump should be optimised further to increase the flow capacity to 
ensure that the pump can supply enough blood perfusion at a low pump 
speed. 
 The prototype of this pump with a transplant housing can be made for 
particle image velocimetry (PIV) experimentation to verify the flow 
path and possible stagnation in the pump.  
 The current pump results still lack the impeller force evaluation because 
the current magnetic driving mechanism does not allow the installation 
of the sensors. In order to measure the force, another pump prototype 
driven by a shaft must be produced, so that force sensors can be 
attached directly onto the shaft. In addition, it will also allow the pump 
performance to be measured more accurately. 
 With the predicted force from the CFD analysis in this thesis and the 
measured force suggested above, the suspension system can then be 
designed for the pump so that the impeller will be able to levitate within 
the chamber by magnetic/hydraulic force. 
 The pump developed from this research could be used for further study 
with some minor optimization to increase the flow capacity. A more 
durable prototype can be made with bio-compatibile materials like 
PEEK and titanium using the suggested design in Appendix 3-2 for 
further hemolysis study.   
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 With the pump prototype that is produced with the proper 
hemocompatible material, the pump could be tested with real blood to 
verify the blood damage result obtained from CFD analysis.  
6.2.2 Mock circulation loop 
 The oscillation of ventricle pressure can be reduced by introducing 
additional venous compliance or by including the pulmonary system to 
the MCL with a pulmonary compliance tank.  
 This mock circulation loop can be upgraded to the full circulation loop 
with an additional venous and pulmonary compliance tank, right 
atrium, and right ventricle simulator. This will allow the full version of 
the BiVAD prototype to be tested under the bi-ventricular failure 
condition.   
 The motor of the ventricle simulator can be redesigned and replaced 
with a servo motor which will allow a higher degree of control over the 
stroke volume and ejection fraction. 
 The flow meters should be replaced with a meter type that has a high 
enough sampling rate to capture the flow rate change in the pulse 
system and that should be able to measure the reversed flow. A medical 
clamp-on ultrasonic flow meter with a high sampling rate is 
recommended because it has lower resistance to the system and will be 
able to capture the pulsatile flow at high frequency. 
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 Appendices  
Appendix 3-1 
BiVAD Simulation results at the design condition 
Turbulence Kinetic Energy 
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Turbulence kinetic energy distribution found to be highest at the leading edge of all 
the impeller designs. The overall kinetic energy in Impeller II is lowest among the 
designs, however the magnitude is still in the same range and does not have 
significant difference compare to other designs. 
Velocity 
 
The low velocity regions observed at the inlet elbow and near wall of the outlet port 
in all the designs. The overall velocity in the volute of the LVAD side is higher than 
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the RVAD due to higher impeller speed. The velocity is found to be high at the 
region around the impeller and reduced as the fluid flow toward the expansion of the 
outlet port. 
Pressure 
 
The pressure is higher on LVAD than RVAD side in all the design due to the higher 
impeller speed. It can clearly see from the figure that the Impeller I & II has highest 
pressure at the pump outlet follows by Impeller V, while the Impellers III and IV 
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which have lowest number of blade has lowest outlet pressure. This pressure plot 
shows an agreement with the head pressure results in shown in section 3.5.4 of this 
thesis.  
Shear Stress 
 
Shear stress found to be highest at the leading edge of all the impeller designs. 
According to this figure, Design V has the largest region of high shear stress above 
125 Pa which can be related to the highest blood damage as shown in Figure 3-27. 
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Appendix 3-2 
Proposed design of hemocompatible prototype. 
 
 
The modified drawing of VAD for future prototype which will be suitable for the 
experiment with real blood for hemolysis evaluation. This design mainly aim for the 
ease of machining on hard material like Titanium and reducing the manufacturing 
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cost. The chamber was designed to incorporate additional O-rings instead of sealant 
that use on the current prototype to prevent hemo-compatibility issue. 
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Appendix 4-1 
Specification of the equipment: 
Pressure Transducer: GE UNIK5000 
Power supply 7-32 V 
Output 4-20 mA 
Current consumption 4-20 mA 
Frequency response 5 kHz 
Operating Pressure range - guage 70 mbar to 70 bar 
Operating Pressure range - absolute 350 mbar to 700 bar 
Accuracy ±0.5%  
Pressure connector ¼ NPT female 
Flow meter: Measuring sensor Krohne Optiflux 1000 / Signal converter Krohne 
IFC050C 
Power supply 100-230 VAC 
Power consumption 5.6W 
Output 4-20 mA 
Pulse rate  0.01 – 10000 pulse/s 
Measuring accuracy ±0.5% above 0.5 m/s, ±2.5% below 
0.5m/s 
Operating Range  0.03 – 12 m/s 
DAQ I/O module: NI9207 
Number of channels 16 analog input channels: 8 voltage and 8 
current  
ADC resolution  24 bits 
Input range Voltage channels: Min ±10.2 V, Typical 
±10.4V 
Current channels: Min ±21.5 mA, 
Typical ±22.0mA 
Conversion time (per channel) 2ms /52 ms 
Power consumption  295 mW max 
Compact DAQ Chassis: cDAQ9172 
Input voltage range 11 – 30 V 
Maximum required input power  15 W 
Input FIFO size 2,047 samples 
Maximum sample rate 3.2 MS/s (multi-channel, aggregate) 
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Number of channels supported 16 
Maximum output update rate 1.6 MS/s (multi-channel, aggregate) 
Output FIFO size 8,191 samples shared among channels 
used 
Variable speed controller: Invertek Optidrive E2 
Supply voltage 110-115V ± 10% 
200-240V ± 10% 
Supply frequency 48-62 Hz 
Output power 110V 1 Phase Input: 0.5-0.75HP 
230V 1 Phase Input: 1-1.5HP 
Overload Capacity 150% for 60 s, 175% for 2s 
Output Frequency 0-120Hz, 0.1 Hz resolution 
Control Method Single Phase V/F with starting boost 
 
  
  
Appendices 253 
Appendix 5-1 
The plots in this section shows the pressure signals of CHF heart with VAD support 
under different flow rates in the pulsatile flow environment. The pump speed was 
varied from 2500 to 4500 rpm to investigate the pump characteristic as discussed in 
Chapter 5. 
Pump speed = 2500 rpm 
 
‐25
0
25
50
75
100
125
0 1 2 3 4 5P
re
ss
ur
e (
m
m
Hg
)
Time (s)
LVP
AoP
AP
‐25
0
25
50
75
100
125
0 1 2 3 4 5P
re
ss
ur
e (
m
m
Hg
)
Time (s)
LVP
AoP
AP
‐25
0
25
50
75
100
125
0 1 2 3 4 5P
re
ss
ur
e (
m
m
Hg
)
Time (s)
LVP
AoP
AP
‐25
0
25
50
75
100
125
0 1 2 3 4 5P
re
ss
ur
e (
m
m
Hg
)
Time (s)
LVP
AoP
AP
‐25
0
25
50
75
100
125
0 1 2 3 4 5P
re
ss
ur
e (
m
m
Hg
)
Time (s)
LVP
AoP
AP
Q = 0.00 L/min 
Q = 0.83 L/min 
Q = 1.39 L/min 
Q = 1.72 L/min 
Q = 1.88 L/min 
 
 
254 Appendices 
Pump speed = 3070 rpm 
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Pump speed = 3500 rpm 
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Pump speed = 4020 rpm 
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Pump speed = 4500 rpm 
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